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ABSTRACT
Wnt signaling is involved in self-renewal and maintenance of hematopoietic 
stem cells (HSCs); however, the particular role of non-canonical Wnt signaling in 
regulating HSCs in vivo is largely unknown. Here I show Flamingo and Frizzled8, 
members of non-canonical Wnt signaling, both express in and functionally maintain 
quiescent long-term HSCs. Flamingo regulates Frizzled8 distribution at the interface 
between HSCs and N-cadherin+ osteoblasts (N-cad+OBs that enrich 
osteoprogenitors) in the niche. I further show that N-cad+OBs predominantly express 
non-canonical Wnt ligands and inhibitors of canonical Wnt signaling under 
homeostasis. This non-canonical Wnt signaling is attenuated prior to activation of 
HSCs. In the activated HSCs, however, canonical Wnt signaling is enhanced. 
Mechanistically, non-canonical Wnt signaling mediated by Frizzled8 suppresses the 
Ca2+-NFAT- IFNy pathway and antagonizes canonical Wnt signaling in HSCs. My 
findings demonstrate that non-canonical Wnt signaling maintains quiescent long­
term HSCs through Flamingo and Frizzled8 interaction in the niche.
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Chapter 1. Introduction
In this chapter, I will present the hematopoietic stem cell (HSC) and its 
associated cellular components, termed “niches”, and the signals emanating from the 
niches, with a particular emphasis on Wnt signaling.
1.1 Stem Cells
Stem cells are a population of cells with the ability to self-renew and the 
pluripotential or multipotential to give rise to all the different cells in a body 
(embryo) or in a given tissue (adults). The regulation of stem cells is crucial to 
support embryo development, establishment of organs, and homeostasis of tissues in 
the body. The disruption of stem cell regulation often leads to diseases including 
tissue defects or cancer (Perry and Li, 2007; Reya and Clevers, 2005; Yilmaz et al., 
2006a; Zhang et al., 2006). Accumulated evidence reveals that extrinsic signaling is 
important for the maintenance, proliferation, and lineage fate determination of stem 
cells. Among the various types of extrinsic signaling, Wnt signaling is one of the best 
characterized pathways to regulate stem cells (Reya & Clevers, 2005).
1.2 Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are multipotent stem cells that give rise to all 
the blood cell types (Weissman et al., 2001). HSCs are comprised of long-term (LT)- 
HSCs, short-term (ST)-HSCs, and differentiate to multipotent progenitors (MPPs). 
LT-HSCs are enriched with quiescent HSCs and function over 16-44 weeks when 
transplanted to mice. In contrast, ST-HSCs are enriched with actively cycling HSCs 
and can sustain hematopoiesis for only 4-6 weeks, ending up with loss of myeloid 
cells first, followed by loss of lymphoid cells (Benveniste et al., 2010). MPPs are
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transient-amplifying cells and differentiate to either myeloid or lymphoid lineages 
(Larsson and Karlsson, 2005) (Figure 1-1). HSC is the best characterized stem cell, 
and studies of HSCs have revealed new concepts and functions regarding their 
maintenance and regulation. Furthermore, the insights from HSC study can lead to 
improvements in clinical practice, such as bone marrow (BM) transplantation and 
targeting cancer stem cells.
“LSK” (Lineage* Sca1+ c-kit+)in mouse
Lymphoid
V
LT-HSC
ST-HSC
Myeloid
Pro-B Pro-T
▼
Megakaryocyte
Eosinophil 
Neutrophil Basophil
Erythrocyte Platelets Macrophage
B Cell T Cell NKCell
Dendritic Cell
Stem Cell
Multipotent
progenitor
Committed
progenitor
Mature
cells
Figure 1-1 The process of hem atopoiesis in adults.
HSCs give rise to multipotent progenitors (MPPs) which further differentiate to common myeloid 
progenitors (CMPs) and common lymphoid progenitors (CLPs). (Adapted from Larsson & Karlsson, 
2005.0ncogene)
1.3 HSCs in Development, Adult and Aging
Recently it was shown that HSCs are de novo generated from endothelial cells 
located in Aorta-gonad-mesonephros (AGM) at E l0.5 (in mouse) (Boisset et al., 
2010). After E12.5, HSCs migrated to fetal liver where HSCs underwent expansion
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and reached a peak during E15.5-16.5. Around E17.5, fetal HSCs seeded to BM 
(Mikkola and Orkin, 2006). After birth, BM became the main hematopoietic organ 
through the rest of adult life. Under stress, however, HSCs can migrate to spleen or 
potentially to liver and undergo extramedullary hematopoiesis. A portion of HSCs in 
adult mice are in the quiescent state for long-term maintenance, and a portion of 
HSCs are in cycling to support blood production. A regulation of the balance 
between the quiescent and proliferating states of HSCs is critical. Loss of the balance 
can result in either HSC exhaustion or HSC aging. For example, in adult mice (>2 
years), HSCs have a feature of an increased quiescence (cannot be activated) with a 
bias towards myeloid and reduced lymphoid lineages.
The underlying mechanism of HSC aging is actively investigated in the stem 
cell field. A recent report showed that an increase of Cdc42 activity is responsible for 
aging of HSCs. When adult HSCs were treated with Cdc42 inhibitor, they became 
rejuvenated (Florian et al., 2012). Additionally, Eaves and colleagues reported 2 
types of HSCs: a-HSC (lymphoid deficient) and p-HSC (balanced lineage). In fetal 
liver, p-HSC is predominant. In contrast, a-HSC becomes predominant in BM with 
aging (Benz et al., 2012). However, the mechanisms that regulate the transition of 
HSC state and correlation with potential changes in the associated niches are not 
clear.
1.4 The Stem Cell Niche
1.4.1 Stem cell niches in different tissues
In 1978, Ray Schofield proposed a concept of stem cell niche. According to 
this concept, stem cells are not randomly distributed but rather located in a specified 
microenvironment where specific extrinsic signals play a role in maintaining stem
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cells at an undifferentiated state (Schofield, 1978). Another 20 years passed before 
the stem cell niche was identified in 1998 when it was first found in Drosophila 
ovary where germ line stem cells reside (Xie and Spradling, 1998). Our lab together 
with another lab independently identified mammalian HSC niche in BM using 
genetic models. (Calvi et al., 2003; Zhang et al., 2003a). For long-term maintenance 
of adult stem cells, a subset of stem cells needs to be kept in the long-term quiescent 
state in a specialized niche (Arai et al., 2004; Cotsarelis et al., 1990; Haug et al., 
2008; Li and Clevers, 2010; Wilson et al., 2008; Zhang et al., 2003a). Quiescent 
long-term HSCs are mainly located in the endosteum of the trabecular bone region 
(TBR), where HSCs are found directly attached to N-cad+OBs known to enrich 
osteoprogenitors (Wilson et al., 2008; Xie et al., 2009; Zhang et al., 2003a). The key 
signals emanating from this niche to maintain HSC quiescence, however, remain 
largely unknown (Li and Clevers, 2010).
The endosteal bone surface is covered by bone-lining cells which include pre­
osteoblasts and a specific type of macrophages (osteomacs) (Hauge et al., 2001; 
Raggatt and Partridge, 2010). Pre-osteoblasts are derived from mesenchymal stem 
cells (MSCs) and can differentiate into mature osteoblasts to form bone.
1.4.2 Other components of hematopoietic stem cell niches
Recent studies of HSCs have revealed that the endosteal region is a niche to 
maintain quiescent HSCs and that N-cadherin+ bone-lining pre-osteoblasts are one of 
the major components of this niche (Xie et al., 2009; Zhang et al., 2003a). Many 
adhesion molecules and signaling molecules have been reported to affect the 
maintenance of quiescent HSCs in the endosteal niche (Wilson and Trumpp, 2006). 
Once HSCs are activated by extrinsic signaling, they will mobilize from the
15
endosteal niche to central marrow (Levesque et al., 2010). Canonical Wnt signaling 
is one of the factors known to activate HSCs as well as to prompt bone-lining pre­
osteoblasts to differentiate into mature osteoblasts (Malhotra and Kincade, 2009).
MSCs are able to give rise to osteoblasts, chondrocytes, and adipocytes in 
BM (Pittenger et al., 1999). Transplantation of MSCs showed improved engraftment 
of hematopoietic cells, implying that differentiated mesenchymal cells in BM support 
hematopoiesis (Drouet et al., 2005).
Recent reports have identified other niche components in the perivascular 
zone, such as Nestin+ MSCs (Mendez-Ferrer et al., 2010), Leptin receptor* 
perivascular cells (Ding et al., 2012), nonmyelinating Schwann cells (Yamazaki et 
al., 2011), and CXCR12 abundant reticular (CAR) cells (Sugiyama et al., 2006) 
(Figure 1-2). In contrast to the endosteal zone where HSCs are kept in quiescence, 
the perivascular cells maintain HSCs in an active state (Perry and Li, 2012).
However, the molecular mechanisms that regulate the transition of HSCs between 
the endosteal zone and the perivascular zone remain unclear.
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Sinusoid
Nestin
Active
Actively eyeing
CAR
Vasculature Schwann cell
Bone
Endosteal zone I  Perivascular zone
Figure 1-2 HSC n iche in zo n es.
R e se rv e d  HSCs a r e  a d j a c e n t  w i th  N -c a d h e r in + o s t e o b p a s t s  as  well as  CAR cells a n d  N e s t in + cells in t h e  
e n d o s t e a l  z o n e .  Active  HSCs a r e  l o c a t e d  in t h e  p e r iv a s c u l a r  z o n e  w h e r e  s in u s o id a l  e n d o t h e l i a l  cells ,  
Leprin r e c e o p t o r  (Lepr)+ cells , CAR cells a n d  N e s t in + cells ex is t .  (M o d if ie d  f r o m  P e r ry  a n d  Li, 2 0 1 2 .  
EMBO Jo u rn a l )
1.4.3 Bone remodeling and HSC niche in the endosteal zone
Bone is a dynamic tissue that undergoes continual remodeling by osteoblasts 
and osteoclasts. Osteoclasts are terminally differentiated monocytes which remove 
mineralized bone matrix. Osteoblasts are specialized bone-forming cells derived 
from MSCs (Raggatt and Partridge, 2010).
17
One of the questions to address in studying the osteoblast niche is what 
happens to this niche during bone remodeling. Our lab previously has shown that N- 
cadherin is expressed in a specific subset of pre-osteoblasts (N-cad+OBs) (Zhang et 
al., 2003a), to which BrdU label-retaining quiescent HSCs are attached. In my 
preliminary data, N-cad+OBs are quiescent. Their position in TBR and bone-lining 
cell appearance suggests that N-cad+OBs may be located on the “inactive bone 
surface” and do not engage in bone remodeling, but can be activated upon large loss 
of mature osteoblasts (Miller and Jee, 1987). It is interesting to conduct a lineage- 
tracing starting from N-cad+OBs to determine whether they contribute to bone 
remodeling.
1.4.4 Bone remodeling and Wnt signaling
Canonical Wnt signaling is a key pathway in bone formation. The activation 
of p-catenin through co-receptor LRP5/6 induces osteoblast formation and high bone 
mass (Boyden et al., 2002). Non-canonical Wnt signaling regulates commitment of 
MSCs to the osteoblasts (Baksh and Tuan, 2007). In the following sections, I will 
describe molecular components and function of canonical and non-canonical Wnt 
signaling.
1.5 Canonical Wnt Signaling
Wnt signaling plays a central role in many processes during development and 
adult stages of life, and its abnormality is involved in a variety of diseases (Logan 
and Nusse, 2004). Wnt signaling can be broadly categorized as canonical and non- 
canonical (Nelson and Nusse, 2004; Veeman et al., 2003).
In 1982, Nusse and Varmus identified the mouse proto-oncogene Integration 
1 ( Inti) (now designated as Wntl) in the breast tumors of mice infected with mouse
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mammary tumor virus (MMTV). Int was identified as a vertebrate gene near several 
integration sites of MMTV (Nusse and Varmus, 1982). The name of Wnt came from 
Wg (Wingless) and Int in Drosophila. Wg was originally identified as a recessive 
mutation affecting wing and haltere (appendage behind the wing) development in 
Drosophila (Sharma and Chopra, 1976), and then Wg was identified as a homolog of 
Intl. Canonical Wnt signaling controls the stability of p-catenin. In the absence of 
Wnt ligands, a P-catenin degradation complex (comprising two ser/thr kinases: GSK- 
3 and CK-1, and two scaffold proteins: Axin and APC) promotes degradation of p- 
catenin. Wnt receptor, Frizzled, is a family of 7-path transmembrane molecules and 
G-protein coupled receptors. Wnt ligands bind to Frizzled receptors. The lipoprotein 
receptor-related protein (LRP) family is well defined for its role in mediating the 
interaction between canonical-Wnt and Frizzled. When Wnt ligands engage a 
cognate receptor Frizzled along with a LRP 5/6 co-receptor, the Dishevelled (Dvl) 
protein is recruited to the plasma membrane. Dvl is a central component to mediate 
downstream events of both canonical and non-canonical Wnt signaling. Wnt binding 
to Frizzled protein recruits Dvl to the plasma membrane, which leads to activation of 
downstream pathways. Different domains within Dvl, including DIX, PDZ and DEP, 
diverge different downstream pathways (Habas and Dawid, 2005). DIX and PDZ 
domains function together in canonical Wnt signaling to stabilize P-catenin. DIX 
domain binds with Axin and results in inhibition of the p-catenin degradation 
complex in canonical Wnt signaling (Kishida et al., 1999). Phosphorylated p-catenin 
at C-terminal Serine552 by Akt (He et al., 2007) is translocated to the nucleus where 
it interacts with members of the T-cell factor (TCF)/lymphoid enhancer factor (LEF) 
transcription factors to regulate gene expression. The signaling regulates embryo
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body axis and proliferation o f cells (Liu et al., 1999; Pinto et al., 2003). The 
transcriptional targets o f p-catenin-TCF complex include cMyc, Cyclin D and Axin2. 
cMyc and Cyclin D positively regulate cell-cycle. Axin2 is a negative regulator o f 
canonical Wnt signaling (Jho et al., 2002) (Figure 1-3).
beta-catenin 
Degradation Complex C K j j l
Axin
I :| 
GSK3
APC
beta-catenin
U b U b  U b
LRP5/6
Wnt
Frizzled
Dishevelled
G-protein
©
DIX PDZ DEP
Axin "
beta-cateni
GSK3
beta-catenii beta-catenii
beta-catenii
Regulation of Gene Expression
beta-catenin
Figure 1-3 Canonical W nt signaling
In t h e  a b s e n c e  o f  W n t  ligand,  (3-catenin is d e g r a d e d  by a c o m p le x  c o m p o s e d  f r o m  Axin, APC, CK-1 
a n d  GSK3. O n c e  W n t  l igand is b o u n d  w i th  Fz a n d  LRP5/6 c o - r e c e p t o r ,  D ish e v e l led  s c a f fo ld s  |3 -ca ten in  
d e g r a d a t i o n  c o m p le x  r e s u l t in g  in a c c u m u l a t i o n  o f  3 - c a t e n in  in cy to s o l  a n d  n u c l e u s .  3 - c a t e n in  
p h o s p h o r y l a t e d  a t  S552  (He e t  al., 2 0 0 7 )  a n d  t r a n s l o c a t e d  t o  t h e  n u c l e u s  w h e r e  it f o r m e d  a c o m p l e x  
w i th  TCF, Lgs a n d  Pygo t o  t r a n s c r i b e  t a r g e t  g e n e s .  (M o d if ie d  f r o m  S u g im u ra  & Li, Birth D e fe c t  
R e s e a rc h  P a r t  C, 90:  2 4 3 -2 5 6 ,  2010)
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1.5.1 Canonical Wnts
Canonical Wnt ligands include the following: Wnt2 (Sousa et al., 2010), 
Wnt2b (Goss et al., 2009), Wnt3 (Bhat et al., 2010), Wnt3a (Nygren et al., 2007), 
Wnt7a (Ohira et al., 2003), Wnt7b (Wang et al., 2005b), Wnt8a (Lindsley et al., 
2006), Wnt8b (Lee et al., 2006), Wnt9a (Spater et al., 2006), Wnt9b (Lan et al.,
2006), WntlOa (Gelebart et al., 2008), WntlOb (Longo et al., 2004) (Table 1-1).
1.5.2 Canonical receptor Frizzleds
The receptors that mediate canonical Wnt signaling include: Fzl (Bhat et al., 
2010), Fz2 (Li et al., 2008), Fz4 (Planutis et al., 2007), Fz9 (Ranheim et al., 2005), 
FzlO (Wang et al., 2005b) (Table 1-1)
Table 1-1 Canonical Wnt signaling
C anonical W nt ligands
Wnt2 Sousa, 2010
Wnt2b Goss, 2009
Wnt3 Bhat, 2010
Wnt3a Nygren, 2007
Wnt7a Ohira, 2003
Wnt7b Wang, 2005
Wnt8a Lindsley, 2006
Wnt8b Lee, 2006
Wnt9a Spater, 2006 .
Wnt9b Lan, 2006
WntlOa Gelebart, 2008
WntlOb Longo, 2004
C anonical Frizzleds
Fz1 Bhat, 2010
Fz2 Li, 2008
Fz4 Planutis, 2007
Fz9 Ranheim, 2005
Fz10 Wang, 2005
C o-recep to r
LRP6 Mao, 2001
M ediator
Dvl Kinoussi, 2002
GSK-33 Hur, 2010
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Axin Hsu, 2001
APC Nishisho, 1991
CK1a
T ranscrip tion  fac to r
|3-catenin G rass II, 2005
TCF Staal, 2000
LEF DasGupta, 1999
1.5.3 Role of Canonical Wnt signaling in vivo
Canonical Wnt signaling is involved in the regulation of many events such as 
embryonic development, morphogenesis, cell proliferation, and lineage fate 
determination. Wnt3 is expressed in the primitive streak in the early mouse embryo, 
and Wnt3 mutants display gastrulation defects (Liu et al., 1999). Wntl has 
redundancy with other Wnts. For example, Wntl knockout showed deficiency in 
neural crest derivatives, reduction in dorsolateral neural precursors in the neural tube 
(with Wnt3a knockout) (Ikeya et al., 1997), and decline in thymocyte number (with 
Wnt4 knockout) (Mulroy et al., 2002). Wnt7a defect caused female infertility and 
delayed maturation of synapses in cerebellum (Ciani et al., 2011). Wnt7b knockout 
showed placental development defect and respiratory failure (Parr et al., 2001).
1.5.4 Classification of Wnts and Frizzleds
In this study, I have classified Wnts and Frizzleds into canonical and non- 
canonical according to previous literature with in vivo model. Wnt3 and Wnt3a have 
been well characterized as canonical Wnt. Wnt5a, Wnt5b, Wntl 1 and Wntl6 have 
been well characterized as non-canonical Wnts. Some Wnts and Frizzleds can 
function for either canonical or non-canonical depending on tissue context. In this 
case, Wnts and Frizzleds have been classified according to evidence in hematopoietic 
system or cancer. For example, Frizzled8 has been documented as non-canonical
Wnt receptor in chronic myeloid leukemia (CML) (Gregory et al., 2010). In the 
following sections, I will describe non-canonical Wnt signaling.
1.6 Non-canonical Wnt Signaling
1.6.1 Non-canonical Wnt signaling components
1.6.1.1 Ligand-Wnts
Through their efforts to identify homologs of Wntl, Moon and colleagues 
identified Wnt5a in Xenopus, which turns out to regulate non-canonical Wnt 
signaling (Christian et al., 1991). In contrast to canonical Wntl injection which led to 
duplication of the embryonic axis in Xenopus, Wnt5a injection led to developmental 
defects of the head and tail resulting from a perturbation of cellular movements, 
without inducing ectopic axis. This implied that Wnt5a signaling differs from 
canonical Wnt signaling (Moon, 1993). Using zebrafish, Moon and colleagues 
showed that ectopic expression of Xenopus Wnt5a increased intracellular 
concentration of calcium ion (Slusarski et al., 1997). Furthermore, they proved that 
stimulation of calcium signaling phenocopied Wnt5a signaling. Following this 
discovery of non-canonical Wnt signaling, various researchers identified multiple 
contributing Wnt ligands and Frizzled receptors (Table 1-2).
Table 1-2 Ligands of non-canonical Wnt signaling
N on-canonical W nt 
ligands
W ntl You, 2004
Wnt4 Chang, 2007; Heinonen, 2011
Wnt5a Wallingford, 2001
Wnt5b Hardy, 2008
Wnt6 Schmidt, 2007
Wnt11 Flaherty, 2008
Wnt16 Clements, 2011
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Wnt5a is one of the major ligands responsible for non-canonical signaling. In 
addition to embryo development, non-canonical Wnt signaling regulates tissue
development and homeostasis. For example, it recently became known that non-
/
canonical Wnt signaling is involved in regulation of bone formation (Piters et al., 
2008). Osteoblasts derived from MSCs (MSCs) are responsible for bone formation. 
Because MSCs can differentiate to both osteoblasts and adipocytes, regulation may 
be required to balance the lineage choices. PPAR-y and Runx2 transcriptional 
factors are key regulators that determine respectively the lineage fate of MSCs to 
adipocytes or osteoblasts (Sugimura and Li, 2010). How PPAR-y and Runx2 
expression are regulated is an important question. Kato and colleagues showed that 
Wnt5a suppresses transcription of PPAR-y and activates the expression of Runx2 in 
ST2 mesenchymal progenitor cell line (Takada et al., 2007). A mouse model with 
haploinsufficiency of Wnt5a revealed bone loss with enhanced adipogenesis in BM. 
Non-canonical Wnt signaling has been implicated in regulating the balance between 
osteogenesis and adipogenesis through regulation of PPAR-y and Runx2 (Kang et al.,
2007). However, it remains unknown whether and how non-canonical Wnt signaling 
interacts with canonical Wnt signaling. To examine this, Tuan and colleagues asked 
how MSCs in BM are regulated by canonical and non-canonical Wnt signaling 
(Baksh and Tuan, 2007). They showed that Wnt5a is required for the maintenance of 
MSCs under the culture condition mimicking BM niche. In contrast, when MSCs 
were cultured with Wnt5a directly in a plastic dish, MSCs showed enhanced 
osteogenesis. Wnt3a, however, suppressed osteogenic differentiation but favored 
adipogenesis (Boland et al., 2004). Furthermore, canonical Wnt signaling suppressed
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osteogenesis, which indicates opposing aspects of canonical and non-canonical Wnt 
signaling.The evidence has shown a dual role of non-canonical Wnt signaling: to 
maintain MSCs and to induce osteoblastic differentiation.
Since non-canonical Wnt signaling is required for development of many 
organs through regulation of cell motility, signal disruption may lead to organ 
malformation. Indeed, supporting evidence of such has been provided in studies of 
transgenic or knockout mice (Luo et al., 2007; Moon et al., 2004; van Amerongen 
and Bems, 2006). Wntl 1 is required for kidney development, and its knockout 
showed defect of ureteric branching and consequent kidney hypoplasia in newborn 
mice (Merkel et al., 2007). Wntl 1 also regulates migration of Xenopus neural crest 
cells, which are multipotent cells that produce neurons, glial cells, melanocytes, and 
others. Non-canonical Wnt signaling guides this migration to place those cells in the 
proper microenvironments (Matthews et al., 2008). Recent work by Travers and 
colleagues identified that Wntl 6 induces HSC de novo formation in zebrafish 
through somatic expression of Notch ligands deltaC and deltaD (Clements et al., 
2011).
Another ligand of non-canonical Wnt signaling, Wnt4, promotes female 
gonadal development by blocking the synthesis of gonadal androgens in female 
embryos. Interestingly, an XY intersex patient with ambiguous genitalia was found 
to carry a duplication of chromosome lp35 where Wnt4 is located. Transgenic mice 
with a human Wnt4 locus (as an extra copy of Wnt4 locus) showed abnormal 
testicular vasculature, and their testosterone synthesis was inhibited (Jordan et al., 
2003).
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1.6.2 Non-canonical Wnts
Noncanonical Wnts include: Wntl (You et al., 2004), Wnt4 (Chang et al., 
2007; Heinonen et al., 2011), Wnt5a (Wallingford et al., 2001), Wnt5b (Hardy et al.,
2008), Wnt6 (Schmidt et al., 2007), Wntl 1 (Flaherty et al., 2008), W ntl6 (Clements 
et al., 2011).
1.6.2.1 Receptors - Frizzleds
To understand the role of non-canonical Wnt signaling in neurogenesis, 
Nathans and colleagues knocked out both Frizzled3 (Fz3) and Frizzled6 (Fz6), which 
are receptors of non-canonical Wnt signaling (Wang et al., 2006). Fz3 is required for 
axonal outgrowth and guidance of the central nervous system (Lyuksyutova et al., 
2003; Wang et al., 2002). Fz6 regulates hair patterning in skin (Guo et al., 2004). 
Since substantial redundancy in Frizzled genes had been previously reported in 
Drosophila (Bhanot et al., 1999; Chen and Struhl, 1999; Kennerdell and Carthew, 
1998), Nathans et al suspected that Fz3 and Fz6 functionally interact with each other. 
Their double mutant mouse (knockout of Fz3 and Fz6) indeed showed a defect of 
neural tube closure while neither of the single mutants showed the phenotype. This 
suggests that both molecules redundantly regulate neural tube development.
Frizzled regulates development as well as adult tissue homeostasis, e.g. 
cardiac hypertrophy: the thickening of cardiac muscle in response to an increased 
work load. One report showed that Frizzled2 (Fz2) was upregulated during 
development of cardiac hypertrophy (Blankesteijn et al., 1996) Also, re-expression 
of Fz2 in cardiac hypertrophy of genes associated with fetal development has been 
well documented (van Gijn et al., 2002) (Table 1-3).
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1.6.3 Non-canonical Frizzleds
The receptors that mediate non-canonical Wnt signaling include Fz3 
(Rasmussen et al., 2001), Fz5 (van Es et al., 2005), Fz6 (Heinonen et al., 2011), Fz7 
(De Calisto et al., 2005), Fz8 (Gregory et al, 2010)
Table 1-3 Receptors of non-canonical Wnt signaling
N on-canonical Frizzleds
Fz3 Rasm ussen, 2001
Fz5 van Es, 2005
Fz6 Heinone, 2011
Fz7 De Calisto, 2005
Fz8 Gregory, 2010
1.6.3.1 Co-receptor -  Flamingo
Co-receptors for non-canonical Wnt signaling include Flamingo or Cadherin 
EGF LAG 7-path G type receptor (Celsr) 1,2 ,3 and Vangl2 (see Table 1-4).
1.6.4 Function of Flamingo
Recent studies have revealed other types of receptor molecules involved in 
non-canonical Wnt signaling. One of them is the Flamingo family. Flamingo is a 
type of atypical cadherin molecule, which has both cadherin repeat domain and G 
protein-coupled receptor (GPCR) domain, and hence is named Cadherin EGF LAG 
7-path G type receptor (Celsr). Flamingo was initially shown in Drosophila to 
mediate non-canonical Wnt signaling with Frizzled proteins (Usui et al., 1999). The 
functional interaction of Flamingo with Frizzled raises the question whether these 
proteins directly interact with each other. A recent study showed that Flamingo
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indeed binds with Frizzled, and the resulting protein complex mediates non- 
canonical Wnt signaling (Chen et al., 2008). The Flamingo protein family includes 
several isoforms in mammals: Celsr 1, 2, and 3 (Tissir et al., 2002), which have been 
shown to interact with Frizzled proteins (Devenport and Fuchs, 2008; Tissir et al., 
2005) (Table 1-4). Vangl2 is another component of non-canonical Wnt signaling 
shown to interact with Flamingo and Frizzled proteins (Devenport and Fuchs, 2008; 
Tissir et al.).
Table 1-4 Co-receptors of non-canonical Wnt signaling
C o-recep to rs
Celsrl Tisser, 2002
Celsr2 Tisser, 2002
Celsr3 Tisser, 2002
Vangl2 Davenport &Fuchs, 2008
1.6.5 Mechanism of Flamingo function
The functional role of G-protein in Flamingo (Fmi) has not been 
characterized. A recent report showed that the downstream molecular mechanism of 
Flamingo subtype Celsr3 is to regulate intracellular Ca2+ level; however, it was not 
made clear whether G-protein is involved in this process (Shima et al., 2007) (Figure 1-4).
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Figure 1-4 Flamingo signaling
H o m o p h i l ic  b in d in g  o f  Fmi b e t w e e n  e a c h  cell in i t ia te s  s igna ling  t h r o u g h  Fz a n d  V ang l2  t o  e s t a b l i s h  
p o la r i ty  o f  cells.  T h e  c o n t r i b u t i o n  o f  ca lc iu m  is s u g g e s t e d ;  h o w e v e r ,  its e x a c t  lo c a t io n  in d o w n s t r e a m  
p a t h w a y s  is n o t  k n o w n .  (M o d if ie d  f ro m  S u g im u ra  & Li, Birth D e fe c t  R e se a rc h  P a r t  C, 90 :  2 4 3 - 2 5 6 ,  
2010 )
The Flamingo family protein regulates cell polarity through cell-cell contact (Chen et 
al., 2008; Usui et al., 1999). It affects morphogenesis o f neurons and skin 
keratinocytes (Devenport and Fuchs, 2008; Tissir et al., 2005). Goffinet and 
colleagues showed Celsr3 is required for neural growth and neural axon guidance in 
brain development (Tissir et al., 2005). They found Fz3 expressed together with 
Celsr3 in developing neurons. The single knockout o f Celsr3 showed the similar 
phenotype as Fz3 defect, suggesting that Celsr3 and Fz3 function together to guide 
the neural axon. The double knockout o f both Celsr2 and Celsr3 impaired the 
membrane distribution o f Fz3 (Tissir et al., 2010). This implies that Flamingo 
(Celsr2 and Celsr3) may regulate the membrane distribution o f Fz3, which in turn 
mediates non-canonical Wnt signaling.
Fz6 regulates hair patterning in skin, a typical function o f non-canonical Wnt 
signaling initially revealed in Drosophila. Recently, Fuchs and colleagues reported 
that Celsrl is required to establish polarity o f developing hair follicles (Devenport
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and Fuchs, 2008). Celsrl, Fz6 and Vangl2 proteins were asymmetrically localized in 
hair germs. Interestingly, Fz6 required Vangl2 for its asymmetric localization. In 
addition, Celsrl recruited Fz6 to cell-cell contacting sites. This suggested that Fz6 
shares a common pathway with Celsrl and Vangl2. Considering the finding that 
Celsrl forms calcium-dependent intracellular interactions necessary for recruiting 
Vangl2 and Fz6, the researchers proposed that Celsrl homodimer at the adherent site 
of two cells may initiate the hierarchical events leading to an induction of planer cell 
polarity (PCP) components through Vangl2 and Fz6. Thus, Flamingo interacts with 
Frizzled to mediate non-canonical Wnt signaling in a cell adhesion dependent 
manner.
Mechanistically, Fmi proteins homophilically adhere neighboring cells and 
determine the polarized or focal distribution of Frizzled protein on the surface of the 
cell, allowing local interaction with Wnt ligands (Beall et al., 2005; Lee et al., 2003; 
Tissir et al., 2010). Furthermore, Fmi homophilic junction via cadherin domain 
mediates contact inhibition as shown in control of dendrite overgrowth (Kimura et 
al., 2006). Whether Fmi and Fz8 play a role in regulating HSCs has yet to be 
determined.
1.6.6 Dishevelled-JNK pathway
Non-canonical Wnt signaling antagonizes P-catenin-dependent canonical Wnt 
signaling by either or both CaMKII-TAKl-NLK pathway and NFAT-mediated 
transcriptional regulation. CaMKII-TAKl-NLK pathway inhibits P-catenin-TCF 
dependent transcription through phosphorylation of TCF (Ishitani et al., 2003).
NFAT suppresses p-catenin-dependent transcription (Saneyoshi et al., 2002) (Figure
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1-5, Table 1-1). The detailed components and function of the downstream pathways 
will be discussed below.
PDZ and DEP domains of Dvl cooperate in different sub-pathways of non- 
canonical Wnt signaling (Sheldahl et al., 2003). Activation of small GTPases, such 
as Rho and Rac, occurs downstream of DEP. These small GTPases activate JNK to 
regulate cellular polarity (Boutros et al., 1998; Yamanaka et al., 2002) (Figure 1-5). 
There are 3 subtypes of JNK in mammals: Jnkl, 2 and 3. Jnkl is required for 
embryonic eyelid closure (Weston et al., 2003). Mice lacking Jnkl and Jnk2 die 
during embryonic development because of a defect in neural tube closure (Kuan et 
al., 1999). These observations indicate that the JNK pathway regulates migration of 
epithelial and neuroepithelial cells. PDZ domain of Dvl is bound by PCP factors such 
as Dvl associated activator of morphogenesis 1 (DAAM1), Strabismus, Prickle, 
Prader-Willi/Angelman region -  1 (PARI), and Diego (Wallingford and Habas, 
2005).
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Figure 1-5 Non-canonical W nt signaling
T h e  a c t iv a t io n  o f  Fz by W n t  l igand is m e d i a t e d  by D ish e v e l led  o r  h e t e r o t r i m e r i c  G - p ro t e in s .  T h e  
s igna ling  ca n  b e  s e p a r a t e d  in 3 b r a n c h e s .  P la n a r  Cell Po la r i ty  is m e d i a t e d  by  sm all  G T P a se  (R ho  a n d  
Rac), JNK a n d  Cdc42  w h ic h  is a c t i v a t e d  by  PKC. NFAT t r a n s c r ip t io n a l  f a c t o r  is a c t i v a t e d  by  C a2+-  
Ca lc ineu r in  p a t h w a y  t o  r e g u la t e  g e n e  e x p r e s s io n .  Ca lc ium  in d u c e d  CaMKII-TAKl-NLK p a t h w a y  
s u p p r e s s e s  c a n o n ic a l  W n t  s igna ling  by inh ib i t in g  (3-catenin d e p e n d e n t  t r a n s c r ip t io n  ( S e m e n o v  e t  al., 
20 0 7 ) .  (M o d i f i e d  f r o m  S u g im u ra  & Li, Birth D e fe c t  R e s e a rc h  P a r t  C, 90 :  2 4 3 -2 5 6 ,  2010)
1.6.7 Calcium mediated pathways
1.6.7.1 PKC-Cdc42 pathway
As a consequence o f Frizzled activation by Wnt ligand, Frizzled mediates 
activation o f heterotrimeric G-proteins. Activated G-proteins regulate phospholipase
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C (PLC), phosphor di esterase (PDE) and p38 (Ahumada et al, 2002). After 
activation of these components, calcium ion relays signaling via downstream 
pathways as one of the secondary messengers (Kohn and Moon, 2005; Ma and 
Wang, 2007). Increase of intracellular calcium ion activates protein kinase C (PKC) 
(Sheldahl et al., 2003). Then, it regulates small GTPase Cdc42 (Schlessinger et al.,
2007). Small GTPase Cdc42 is the key effector of PCP to remodel actin cytoskeleton 
and shape polarity of cells (Habas et al., 2003; Schlessinger et al., 2009; Schlessinger 
et al., 2007). Cdc42 is activated at the leading edge of migrating cells and provides 
actin-driven protrusions of cells (Etienne-Manneville and Hall, 2001, 2003) (Table 1-5).
Table 1-5 Mediators and transcription factors of non-canonical Wnt signaling
M ediator Function Reference
Dvl Polarity of cells Sheldahl, 2003
JNK Polarity of cells Sheldahl, 2003
Cdc42 Migration of cells Etienne-Manneville,2001
CK1a Suppress NFAT Dejmek, 2006
Calcineurin Angiogenesis Courtwright, 2009
CaMKII Bone formation Takada,2007
Inhibit canonical Wnt Ishitani,2003
TAK1 Antagonize canonical Wnt signaling Ishitani,2003
NLK Antagonize canonical Wnt signaling Ishitani,2003
T ranscrip tion  fac to r Function Reference
NFAT T-cell activation Macian,2005
Bone formation with Osterix Koga,2005
Inhibit canonical Wnt signaling Saneyoshi,2002
1.6.7.2 CaMKII-TAKl-NLK pathway
The increase of calcium ion concentration in cytosol activates 
calcium/calmodulin-dependent kinase II (CamKII). CaMKII induces activation of 
Transforming growth factor-|3-activated kinase 1 (TAK1) and Nemo-like kinase 
(NLK) kinases in Mitogen-activated protein kinase (MAPK) pathway (Ishitani et al.,
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2003). CaMKII is involved in pathogenesis in the heart and brain (Wang et al.,
2005a; Zhang et al., 2003b) (Table 1-5).
1.6.7.3 Calcineurin -  NFAT pathway
Another branch of the calcium ion pathway is calmodulin-mediated activation 
of calcineurin (Saneyoshi et al., 2002). Calcineurin is a protein phosphatase known to 
activate NFAT transcription factor as described below.
1.6.8 Transcription factors
1.6.8.1 NFAT
NFAT alters cellular behavior through regulation of gene expression. The 
activated NFAT translocates to nucleus to regulate multiple processes such as T-cell 
proliferation and differentiation (Macian, 2005). The Calcineurin-NFAT pathway is 
one of the major non-canonical Wnt signaling pathways in vertebrates, and its 
deregulation leads to several diseases. In Down’s syndrome, for example, the Down 
syndrome critical region gene 1 (DSCR1) and Dual specificity tyrosine- 
phosphorylation-regulated kinase 1A (DYR K1 A) genes are not only located in 
trisomy chromosome 21, but also their expression is increased, suggesting a role of 
these genes in Down’s syndrome (Fotaki et al., 2002; Fuentes et al., 2000). Crabtree 
and colleagues found that Calcineurin and NFATc2 and NFATc4 double knockout 
mice had similar phenotypes as human Down’s syndrome, such as defects in 
placenta, and in cardiovascular, neurological, gastrointestinal, skeletal, immune, and 
genitourinary systems (Arron et al., 2006). Mechanistically, increased expression of 
DSCR1 and DYRK1A synergistically prevent nuclear occupancy of NFAT 
transcriptional factors. In addition, NFAT is required for bone formation through
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regulation of osteoblasts. Takayanagi and colleagues found that NFATcl formed a 
complex with transcription factor Osterix in osteoblasts to induce bone formation. 
This observation provided important insight for management of osteoporosis as well 
as bone regeneration in osteogenic diseases (Koga et al., 2005) (Table 1-5).
1.6.9 Non-canonical Wnt signaling in stem cells
1.6.9.1 Hematopoietic stem cells
Recent studies revealed that HSCs contain two subpopulations: dormant 
(quiescent) and active, defined by function. The underlying mechanism that regulates 
these states is not clear. It has been proposed that active HSCs supply differentiated 
hematopoietic cells and support homeostasis. When active HSCs are depleted, such 
as by injury or disease, dormant HSCs function as a reserve pool to replenish active 
HSCs (Benveniste et al.; Elmslie et al., 1995; Haug et al., 2008; Wilson et al., 2008). 
A recent study by Morrison and colleagues knocked out Stem Cell Factor (SCF) in 
the perivascular cells and showed more than 90% loss of HSCs. However, the 
remaining HSCs still had 50% functional capacity (Ding et al., 2012). This suggests 
that the 10% remaining HSCs are a reserve population and are kept in quiescence 
and not affected by loss of SCF. But it is not known how this reserve pool of HSCs is 
maintained.
The function of canonical Wnt signaling is well-characterized in HSCs. f3- 
catenin mediated transcription regulation promotes proliferation of HSCs. However, 
the role of non-canonical Wnt signaling in HSC development and maintenance 
remains largely unknown.
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A recent report showed that knockout of Fz5 disrupted development of yolk 
sac and placenta, which are both primary sites for HSC development (Ishikawa et al., 
2001). Another report showed that non-canonical Wnt signaling via Wntl 1 induced 
hematopoietic cell fate from embryonic stem cells (Vijayaragavan et al., 2009). But 
the downstream event of non-canonical Wnt signaling that induces HSC 
development is not known. Given that NFAT has been shown to regulate HSC 
lineage (Muller et al., 2009), NFAT may be a link in this regard.
Wnt4 is one of the non-canonical Wnt signaling molecules that regulate 
HSCs (Louis et al., 2008). Wnt4 in HSCs activates genes required for cell 
maintenance such as Cxcr4, Meisl, Pten, Ccnd2, Foxol, Foxo4, Hoxa9, HoxalO and 
Hoxb4. Wnt4 inhibits cell-cycle through Cdknlb, Cdknlc, Cdkn2d, Mxdl and Rbl2. 
Wnt4 deficient mice showed low frequency of HSCs in BM, which raised the 
question whether non-canonical Wnt signaling is required to maintain HSCs in BM. 
A recent study by Bodine and colleagues provided evidence to support this idea 
(Nemeth et al., 2007). The researchers cultured HSCs in the presence of non- 
canonical Wnt5a protein. Wnt5a increased short- and long-term HSC repopulation by 
maintaining HSCs in the quiescent GO phase. Also, Wnt5a inhibited Wnt3a-mediated 
canonical Wnt signaling in HSCs. However, this study was conducted only in vitro 
HSC culture, and in vivo function of non-canonical Wnt ligand remains unknown. In 
addition, the responsible receptor for non-canonical Wnt in HSCs is not clear.
Other reports have indicated that non-canonical Wnt signaling is required to 
maintain quiescent HSCs. In mice, deletion of Rac2 (a component of non-canonical 
Wnt signaling) led to enhanced mobilization of HSCs from BM which suggested 
activation of HSCs (Yang et al., 2001). The phenotype was associated with defective
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cell adhesion and increased motility. In Rac2 deficient HSCs, Cdc42 (another 
component of non-canonical Wnt signaling) was upregulated as a compensation, 
which was associated with an increase in HSC motility. Conditional deletion of 
Cdc42 in HSCs showed a decrease of quiescent GO phase and a defect of cell 
adhesion, resulting in impaired interaction between HSC and its endosteal niche 
where HSCs are kept in quiescence. Cdc42 deficient HSCs revealed significantly 
decreased expression of pl-integrin and N-cadherin, which may explain the loss of 
HSC adhesion with the HSC niche. Also Cdc42 deficient HSCs showed a 
significantly decreased p21 level and increased c-Myc level which would activate 
HSC proliferation (Yang et al., 2007). These reports suggest that HSCs are 
maintained in quiescence by non-canonical Wnt signaling; in contrast, canonical Wnt 
signaling activates HSCs (Table 1-6). My study has revealed in vivo function of non- 
canonical Wnt signaling for HSCs by investigating receptors and co-receptors of the 
signaling, Frizzled8 (Fz8) and Flamingo/Celsr2.
1.6.9.2 Skin stem cells
Skin stem cells are located in the bulge of hair follicles and are regulated by 
canonical Wnt signaling. Skin stem cells are activated by |3-catenin-TCF mediated 
regulation of transcription, including activation of CyclinDl and c-Myc, and 
inhibition of Bmp4 and E-cadherin (Alonso and Fuchs, 2003a, b). The function of 
non-canonical Wnt signaling was unknown until recently.
One of the main events downstream of non-canonical Wnt signaling in 
mammals is the regulation of NFATcl. A recent study by Fuchs and colleagues 
showed that NFATcl was required to maintain quiescence of skin stem cells in hair
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follicle (Horsley et al., 2008). NFATcl expression in skin stem cells was activated 
by BMP signaling, which repressed Cdk4 expression. Repression of Cdk4 led to 
inhibition of cell-cycle progress which maintained skin stem cells in quiescence. 
(Table 1-6).
1.6.93 MSCs
MSCs (MSCs) in BM can self-renew and differentiate to other stromal 
components such as chondrocytes, adipocytes and osteoblastic cells (Uccelli et al.,
2008) (Friedenstein et al., 1974; Friedenstein et al., 1976; Friedenstein et al., 1978). 
Wnt signaling plays a key role in regulation of MSCs, and its contribution has been 
studied in both canonical and non-canonical Wnt signaling. Tuan and colleagues 
showed that Wnt3a canonical signaling activated MSCs. Wnt5a non-canonical 
signaling maintained MSCs and induced osteogenesis ex vivo (Baksh and Tuan,
2007). Because MSCs are exposed by dynamic tension in vivo to form tendon or 
ligament tissues, researchers asked whether the same principle applied to in vitro 
culture. They observed regulation of Wnt gene expression with cyclic stimulation of 
tension, which suggested involvement of Wnt signaling during tendon formation 
from MSCs (Kuo and Tuan, 2008). Rubin and colleagues showed that mechanical 
stimulation of MSCs activated both p-catenin and NFATcl through inhibition of 
GSK3p. This resulted in enhancing osteogenesis and inhibiting adipogenesis from 
MSCs. Molecular mechanisms underlying the observation are not yet known; 
however, the researchers indicated that induction of Cox2 by NFATcl may regulate 
osteogenic or adipogenic differentiation of MSCs (Sen et al., 2009). Recent reports 
have suggested that MSCs and their progenies regulate HSCs (Arai et al., 2004;
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Calvi et al., 2003; Mendez-Ferrer et al.; Naveiras et al., 2009; Nilsson et al., 2001; 
Sugiyama et al., 2006; Xie et al., 2009; Zhang et al., 2003a). Non-canonical Wnt 
signaling may be involved in the regulation of the interaction between MSCs and 
HSCs (Table 1-6).
Table 1-6 Stem cell and non-canonical Wnt signaling
Stem cell Gene Function Reference
Hematopoietic Wnt5a Maintain quiescence Nemeth,2007
Wnt4
Wnt11
Fzd5
Maintain quiescence 
Induce
hematopoietic 
lineage from ES 
cells
Yolk sac  and . 
placenta
Louis,2008 
Vijayaragavan,2009
lshikawa,2001
Rac2
development
Regulate
mobilization Yang,2001
Cdc42 Maintain quiescence
Inhibit cell-cycle
Regulate
mobilization
Yang,2007
Skin NFATcl Maintain quiescence Horsley,2008
Mesenchymal Wnt5a Maintain stem cells 
Induce osteogenesis 
Induce tendogenesis
Baksh,2007 
Kuo,2008
NFATcl Induce osteogenesis Sen,2009
Neural Wnt5a
Regulate
dopaminergic
differentiation
Parish,2008
1.6.9.4 Intestinal stem cells
Both the location and signaling regulation of intestinal stem cells (ISCs) have 
been a focus of study in gastroenterology (Scoville et al., 2008). The contribution of 
canonical Wnt signaling has been established in the activation of ISCs (He et al.,
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2007; He et al., 2004a; Sancho et al., 2004); however, the function of non-canonical 
Wnt signaling is not clear. Clevers and colleagues reported that deletion of Frizzled5 
(Fz5) changed the distribution of Paneth cell location in intestinal crypts (van Es et 
al., 2005). However, it is not understood whether non-canonical Wnt signaling 
contributes to this phenotype or whether this phenotype has significance in ISCs.
1.6.10 Non-canonical Wnt signaling in disease
Canonical Wnt signaling has been well characterized as one of the most 
important contributors to tumorigenesis (Reya and Clevers, 2005; Reya et al., 2001), 
and it has been implicated in over 40 types of solid tumors (Giles et al., 2003). 
Secretion of Wnt antagonists (such as DKK-1, Wnt inhibitory factor WIF, and 
sFRPs) is often downregulated in cancer. Many cancer cells show accumulation and 
nuclear localization of P-catenin. Since non-canonical Wnt signaling regulates stem 
cells, it may also play an important role in cancer. As non-canonical Wnt signaling 
maintains quiescence of stem cells and inhibits canonical Wnt signaling, it has been 
considered primarily a tumor suppressor. For example, mouse mammary cell 
transformation by an anti-sense Wnt5a mimicked canonical Wntl-mediated 
transformation (Olson and Gibo, 1998). For another example, ectopic expression of 
Wnt5a in uro-epithelial cancer reverted tumorigenesis (Olson et al., 1997).
However, other studies have indicated a different role for Wnt5a in tumorigenesis. 
Wnt5a was found unexpectedly to be overexpressed in cancers of lung, breast and 
prostate (Iozzo et al., 1995; Lejeune et al., 1995). More recently, it was reported that 
Wnt5a may enhance motility of malignant cells and tumor invasion such as in breast 
cancer, melanoma and gastric cancer (Kurayoshi et al., 2006; Pukrop et al., 2006). 
Trent and colleagues overexpressed Wnt5a in melanoma cells to determine its
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function in tumor progression (Weeraratna et al., 2002). They found that Wnt5a 
increased motility and invasion of melanoma cells. To analyze further, they disrupted 
Fz5, a receptor of Wnt5a, by functional antibody. Disruption of Fz5 reduced 
melanoma invasion associated with inhibition of PKC activation. From Wnt5a 
staining of human melanoma tissues, the researchers found that a strong expression 
of Wnt5a correlated with a higher grade of tumor.
Gastric cancer is the fourth most common malignancy in the world (Parkin, 
2001). To examine the relationship between aggressiveness of gastric cancer and the 
expression of Wnt5a, Kikuchi and colleagues studied 237 human gastric cancer cases 
(Kurayoshi et al., 2006). Expression of Wnt5a was observed in 30% of the cases. The 
intensity of Wnt5a expression correlated with advanced disease and poor prognosis. 
Also, cytosolic or nuclear accumulation of P-catenin was identified in 21% of the 
cases. However, Wnt5a and p-catenin were rarely expressed in the same gastric 
cancer cells, which implies that Wnt5a and P-catenin express in a mutually exclusive 
manner in gastric cancer, or in different stages of cancer. Whereas the contribution of 
P-catenin to tumorigenesis has been well characterized, the function of Wnt5a in 
gastric cancer is not known. When Wnt5a was knocked down in gastric cancer cells, 
cell migration activity was suppressed. Wnt5a activated both focal adhesion kinase 
and small GTP-binding protein Rac, which both play a role in cell migration. Since 
non-canonical Wnt signaling regulates cell motility, it may be that Wnt5a also 
enhances invasion of cancer in its later stages.
Deregulation of non-canonical Wnt signaling has been observed in 
hematologic malignancies. Using a Wnt5a null mice model, Jones and colleagues 
showed expansion and hyperproliferation of myeloid and B lymphocytes leading to
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myeloid leukemia and B-cell lymphomas. (Liang et al., 2003). Wnt5a suppressed the 
expression of Cyclin D1 through the calcium pathway of non-canonical Wnt 
signaling and negatively regulated B-cell proliferation. To determine whether Wnt5a 
expression level is modulated in leukemia patients, researchers have studied the 
DNA methylation status of a Wnt5a promoter in acute lymphoid leukemia patients 
(Roman-Gomez et al., 2007). 43% of patients showed hypermethylation of a Wnt5a 
promoter, suggesting that Wnt5a was inactivated in those patients. Promoter 
hypermethylation of genes inhibiting canonical Wnt signaling (including Wnt5a) 
correlated with decreased rates of disease-free and overall survival (Martin et al.,
2008). This indicates that non-canonical Wnt signaling suppressed leukemogenesis. 
In contrast, another recent study with chronic lymphoid leukemia (CLL) patients 
showed that Wnt5a increased viability of leukemia cells through Receptor-tyrosine- 
kinase-like orphan receptor 1 (ROR1) and NF-kB induction (Fukuda et al., 2008). 
However, in vivo function of Wnt5a in CLL was not elucidated.
Wnt5a plays a role in tumor suppression, part of which may be via 
downregulating canonical Wnt signaling. In contrast, Wnt5a also promotes 
malignancy by enhancing invasion of cancer cells in the later stages of cancer 
(Figure 1-6). This discrepancy may arise from multiple factors regulating Wnt5a as 
well as from observations at different stages of tumor progression.
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Figure 1-6 Dual function of non-canonical Wnt signaling in cancer
Non-canonical Wnt signaling suppresses transformation of cells. However, in late stage cancer, non- 
canonical Wnt signaling enhances invasion of cancer cells which leads to metastasis of cancer. 
(Modified from Sugimura & Li, Birth Defect Research Part C, 90: 243-256, 2010)
Wnt5a is a main focus of study of non-canonical Wnt signaling in cancer. However, 
there are few reports regarding receptors and cytoplasmic mediators of non-canonical 
Wnt signaling in cancer. A recent study by DeGregori shed light on Frizzled8 (Fz8), 
a receptor of Wnt signaling (Gregory et al., 2010). Using shRNA library, researchers 
screened genes which, when inhibited, made chronic myeloid leukemia (CML) cells 
sensitive to imatinib, an inhibitor of Bcr-Abl tyrosine kinase. Although imatinib is a 
highly effective treatment for patients with CML, it is rarely curative because of 
relapse, even in patients that initially show a complete response (Deininger et al., 
2005; Rousselot et al., 2007). This underscores the need to identify targets that will 
cooperatively treat CML with imatinib. From the gene screening, Fz8 was identified 
by three different shRNAs. Ectopic expression of Fz8 was capable of activating P- 
catenin-dependent canonical Wnt signaling when co-expressed with co-receptor 
LRP6 (Liu et al., 2005). However, studies performed in Xenopus implicated that Fz8 
function in p-catenin is independent of Wnt signaling (Wallingford et al., 2001). 
Through screening in CML cells, researchers identified isoforms of both CaMKII
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and PKC, components of non-canonical Wnt signaling. They tested whether Fz8 
mediates non-canonical Wnt signaling in CML cell line K562 by knocking down 
Fz8. K562 was infected with NFAT reporter construct to measure activity of non- 
canonical Wnt signaling. Calcium ionophore ionomycin rescued downregulation of 
NFAT activity when Fz8 was knocked down, suggesting that Fz8 mediated non- 
canonical Wnt signaling through the calcium pathway to regulate NFAT activity. 
Furthermore, the researchers showed that NFATcl protected CML cells from 
imatinib-induced cell death via induction of IL-4 expression. They indicated that 
Fz8-mediated non-canonical Wnt signaling was responsible for imatinib resistance in 
CML.
There is growing body of evidence that interaction between tumor cells and 
the stromal components is crucial for malignant progression (Raaijmakers et al., 
2010). Binder and colleagues co-cultured breast cancer cell lines with macrophages, 
which led to upregulation of Wnt5a (Pukrop et al., 2006). Wnt5a derived from 
macrophages induced invasion of breast cancer cells. The report suggested that 
Wnt5a-mediated non-canonical Wnt signaling contributed to enhanced malignancy 
through interaction with neighboring macrophages. Surprisingly, DKK-1, a well- 
characterized inhibitor of canonical Wnt signaling, antagonized Wnt5a-induced 
invasion of breast cancer cells without affecting p-catenin signaling. Though further 
study is required, this indicates that DKK-1 may regulate Wnt5a-mediated non- 
canonical Wnt signaling (Table 1-7).
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Table 1-7 Diseases and non-canonical Wnt signaling
Cancer Genes
Hematologic malignancy
B-cell lymphoma Wnt5a B-cell lymphoma in null mice
Acute lymphoid leukemia Wnt5a Hypermethylation of Wnt5a promoter in patients
Chronic lymphoid leukemia Wnt5a Increased viability of leukemia cells
Chronic myeloid leukemia Fzd8 Resistance to imatinib
NFAT Resistance to imatinib
Solid tumor
Mammary cell transformation Wnt5a Antisense Wnt5a mimes Wntl-mediated transformation
Uro-epithelial cancer Wnt5a Reverted tumorigenesis
Lung cancer Wnt5a Upregulated expression
Breast cancer Wnt5a Upregulated expression, macrophage-induced invasion
Prostate cancer Wnt5a Upregulated expression
Melanoma Wnt5a Upregulated expression, increased motility
Gastric cancer Wnt5a Increased motility
Other diseases
XY intersex Wnt4 Overexpression inhibited testicular development
Down's syndrome Calcineurin Knockout mice showed phenocopy of human Down's
NFATc Knockout mice showed phenocopy of human Down's
Cardiac hypertrophy Fzd2 Expressed during hypertrophy
NFAT Pathological hypertrophy
CaMKII Activated in hypertrophy
Alzheimer's disease CaMKII CaMKII containing neurons were lost selectively
1.7 My Study in Context of the HSC Field
In the HSC field, it has not yet been made clear how quiescent and active 
HSCs are regulated in the niche. Although Wnt signaling is one of the best 
studied signaling in the field, the functional role of non-canonical Wnt signaling 
has not been identified in vivo. In addition, it has been controversial where 
quiescent HSCs are located in the BM niche. In my study, I have investigated the 
functional role of non-canonical Wnt signaling by studying receptors 
Flamingo/Celsr2 (Fmi) and Frizzled8 (Fz8) expressed in quiescent HSCs.
45
Furthermore, I have analyzed the niche components which facilitate non- 
canonical Wnt signaling.
1.8 Hypothesis
Non-canonical Wnt signaling via its receptors in quiescent HSCs functions to 
maintain HSCs.
1.9 Strategy of My Study
First, microarray analysis of quiescent HSC was done to pick up non-canonical 
Wnt genes. Then, shRNA of each gene was done to see the phenotype in HSCs, 
which was further confirmed by knockout mouse model. Finally, I analyzed the 
cellular mechanism and molecular mechanism of non-canonical Wnt signaling 
function in HSCs (Figure 1-7).
Non-canonical Wnt
Reduction of HSC in vitro 
Reduction of HSC in vivo
Reduction of HSC in vivo 
Loss of quiescence
Analyze the mechanism
Microarray quiescent HSC
shRNA to check phenotype
Confirm phenotype in KO mouse
Interaction with niche 
Downstream pathway
Figure 1-7 Strategy of my study
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Chapter 2. Materials and Methods
2.1 Animals
Both Flamingo/Celsr2+/~ (Tissir et al., 2010) and Frizzled8+/~ (Ye et al., 2011) 
mice were obtained from the Jackson Laboratory (Celsr2tml and Fzd8tm 
respectively) and bred to obtain homozygous mice. Some heterozygous female mice 
were infertile from uterus atresia, and I observed less number of homozygous. H2B- 
GFP mice and SCL-tTA mice were also obtained from Jackson labs (TRE-mCMV- 
H2B-GFP and Tall-tTA respectively). Nestin-GFP and Col2.3-GFP mice were 
kindly provided by Grigori Enikolopov (Cold Spring Harbor Laboratory) and David 
Rowe (University of Connecticut Health Center). CD31-GFP mice were generated in 
our lab, in which we used the CD31-GFP ESCs kindly provided by Dr. Virginia 
Bautch (University of North Carolina). TOP-GAL mice were kindly provided by Dr. 
Elaine Fuchs (Rockefeller University). Axin2-d2EGFP mice were kindly provided 
by Dr. Frank Costantini (Columbia University). All of the mice in this study were 
kept in C57BL/6J background. All mice used in this study were housed in the animal 
facility at the Stowers Institute for Medical Research (SIMR) and handled according 
to SIMR and National Institute of Health (NIH) guidelines. All procedures were 
approved by the Institutional Animal Care and Use Committee (IACUC) of SIMR.
2.2 Flow cytometry
For phenotype analysis, hematopoietic cells were harvested from BM (femur 
and tibia), spleen, and peripheral blood. Red blood cells were lysed using a 0.16M 
ammonium chloride solution. For cell surface phenotyping, a lineage cocktail (Lin, 
PE-Cy5) was used including CD3, CD4, CD8, Mac-1, Grl, B220, IgM, and Terl 19
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(eBioscience,). Monoclonal antibodies against Sca-1, c-Kit, Flk2, CD34, CD150, 
GRP78 (Sigma), CD45.1, and CD45.2 were also used where indicated. Biotinylated 
monoclonal N-cadherin antibody (AbD13077, Toshio Suda, Keio University) and 
streptavidin-PE-Cy7 were used for sorting bone cells. Cell sorting and analysis were 
performed using a MoFlo (Dako), InFlux Cell Sorter (BD Biosciences) and/or CyAn 
ADP (Dako). Data analysis was performed using FlowJo.software.
2.3 Cell-cycle analysis
Cell-cycle analysis of HSCs was conducted with BD PhamingenTM FITC 
Mouse Anti-Human Ki67 Set according to manufacturer’s instruction. The cells were 
further incubated with O.lug/uL DAPI for 30min at room temperature followed by 
flow cytometric analysis with InFlux Cell Sorter (BD Biosciences).
2.4 HSC culture
HSC expansion media (ST + insulin media) consisted of StemSpan SFEM 
media (Stem Cell Technologies) supplemented with 10 pg/ml heparin (Sigma), 0.5x 
Penicillin/Streptomycin (Sigma), 10 ng/ml recombinant mouse (rm) Stem cell Factor 
(SCF) (Biovision) and 20 ng/ml rm (Thrombopoietin) Tpo (Cell Sciences) (Perry et 
al., 201 lb). BM cells were harvested from C57BL/6J (CD45.2) mice and made into a 
single cell suspension by gently passing through a 22g needle 3-5 times. Mouse 
Wnt3a (100 ng/uL, Millipore), mouse Wnt5a (500 ng/uL, R&D), and human Wnt7b 
(100 ng/uL, Novus Biologicals) were added in culture as indicated. The 
concentration of Wnt ligands used was according to a previous report (Nemeth et al., 
2007). NFAT inhibitor (11R-VIVIT, Cell-permeable, Calbiochem) was used in the 
HSC expansion media (luM).
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2.5 Lentivirus construction
The pSicoR-EFla promoter-IRES-EGFP lentiviral construct was kindly 
provided by Dr. Ting Xie (SIMR). CA-NFAT from Addgene (distributed by Anjana 
Rao at Immune Disease Institute) and shRNA for Flamingo and Frizzled8 were 
cloned into Smal site of the construct. The sequences of Flamingo and Frizzled8 
shRNA used were from a previous report (Shima et al., 2004) and from RNAi Codex 
(http://cancan.cshl.edu/cgi-bin/Codex/Codex.cgi).
Flamingo shRNA 1 Fwd:
AGCGCCGTGCATGCGCACACGAAGATTAGTGAAGCCACAGATGTAATCT
TCGTGTGCGCATGCACGA
Flamingo shRNA 1 Rev:
GGCATCGTGCATGCGCACACGAAGATTACATCTGTGGCTTCACTAATCTT
CGTGTGCGCATGCACGG
Flamingo shRNA 2 Fwd:
AGCGCGCTGGCTCTCTGTCTATGATATAGTGAAGCCACAGATGTATATCA
TAGACAGAGAGCCAGCA
Flamingo shRNA 2 Rev:
GGCATGCTGGCTCTCTGTCTATGATATACATCTGTGGCTTCACTATATCAT
AGACAGAGAGCCAGCG
Frizzled8 shRNA Fwd:
AGCGCCCGAATCCGTTCAGTCATCAATAGTGAAGCCACAGATGTATTGAT
GACTGAACGGATTCGGA
Frizzled8 shRNA Rev:
GGCATCCGAATCCGTTCAGTCATCAATACATCTGTGGCTTCACTATTGAT
GACTGAACGGATTCGGG
Scramble shRNA Fwd:
AGCGCCGTGCATGCGCACACGAAGATTAGTGAAGCCACAGATGTAATCT
TCGTGTGCGCATGCACGA
Scramble shRNA Rev:
GGCATCGTGCATGCGCACACGAAGATTACATCTGTGGCTTCACTAATCTT
CGTGTGCGCATGCACGG
2.6 Lentivirus infection
Mice were treated with 150 ug/g body weight of 5FU to activate and enrich 
for HSPCs (Miller and Eaves, 1997). 4 days later, BM was harvested and cultured
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overnight in ST media and transduced by MagnetofectionTM using ViroMag R/L 
particles according to the manufacturer’s protocol (OZ Biosciences).
2.7 Transplantation and Homing assay
Sorted 200 LSK cells and 2x105 rescue BM cells were transplanted for 
Flamingo and Frizzled8 knockout model. Propidium iode staining was used to 
determine viability of sorted LSK. 50% (100) of the sorted LSK cells were alive. 
Transplantation experiments were conducted in the knockdown model using unsorted 
3xl05 infected BM cells (CD45.2). The cells were transplanted into each lethally 
irradiated (lOGy) Ptprc (CD45.1) recipient. Homing assay was performed according 
to a previous report (Zhang et al., 2006). 5x106 BM cells (labeled with CFDA, 
Invitrogen) were injected to each lethally irradiated (lOGy) Ptprc (CD45.1) recipient. 
16 hours post injection, femur and spleen were collected to compare the number of 
CFDA+LSK prior to injection.
2.8 Repopulation assay
16 weeks post transplantation, peripheral blood was collected from 
submandibular vein. The hematopoietic repopulation was measured from donor- 
derived blood cells (CD45.2).
2.9 RNA-sequencing
The RNA-sequencing library was prepared from approximately 200 ng of 
total RNA [CD31-GFP+ (VEGFR2+CD45'Terl 19') cells, Nestin-GFP+ (CD45'CD31‘ 
Terl 19') cells, N-cad+OBs (CD45'CD3 l'Terl 19') and mature OBs Col2.3-GFP+ 
(CD45'CD31'Terl 19')] for each sample using illumina TruSeq RNA Sample Prep 
Kit (Catalog #: FC-122-1001). The fragment size in the generated library ranged
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from 220 to 500 bps with a peak at 280 bps. A total of 10 fmol library fragments 
were loaded to cBot to generate clusters, followed by sequencing on an Illumina 
HiSeq 2000 to produce 10-30 million paired-end 100 bp reads per sample. Reads 
were trimmed to 70bp due to quality, and aligned to mm9 with Tophat 1.3.1 
(Trapnell et al., 2009) / Bowtie 0.12.7(Langmead et al., 2009), using the Ensembl 63 
GTF file for gene models. Parameters were -g 1 —mate-inner-dist 200 —mate-std- 
dev 70 --segment-length 35 —segment-mismatches 2; this allowed for 4 mismatches 
per read (two per read half) and unique alignments only. Gene expression was 
quantitated using Cufflinks 1.0.3 (Trapnell et al., 2010).
2.10 Calcium level assay
BM cells were incubated in PBS/2%FBS containing Fluo-3 (Molecular 
Probes) according to the manufacture’s instruction. Ionomycin (Sigma) was used as a 
positive control to measure intracellular Ca2+ level in LT-HSCs.
2.11 Mitochondrial activity assay
BM cells were incubated in PBS/2%FBS containing Mitotracker Green FM 
(Molecular Probes) according to the manufacture’s instruction. The Mitotracker 
signal was measured by FITC channel in flow cytometry.
2.12 qRT-PCR
Primary HSCs or infected HSPCs were sorted by flow cytometry as described 
above. The cells were lysed, reverse transcribed, and pre-amplified by TaqMan® 
PreAmp Cells-to-CTTM Kit (Ambion) according to the manufacturer’s instruction. 
TaqMan® gene expression assays (Applied Biosystems) were performed on 
triplicate samples using a 7900HT fast real-time PCR system (Applied Biosystems).
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The primer sequences and TaqMan (Applied Biosystems) serial numbers are listed in 
Appendix.
2.13 Production of the recombinant anti-mouse N-cadherin Fab 
antibody
The phage display library, Human Combinatorial Antibody Libraries 
(HuCAL® Gold, AbD Serotech) was used and isolated recombinant Fab against 
mouse N-cadherin (AbD 13077). In brief, HuCAL phage library was screened by 
biopanning using N-cadherin extracellular fragment-Fc fusion protein. After the first 
screening, the ELISA screening, clone sequencing, and QC ELISA with positive and 
negative control proteins were performed. Since N-cadherin binds not only to N- 
cadherin but also R- and OB-cadherins, R- and OB-cadherins-Fc fusion proteins 
were used for the negative controls. Seven Fab clones were obtained that react to N- 
cadherin but not to R- and OB-cadherin. These Fab clones were characterized for 
their availability for flow cytometry using NIH3T3 cell line and mN-cadherin- 
overexpressing Ba/F3 cell line. AbD 13077 was useful for the flow cytometric 
analysis and cell sorting.
2.14 Immunostaining
Paraffin sections of bone were deparaffmized at 600C for 20min. Then, the 
sections were treated with 100% Xylene for 5min twice, 100% Ethanol for 5min,
95% Ethanol for 5min, 70% Ethanol for 5min, water rinse for lmin, followed by 
antigen retrieval with Citrate buffer at 900C for lOmin. Blocking was done with 
Universal Blocking Reagent (BioGenex). The following antibodies were used: 
Flamingo (Celsr2) antibody (rabbit, 1:25, NLS1943, Novus Biologicals), Frizzled8
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antibody (goat, 1:100, NB100-2439, Novus Biologicals), Osterix antibody (rabbit, 
1:100, ab22552, abeam), NFAT antibody (mouse, 1:100, sc-7294, Santa Cruz), 
biotinylated monoclonal N-cadherin antibody AbD 13077 (against mouse N-cad but 
fused with human-Fc, provided by Dr. Toshio Suda, Keio University), GFP antibody 
(chicken, 1:200, abl3970, abeam), pS552-(3-catenin polyclonal antibody (rabbit, 
1:200, Li lab). Secondary staining was done with donkey anti-rabbit AF546, donkey 
anti-mouse AF546, donkey anti-chicken DL488, donkey streptavidin-DL488, donkey 
streptavidin-AF594 and donkey anti-goat DL649 (Invitrogen). Each dilution was 
1:200. For immunostaining of sorted cells, cells were sorted onto lysine-coated 
slides, fixed with chilled methanol for lOmin followed by blocking and staining with 
primary antibody (Ema et al., 2006). For high-resolution 3D images, the Z-stack 
collected images from LSM 510 VIS Confocal Microscopy (Zeiss) were analyzed 
with Imaris software (Bitplane). For H2B-GFPhi LRC image, H2B-GFP mean 
fluorescence intensity (MFI) was >80,000. The population correlated with H2B- 
GFPhi in flow cytometry.
\
2.15 Isolation of endosteal and central marrow hematopoietic stem 
cells
Central marrow cells were isolated from femur and tibia. For endosteal BM 
cells, the edge of femur and rest of flushed bones were collected and ground, 
followed by digestion with collagenase I (3mg/ml) and dispase II (4mg/ml) at 370C 
for 20 min. in a horizontal shaker (Grassinger et al., 2010).
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Chapter 3. Flamingo regulates non-canonical Wnt 
receptor Frizzled8 distribution in quiescent long-term 
HSCs
In this chapter, I will examine the expression of Flamingo/Celsr2 (Fmi) and 
Frizzled8 (Fz8) in HSC subpopulation. Then, I will test whether and how Fmi 
regulates distribution of Fz8 protein on the surface of HSCs.
Xi He previously reported expression of both Celsr2/Flamingo (Fmi) and 
Frizzled (Fz) 8 in quiescent HSCs (Rhodamine10 or Rhl23loLSK) as detected by 
microarray analysis (Akashi et al., 2003). As these non-canonical Wnt receptors were 
highly expressed in quiescent HSCs, I hypothesized Fmi and Fz8 may regulate HSC 
maintenance. To further confirm Fmi expression in HSCs, I compared its expression 
level in long-term (LT)-HSCs (CD34'Flk2'LSK), short-term (ST)-HSCs 
(CD34+Flk2"LSK), and multipotent progenitors (MPPs) (CD34+Flk2+LSK) (Figure 
3-1A-B) (Yang et al., 2005). qRT-PCR analysis revealed that Fmi mRNA level in 
LT-HSCs was 2-fold and 3-fold higher than in ST-HSCs and MPPs respectively 
(Figure 3-1C).
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Figure 3-1 Expression of Fmi and Fz8 in LT-HSCs, ST-HSCs and MPPs
(A) LT-HSCs, ST-HSCs and MPPs with N-cad+OBs in BM. (B) Gating LT-HSCs (CD34'Flk2'LSK), ST-HSCs 
(CD34+Flk2"LSK), and MPPs (CD34+Flk2+LSK). (C) qRT-PCR analysis of Fm i expression in sorted LT-HSCs, 
ST-HSCs, and MPPs in a setting of triplicates. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
I next examined Fmi and Fz expression in quiescent LT-HSCs that were 
identified using H2B-GFP label-retaining cells (LRCs) (Blanpain et al., 2004; Foudi 
et al., 2008; Tumbar et al., 2004; Wilson et al., 2008). H2B-GFP was expressed 
under the control of Doxycycline (Dox)-inducible SCL-promoter/enhancer -tTA, 
which is specific to hematopoietic stem and progenitor cells (HSPCs) (Koschmieder 
et al., 2005). The mice with SCL- tTA driven H2B-GFP were induced and then 
chased for 120 days by long-term Dox feeding, during which time H2B-GFP 
marking was lost from the majority of cycling HSCs (Figure 3-2A). I excluded H2B- 
GFP background signal derived from non-tTA induced animals (Challen and 
Goodell, 2008; Wilson et al., 2008) and set H2B-GFP gate at the high position (H2B-
hiGFP ) (Figure 3-2B, see Figure 3-2C for unchased positive control).
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Figure 3-2 Labeling quiescent HSCs with H2B-GFP
(A) SCL-tTA: H2B-GFP mouse model. H2B-GFP was expressed under SCL-tTA and chased 120 days 
with Dox to wash out label in cycling cells. (B) Controls for H2B-GFP model. H2B-GFP’ (left panel), Scl- 
tTA': H2B-GFP+ (background control, middle panel) and Scl-tTA+: H2B-GFP+ (sample, right panel). (C) 
Controls for H2B-GFP model. Iso (H2B-GFP*, red), chased (brown), and unchased (blue). (Modified 
from Sugimura et al., Cell 150, 351-365, 2012)
I confirmed that Scl-H2B-GFP 'LSKs enriched LT-HSCs 5-fold and had 
fewer (4.8-fold) MPPs compared to Scl-H2B-GFP'LSKs (Figure 3-3A). I further 
sorted Flk2'LSK HSCs (to exclude MPPs) into H2B-GFP' (active) and H2B-GFPhl 
(quiescent) subpopulations (Figure 3-3B). Consistent with a previous report (Wilson 
et al., 2008), I found that CD34 mRNA had a much higher expression in active HSCs 
than in quiescent HSCs (Figure 3-3C). Fmi expression was 12.5-fold higher in 
quiescent HSCs than in active HSCs (Figure 3-3D). Among Fzs, non-canonical Wnt 
receptor Fz8 showed significantly higher (3-fold) expression in quiescent HSCs than 
in active HSCs (Figure 3-3E-F).
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Figure 3-3 Expression of Fmi and Fzs in quiescent HSC and active HSC
(A) Percentage of LT-HSCs, ST-HSCs and MPPs in H2B-GFP1SK (left) and H2B-GFPhiLSK (right). (B) 
Gating H2B-GFP HSCs (Flk2'LSK). (C-E) qRT-PCR analysis of CD 34 (C), F m i (D), Fzs (E) in H2B-GFP'Flk2' 
LSK and H2B-GFPhlFlk2'LSK. (F) qRT-PCR of Fzs in H2B-GFP‘Flk2'LSK (active HSC) and H2B-GFPhiFlk2’ 
LSK (quiescent HSC). (Modified from Sugimura et al., Cell 150, 351-365, 2012)
To confirm Fmi and Fz8 protein expression in LT-HSCs, I immunostained 
sorted LT-HSCs and found that both Fmi and Fz8 were expressed in LT-HSCs 
(Figure 3-4A). The expression of Fmi and Fz8 protein, as revealed by immunoassay, 
was detected in 18% of H2B-GFP' HSCs compared to 70% of H2B-GFPhl HSCs
57
A  Sorted Flamingo 
LT-HSC DAPI
Frizzled8
DAPI
K_t:
a
.6,
Flamingo
Frizzled8
DAPI
i -v -
B H2B-GFP
Flamingo
Frizzled8^;
H2B-GFFhi
Flamingo
Frizzled8
n  o  100-.
O  CO
'(/) 60-
°° 40-
" 1
*  *  *
X
H2B-GF P ' H2B-GFP hl 
n=25 n=27 cells
! CD34 Flk2 LSK
Iso CD
i—i 111
CD34 CD150
merge
i
CD15tf GD34 Flk2 LSK
Flamingo I  Frizzled8
Figure 3-4 Expression of Fmi and Fz8 in HSC subpopulations
(A-B) Immunostaining Fmi and Fz8 in sorted LT-HSCs (A) and H2B-GFP HSCs (B). Endogenous H2B-GFP 
signal diminished by methanol fixation for further immunostaining. (C) Percentage of Fmi and Fz8 
expressed in sorted H2B-GFP HSCs. (D) Fmi and Fz8 immunostaining of CD150+CD34'Flk2-LSK. 
(Modified from Sugimura et al., Cell 150, 351-365, 2012)
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(Figure 3-4B-C). I also detected the expression of Fmi and Fz8 in CD150+CD34' 
Flk2'LSK HSCs (Figure 3-4D). I used a recently reported hypoxic-related HSC 
marker GRP78 (Miharada et al., 2011) and detected Fmi and Fz8 expression in 
GRP78+CD34‘LSK HSCs as well (Figure 3-5).
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Figure 3-5 Expression of Fmi and Fz8 in HSC subpopulations
qRT-PCR for Fmi and Fz8 comparing GRP78+CD34‘LSK and GRP78-CD34-LSK. (Modified from Sugimura 
et al., Cell 150,351-365,2012)
Fmi has been reported to determine the cellular distribution of Frizzled 
protein (Devenport and Fuchs, 2008; Tissir et al., 2010). I confirmed this by 
overexpressing Fmi and Fz8 fused with fluorescent proteins in 293T cells. I found 
that Fz8 distributed randomly when Fmi was not expressed; however, Fz8 was 
restricted to the site where Fmi was present (Figure 3-6A). To ascertain whether Fz8 
distribution in HSCs was determined by Fmi, I used an in vitro culture system of 
HSCs with OP9, an osteoprogenitor cell line (Mahmood et al., 2011; Nakano et al., 
1994). (Figure 3-6B). Immunostaining showed that Fmi was present at the interface
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Figure 3-6  Fmi reg u la tes  Fz8 localization  in HSC
(A) Fmi re s t r i c t s  Fz8 p r o t e in  d i s t r ib u t io n  in 2 9 3 T  cells.  (B) OP9 o s t e o p r o g e n i t o r  cells e x p r e s s  Fmi, IN- 
cad ,  O s te r ix  a n d  Runx2. (C) I m m u n o s t a in in g  Fmi in s o r t e d  LSK cells (GFP la b e le d )  a n d  OP9 
o s t e o p r o g e n i t o r s .  (D-G) 3 D - im a g e s  o f  Fz8 im m u n o s t a i n i n g  o f  LSK cells o n  OP9. Scale  b a r  is 5 u M .  (H) 
Fmi in OP9 a lso  re s t r i c t s  Fz8 d i s t r ib u t io n  a t  t h e  i n t e r f a c e  b e t w e e n  LSK a n d  OP9, a n d  a f fe c t s  n u c l e a r  
vs. c y to p l a s m ic  loca l iza t ion  o f  NFAT. (I) Fz8 d o e s  n o t  r e s t r i c t  Fmi d i s t r ib u t io n  a t  t h e  i n t e r f a c e  
b e t w e e n  LSK a n d  O P9. (M o d if ie d  f ro m  S u g im u ra  e t  al., Cell 150 ,  3 5 1 -3 6 5 ,  20 1 2 )
between sorted LSK (labeled with GFP) and OP9 cells (Figure 3-6C). When Fmi was 
knocked down, the distribution o f Fz8 protein became random (Figure 3-6D-E). In 
addition, lack o f Fmi in OP9 also resulted in random distribution o f Fz8 in LSK cells 
(Figure 3-6F-H), suggesting that homophilic interaction between two Fmi located in 
adjacent HSC and OP cells functions to restrict Fz8 at the HSC-OP9 interface. In
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contrast, knockdown of Fz8 in LSK did not affect Fmi protein distribution at the 
HSC-OP9 interface (Figure 3-61). These results show that Fmi and Fz8 are both 
expressed in quiescent, long-term HSCs and that Fmi restricts Fz8 distribution at the 
interface between HSCs and osteoprogenitors in vitro.
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Chapter 4. Flamingo and Frizzled8 co-localize 
predominantly at the interface between quiescent LT- 
HSCs and N-cad+OBs in the TBR
In this chapter, I will examine where Fmi and Fz8 co-localized between quiescent 
HSCs and niche components.
I conducted immunostaining of Fmi and Fz8 with H2B-GFPhl label-retaining 
quiescent HSCs and niche reporters with GFP. I next confirmed in vitro observation 
of the Fmi and Fz8 co-localization in vivo. Since HSCs tend to home to the TBR 
(Figure 4-1A-B) rather than the compact bone region (CBR) (Xie et al., 2009), I 
examined the distribution of Fmi-Fz8 co-expressing LT-HSCs in different bone 
regions, including the TBR and the CBR (Figure 4-1B). I sorted LT-HSCs (CD34' 
Flk2'LSK) and immunostained with anti-Fmi and anti-Fz8 antibodies (Figure 4-1C- 
D). I detected a majority (67%) of LT-HSCs derived from the TBR, but only 31% of 
those from the CBR expressed both Fmi and Fz8 (Figure 4-1E).
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Figure 4-1 Distribution of Fmi and Fz8 expressing HSCs in bone
(A) HSC and niche components N-cad+OBs, Nestin+-MSCs, and endothelial cells (CD31+). (B) Femur 
sagittal section showing TBR and CBR, (C-D) Sorted LT-HSCs from TBR (C) and CBR (D) and 
corresponding immunostaining of Fmi and Fz8. (E-F) Percentage of LT-HSCs (E) and H2B-GFPhl LRCs in 
total nuclear cell (TNC) (F) expressing both Fmi and Fz8 from TBR and CBR. (Modified from Sugimura 
et al., Cell 150,351-365, 2012)
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I next determined the distribution of quiescent LT-HSCs in the sagittal 
section of the femur. I identified quiescent LT-HSCs using the Scl-tTA-induced 
H2B-GFPhi LRCs (H2B-GFPhiLRCs) (Blanpain et al., 2004; Foudi et al., 2008; 
Tumbar et al., 2004; Wilson et al., 2008), and I compared the distribution of 
quiescent LT-HSCs between the TBR and the CBR (Figure 4-1F, 4-2A-B). Flow 
cytometry analysis showed the frequency of quiescent HSCs (H2B-GFPhl LRCs) was 
more than 3-fold higher in the TBR than in the CBR (Figure 4-IF). Immunostaining
Hiconfirmed this observation, revealing H2B-GFP LRCs mainly in the TBR but not in 
the CBR endosteum (Figure 4-2A-B).
I then examined the correlation between the distribution of quiescent LT- 
HSCs (H2B-GFPhlLRCs) and the distribution of niche components known to regulate 
HSCs, including endothelial cells, Nestin+ MSCs, and N-cad+OBs (Kiel et al., 2005; 
Mendez-Ferrer et al., 2010; Wilson et al., 2008; Xie et al., 2009; Zhang et al., 2003a) 
(Figure 4-1A, 4-2D-P). Using a CD31-GFP endothelial reporter (established in our 
lab) and Nestin-GFP reporter (Mignone et al., 2004), I found that CD31-GFP+ 
endothelial cells and Nestin-GFP+ cells were distributed in both TBR and CBR 
without bias (Figure 4-2D-E, 4-2G-H). In contrast, N-cad+OBs were predominantly 
detected in the TBR but rarely in the CBR (Figure 4-2J, L). The anti-N-cad 
monoclonal antibody (AbD13077) was newly generated by Suda’s lab, and its 
specificity was confirmed by loss of N-cad staining in the N-cad knockout mice 
(Figure 4-2K, R). I detected expression of Fmi and Fz8 in N-cad+OBs mainly in the 
TBR endosteum (yellow arrow, compare Figure 4-2J, N to 4-2L, O).
Next I compared the relationship between Fmi and other niche markers 
(Figure 4-2C, F, I, M, P, Q). I found that Fmi expression as shown by
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immunostaining was almost absent in CD31-GFP+ endothelial cells, low in Nestin- 
GFP+ cells (Figure 4-2F, I, Q), and high in N-cad+OBs (Figure 4-2M, Q). Fz8 was 
also expressed in N-cad+OBs (Figure 4-20-P). Notably, I detected Fmi and Fz8 at 
the interface between H2B-GFPhlLRCs and N-cad+OBs in the TBR endosteum 
(Figure 4-2C, P), supporting a role o f Fmi and Fz8 in mediating a niche signal to 
regulate quiescent LT-HSCs.
TBR CBR
Nestin-GFP
Fmi
Nestin-@FP
n=10 im ages
r  Mx1-Cre-: N-cadm Mx1-Cre+: N-cadF"
Figure 4-2 Distribution of quiescent HSCs and niche components
(A-P). Im m unostain ing  o f TBR and CBR w ith  d iffe re n t HSC or niche co m p o n en t m arkers. (A-B) H2B- 
GFP ' LRCs representing  quiescent LT-HSCs. H2B-GFP signal was m easured using m ean fluorescence  
in tensity  (M F I) and M FI o f H2B-GFPhl LRCs was fo u n d  to  be > 8 0 ,0 0 0  (u M 2). (D-E) CD31-GFP as 
en do the lia l rep o rte r. (G -H) Nestin-GFP as MSC rep o rte r. (J-L) N-cad staining, Fmi staining. (N -O ) N- 
cad staining, Fz8 staining. (K) N-cad conditional knockout. Scale bar is 2 0 u M . For en larged im ages (C, 
F, I, M , P), scale bar is 5 u M . (Q) Percentage o f niche com ponents expressing Fmi. Q u an tified  fro m  
m icroscopy im ages. n=10 im ages. (R) N-cad staining fo r  M xl-Cre  :N -caJ  fx and M xl-C re+:N-cadf . 
(M o d ifie d  fro m  Sugim ura et al., Cell 150, 3 5 1 -3 6 5 , 20 1 2 )
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The co-localization of Fmi and Fz8 was observed in H2B-GFPhl LRCs 
attached to the bone surface of TBR (Figure 4-3 A), which was further confirmed by 
consecutive sections revealing this co-localization at the interface between H2B- 
GFPhl LRCs and N-cad+OBs (Figure 4-3B). I took a 4-color 3D high-resolution 
image (Figure 4-3C) to confirm the in vivo co-localization of Fmi (red) and Fz8 
(green) at the interface between H2B-GFPhl LRCs (white nucleus) and N-cad+OBs 
(blue). In addition, I used OP9 assay and observed the co-localization of Fmi and Fz8 
at the interface between sorted H2B-GFPhl Flk2‘LSKs and OP9 cells (Figure 4-3D) 
as well as sorted LT-HSCs and OP9 cells (Figure 4-3E). This co-localization was 
observed neither in H2B-GFP"Flk2'LSKs (Figure 4-3D) nor in ST-HSCs (Figure 4- 
3E). Presumably, this was due to lower expression levels of Fmi and Fz8 in these 
cells. In summary, quiescent LT-HSCs are found more in the TBR than in the CBR. 
Fmi and Fz8 are co-localized at the interface between quiescent LT-HSCs and N- 
cad+OBs.
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Figure 4-3 Co-localization of Fmi and Fz8 in quiescent HSCs
(A) C o- loca l iza t ion  o f  Fmi a n d  Fz8 a t  t h e  in t e r f a c e  b e t w e e n  H2B-GFPhl LRC a n d  e n d o s t e u m  o f  TBR. (B) 
C o- loca l iza t ion  o f  Fmi a n d  Fz8 a t  t h e  in t e r f a c e  b e t w e e n  H2B-GFP LRCs a n d  N -cad +OBs in s u b -  
s e q u e n t i a l  s e c t io n s .  (C) H ig h - re s o lu t io n  3D im a g e s  o f  H2B-GFPhl LRC (w h i te ,  M F I= 1 2 2 ,0 0 9  u M 2), Fmi 
( red) ,  Fz8 (g re e n )  a n d  N-cad (b lue)  in TBR. Co-loca l iza t ion  o f  Fmi a n d  Fz8 a t  t h e  i n t e r f a c e  b e t w e e n  
H2B-GFPhl LRCs a n d  N -cad+OBs (w h i t e  a r ro w ) .  (D) H ig h - re s o lu t io n  3D im a g e  o f  s o r t e d  Flk2‘H2B- 
GFPhlLSK a n d  Flk2’H2B-GFP"LSK o n  OP9 cells.  C o- loca l iza t ion  o f  Fmi a n d  Fz8 a t  t h e  i n t e r f a c e  b e t w e e n  
Flk2"H2B-GFPhlLSK a n d  OP9 cells (ye l low  a r ro w ) .  (E) C o- loca l iza t ion  o f  Fmi a n d  Fz8 a t  t h e  i n t e r f a c e  
b e t w e e n  LT-HSC a n d  O P9 cells,  b u t  n o t  b e t w e e n  ST-HSC a n d  OP9 cells.  (M o d if ie d  f r o m  S u g im u ra  e t  
al., Cell 1 5 0 , 3 5 1 - 3 6 5 ,  20 1 2 )
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Chapter 5. N-cad+OBs and HSCs maintain non- 
canonical Wnt signaling during homeostasis, but are 
attenuated in response to stress
In this chapter, I will analyze which Wnt ligands are produced from each 
niche component using RNA-sequencing technology. Also, I will analyze the 
dynamic change of Wnt ligand expression patterns in the niche following stress.
Fmi and Fz8 have been shown to mediate non-canonical Wnt signaling, 
which in turn suppresses canonical Wnt signaling (Morgan et al., 2003). Apama 
Venkatraman used RNA-sequencing analysis to examine the expression patterns of 
ligands and inhibitors for canonical and non-canonical Wnt signaling in the niche 
components, including CD31+VEGEFR2+ cells (endothelial progenitor cells), 
Nestin-GFP+ MSC-like cells, N-cad+ OBs, and Col2.3-GFP+ mature OBs (Kalajzic et 
al., 2002; Lyden et al., 2001; Mendez-Ferrer et al., 2010; Xie et al., 2009; Zhang et 
al., 2003a) (Figure 5-1A). Expression level was measured by Fragments per Kilobase 
of exon per Million fragments mapped (FPKM) (Trapnell et al., 2010). Expression of 
canonical Wnt ligands overall was either absent or low (3-6 FPKM) in all three niche 
components (Figure 5-1B, Table 5-1). There were expressions of Wnt2b and Wnt7b 
only in N-cad+OBs; Wnt9a in both N-cad+OBs and mature OBs; and WntlOb in 
Nestin-GFP+, N-cad+OBs, and mature OBs (Figure 5-1B). In contrast, expression of 
canonical Wnt inhibitors was much higher (15-168 FPKM) and mainly in Nestin- 
GFP+ cells, N-cad+OBs, and mature OBs, with N-cad+OBs expressing the highest 
levels. For example, expressions of Sfrp4 and Dkk3 were 6 and 5 times higher 
respectively in N-cad+OBs than in Nestin-GFP+ cells. Wifi expression in N-cad+OBs
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was 6.5-fold and 1.6-fold higher than in CD31+VEGEFR2+ and Nestin-GFP+ cells 
respectively (Figure 5-1C). Wifi as a non-canonical Wnt inhibitor was 2- and 5-fold 
higher than DkkS and Sfrp4 respectively in Nestin+ cells, suggesting a favored 
canonical Wnt environment maintained by Nestin+ cells (Hsieh et al., 1999). In 
contrast, Sfrp4, a canonical Wnt inhibitor, was 3-fold higher than Wifi in N-cad+OBs 
(Figure 5-1C), suggesting a dominant non-canonical Wnt signaling in N-cad+OBs.
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Figure 5-1 RNA-sequencing of niche com ponents for Wnt genes
(A) BM section with CD31-GFP (green), Nestin-GFP (green), N-cad+OBs (green), and Co!2.3-GFP 
(green) respectively. We used FACS to sort these cells [CD31-GFP+ (VEGFR2+CD45’T e rll9 ‘) cells, 
Nestin-GFP (CD45‘CD31'Terll9') cells, N-cad+OBs (CD45'CD31'Terll9') and mature OBs Col2.3-GFP 
(CD45’CD31’Terll9 ').] and analyzed with RNA-sequencing. (B-D) RNA-sequencing analysis of niche 
components for canonical Wnts (B), canonical Wnt inhibitors (C), and non-canonical Wnts (D). 
Expression level was shown by FPKM (Fragments per Kilobase of exon per Million fragments 
mapped). CD45: hematopoietic cell marker, CD31: endothelial cell marker, T e rll9 : red blood cell 
marker (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Table 5-1 RNA-sequencing FPKM value of niche components
Canonical W nt ligands in niche com ponents
CD31-GFP
(VEGFR2+)
Nestin-GFP
(CD31-)
N-cad+OB Total OB
Wnt2 0.09 0.11 0 0.13
Wnt2b 0.41 0.4 3.39 0.84
Wnt3 0 0 0 0
Wnt3a 0 0 0 0
Wnt7a 0 0 0 0
Wnt7b 0 0.76 3.62 1.08
Wnt8a 0 0.03 0 0.14
Wnt8b 0 0.03 0 0
Wnt9a 0.82 0.98 4.68 2.59
Wnt9b 0.34 0 0 0
Wnt10a 0 0.11 0.28 0
Wnt10b 0.24 2.77 4 5.79
Non-canonical Wnt ligands in niche components
CD31-GFP
(VEGFR2+)
Nestin-GFP
(CD31-)
N-cad+OB Total OB
Wnt1 0.03 0.03 0.09 0.05
Wnt4 0.59 12.7 4.29 16.6
Wnt5a 0.43 7.4 13.8 6.6
Wnt5b 4.31 41.4 18.8 17.4
Wnt6 0 0.09 3.22 0.13
Wnt11 0.53 37 9.76 27.1
Wnt16 0.07 1.17 10.7 8.64
Canonical Wnt inhibitors in niche components
CD31-GFP
(VEGFR2+)
Nestin-GFP
(CD31-)
N-cad+OB Total OB
Sfrpl 1.02 2.73 8.58 4.07
Sfrp4 5.27 26.3 168 79.1
Dkk1 0.05 0.51 0.92 0.51
Dkk3 1.25 10 54.6 25.7
Wifi 14.6 56.4 98 62.6
In summary, canonical Wnt ligands were generally expressed at low levels, 
and their activity was most likely suppressed by very high levels of inhibitors (Figure 
5-1B-C). Non-canonical Wnt ligands overall were expressed at comparable levels in 
Nestin-GFP+ cells, mature OBs, and N-cad+OBs, except for Wnt6 and Wntl6 which 
were predominantly expressed in N-cad+OBs (Figure 5-ID). CD31+VEGEFR2+
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endothelial cells expressed low level Wnt5b (Figure 5-ID). These observations 
suggest that the N-cad+OB niche provides a microenvironment in which canonical 
Wnt signaling is suppressed and non-canonical Wnt signaling is predominant in 
homeostasis.
N-cad+OBs in the TBR have been implicated in maintaining quiescent HSCs 
as evidenced by their physical location adjacent to BrdU+ LRCs, H2B-GFPhl LRCs, 
and transplanted HSCs (Arai et al., 2004; Wilson et al., 2008; Xie et al., 2009; Zhang 
et al., 2003a). During stress, however, quiescent HSCs can be activated and undergo 
expansion. For example, expansion of N-cad+OBs precedes the activation and 
subsequent expansion of HSCs (Dominici et al., 2009) (Figure 5-2A-B). I therefore 
compared the change in expression levels of canonical and non-canonical Wnt 
ligands and inhibitors in N-cad+OBs under 5FU-induced BM (BM) stress. Four days 
post 5FU treatment, I found that N-cad+OBs were resistant to 5FU treatment and 
subsequently expanded (more than 5-fold increase in both frequency and number in 
bone) (Figure 5-2C-E). In contrast, N-cad'OBs were sensitive to 5FU treatment and 
significantly declined -7-fold post treatment (Figure 5-2C). This result suggests that 
N-cad+OBs are normally in a quiescent state and thereby resistant to 5FU treatment.
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Figure 5-2 Changes in N-cad*OBs post 5FU
(A-B) Immunostaining of TBR with N-cad (green), OB marker Osterix (Osx) (red) and DAPI (blue) in 
control (A) and 4 days post 5FU treatment (B). Scale bar is 20uM. (C) Flow cytometric analysis of the 
change in percentage of N-cad+ OBs in total OBs without or with 5FU treatment. The cells were gated 
from Col2.3GFP+CD45'CD3rTerll9‘ OBs. (D-E) Frequency (D) and number (E) of N-cad+OBs in bone 
cells post 5FU. (F-H) qRT-PCR for non-canonical Wnts (F), inhibitors of canonical Wnt (G) and 
canonical Wnts (H) among N-cad+OBs and N-cad’OBs with or without 5FU. (Modified from Sugimura 
et al., Cell 150,351-365, 2012)
The correlation between an increase in N-cad+OBs (Figure 5-2C-E) and 
activation and expansion of HSCs (Dominici et al., 2009) post 5FU treatment 
suggested that 5FU could also induce dynamic changes in the expression of Wnt 
ligands in N-cad+OBs. To test this idea, I sorted N-cad+OBs and N-cad"OBs with or 
without 5FU treatment and examined the expression of Wnt ligands and inhibitors 
using qRT-PCR (Figure 5-2F-H). I found that non-canonical ligands Wnt 11 and 
Wnt 16, as well as canonical Wnt inhibitors Dkkl and Sfrp4, were diminished (Figure 
5-2F-G, 5-3). However, canonical Wnt7b increased 6-fold post 5FU treatment 
(Figure 5-2H). These observations show that 5FU treatment leads to a decline of 
non-canonical Wnt signals but an increase in canonical Wnt signaling via 
upregulation of canonical Wnts and downregulation of inhibitors.
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qRT-PCR of N-cad, non-canonical Wnt ligands, canonical Wnt inhibitors, and canonical Wnt ligands in 
N-cad+OBs, N-cad'OBs with or without 5FU. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
Next, I investigated the impact of 5FU on Fmi and Fz8 in HSCs. I isolated 
LT-HSCs (CD34'Flk2'LSK) from TBR and CBR (Figure 5-4A) and used
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immunostaining to compare the co-localization of Fmi and Fz8 before and after 5FU 
treatment (Figure 5-4C). Observing Fmi and Fz8 co-localization post 5FU by high- 
resolution 3D image (Figure 5-4B), I found an ~8-fold decline in Fmi-Fz8 co­
localization in LT-HSCs from TBR and a 2-fold decline of that in CBR (Figure 5- 
4D). This observation was explained by the reduction of both Fmi and Fz8 mRNA in 
LT-HSCs post 5FU. In addition, Fz8 protein (Figure 5-4G-H) and mRNA (Figure 5- 
41) were reduced by 50%, and Fmi mRNA was increased by 20% in N-cad+OBs post 
5FU (Figure 5-41). The data indicate that non-canonical Wnt receptors Fmi and Fz8 
are reduced in LT-HSCs post 5FU treatment.
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Figure 5-4 5FU-induced change of Fmi and Fz8 expression in HSC and niche
(A) Isolation of LT-HSCs from TBR and CBR. TBR was removed first, then BM was flushed. (B) 3D con- 
focal image of Fmi and Fz8 co-localization in LT-HSCs. (C) Representative flow panels and image of 
Fmi and Fz8 co-staining of LT-HSCs from TBR (upper left), central marrow of CBR (lower left), TBR 4 
days post 5FU treatment (upper right), and central marrow of CBR 4 days post 5FU (lower right); Fmi 
(red), Fz8 (green), and DAPI (blue). (D) Percentage of Fmi and Fz8 co-localization in LT-HSCs from TBR 
(white), central marrow of CBR (black), TBR 4 days post 5FU treatment (smaller dots), and central 
marrow of CBR 4 days post 5FU (larger dots). n=18, 22, 45, 36 cells. (E-F) Fmi expression level (E) and 
Fz8 expression level (F) in LT-HSCs 4 days post 5FU. (G-H). Fmi and Fz8 immunostaining of TBR in 
control (G) and 4 days post 5FU (H). (I) qRT-PCR for Fmi and Fz8 in N-cad+OB post 5FU. (Modified 
from Sugimura et al., Cell 150, 351-365, 2012)
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Next, I asked whether 5FU induced a reduction of non-canonical Wnt 
signaling and subsequent upregulation of canonical Wnt signaling in LT-HSCs 
(Figure 5-5A). As the Ca2+-NFAT pathway is one of the major molecular 
downstream events of non-canonical Wnt signaling in adult tissue (Dejmek et al., 
2006; Gregory et al., 2010), I measured intracellular Ca2+ level by Fluo-3 (Minta et 
al., 1989). LT-HSCs post 5FU treatment showed a 2.5-fold increase of intracellular 
Ca2+ level (Figure 5-5B) and an 8-fold increase ofNFATcl nuclear translocation 
(Figure 5-5C). The downstream target genes of NFAT, IFNy and Cox2, were 
upregulated 6- and 2-fold respectively in LT-HSCs post 5FU treatment (Figure 5- 
5D). I also examined IFNy expression in cytotoxic T cells and regulatory T cells 
(Treg cells) that were recently reported to be a niche component (Treg, CD4+CD25+) 
(Fujisaki et al., 2011) (Figure 5-5E). Notably, IFNy expression was upregulated in 
Treg cells but not in cytotoxic T cells (Figure 5-5E), indicating sources of IFNy 
include both autocrine from HSCs as well as paracrine from surrounding Treg cells.
To measure canonical Wnt signaling in LT-HSCs post 5FU treatment, I 
immunostained the sorted LT-HSCs with p-catenin-pS552, which was 
phosphorylated by phosphor-Akt (pAKT) and became an active form in nucleus (He 
et al., 2007). pAkt staining was observed in more than 70% of LT-HSCs post 5FU 
treatment but in only 10% of control LT-HSCs (Figure 5-5F). p-catenin-pS552 was 
detected in more than 50% of LT-HSCs post 5FU treatment and in 20% of control 
LT-HSCs (Figure 5-5G). This observation was confirmed by TOP-Gal staining 
which showed more than a 2.5-fold increase of signal intensity in LT-HSCs post 5FU 
treatment (Figure 5-5H). Furthermore, canonical Wnt target Axin2 (Luis et al., 2011) 
increased 8-fold in LT-HSCs post 5FU treatment (Figure 5-51). These observations
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indicate that 5FU induces a decline of non-canonical Wnt signaling (Figure 5-5B-D)
and an increase of canonical Wnt signaling (Figure 5-5F-I) in LT-HSCs.
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Figure 5-5 5FU-induced change of canonical and non-canonical Wnt signaling in HSC
(A) Non-canonical Wnt signaling (Ca2+-NFAT pathway) and canonical Wnt signaling (P-catenin-TCF- 
Axin2). Non-canonical Wnt receptors Fmi and Fz8 were declined post 5FU. (B) Intracellular Ca2+ level 
in LT-HSCs post 5FU. 2 independent experiments. Comparison of protein and mRNA levels between 
control and 5FU treated samples (C) NFAT staining of LT-HSCs (D) qRT-PCR analysis of NFAT targets, 
IFNy and Cox2 in LT-HSCs. Reactions were triplicated. (E) qRT-PCR for IFNy in T cells and Treg 
(CD4+CD25+). (F) Immunostaining of pAkt in LT-HSCs post 5FU. White arrow indicates dividing LT- 
HSCs post 5FU. (G) p-catenin-pS552 staining of LT-HSCs. (H) TOP-GAL staining of LT-HSCs. (I) qRT-PCR 
analysis of A xin2  in LT-HSCs. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Chapter 6. Flamingo maintains quiescent long-term 
HSCs in vivo
In this chapter, I will analyze the functional role of Fmi in HSC maintenance 
in vivo. I used the mouse model of Fmi gene conventional knockout.
Since Fmi-Fz8 co-localization is enriched in quiescent HSCs and in the niche 
that expresses non-canonical Wnt ligands, I hypothesized that Fmi may have a role in 
maintaining HSC quiescence. My preliminary results of knockdown of Fmi led to a 
reduction in LT-HSCs but an increase in ST-HSCs and MPPs, and functionally 
resulted in more than a 50-60% decrease of engraftment in repopulation assay 
(Figure 6-1 A). To confirm this, I used Fmi/Celsr2 conventional knockout mouse 
model. The gender and age (>40 days old) of mice were matched for the analysis 
(Figure 6-1B). The frequency of LT-HSCs decreased 60% (Figure 6-1B). In addition, 
the number of LT-HSCs decreased 80%, and the numbers of ST-HSCs and MPPs 
declined as well in the FmTu mice (Figure 6-1C). The results from both knockdown 
and knockout suggest loss of LT-HSC function followed by consequent loss of ST- 
HSCs and MPPs, which correlates with predominant expression of Fmi in quiescent 
LT-HSCs. I used a hypoxic-related HSC marker GRP78 to stain LT-HSCs and 
observed a decline in GRP78+ population from 31.3 ± 0.3% (control) to 11.8 ± 1.1%
(FmfA) (Figure 6-1D-E). In line with this finding, I observed an increase of 
mitochondrial activity in FmfA LT-HSCs (Figure 6-1F). All these suggested an 
increase in HSC activity when Fmi was lost. I therefore performed a cell cycle 
analysis and found that within Flk2'LSK HSCs, the percentage of quiescent (GO) 
cells declined from 23 ± 0.71% (control) to 15 ± 1.1% (FmfA) (Figure 6-1G-H).
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Figure 6-1 Analysis of primary Fmry' mice
(A) Transplantation of Fmi knockdown over 16 weeks. N=10 mice. 3 independent experiments. (B-C) 
Analyses of conventional Fmi knockout mice. Frequency (B) and number (C) of HSCs in TBR. (D) 
GRP78 analysis of LT-HSCs comparing F m r  mice and W t. Wt=2, KO=2 mice, 2 independent 
experiments. (E) Percentage of GRP78+ and GRP78’ LT-HSCs. (F) Mitochondrial activity assay 
comparing F m r  mice and W t. (G) Cell-cycle analysis of Flk2‘LSK comparing F m r  mice and W t. Wt=2, 
KO=4 mice. 2 independent experiments. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
Next, I transplanted 100 LSK (alive) enriched with HSPCs (CD45.2) with 
rescue 2x105 BM (CD45.1) into lethally irradiated recipient mice (CD45.1) (Figure
6-2 A). Homing efficiency analysis of the recipient mice 16 hours posttransplantation 
confirmed that knockout of Fmi did not affect HSPC homing to BM and spleen 
(Figure 6-2B). After 16 weeks, Fmi knockout reduced 80% of the hematopoietic 
reconstitution from donor-derived HSCs (Figure 6-2A). The analyses of recipients
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showed an 80% decrease of donor-derived LT-HSCs and a 70% decrease of donor-
derived ST-HSCs in frequency and number (Figure 6-2C-D). In addition, the loss of 
HSCs was not due to apoptosis, since knockout did not increase 
AnnexinV+SytoxGreen+ LT-HSCs (Figure 6-2E).
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Figure 6-2 Transplantation analysis of F/nf7' mice
(A) Chimerism analysis of transplantation: 100 LSK (CD45.2) + 2x10s BM (CD45.1). Recipients were 
lethally irradiated (CD45.1). The repopulation was analyzed 16 weeks post injection. (B) Homing 
analysis of live CFDA+HSPC (7AAD'CFDA+LSK) comparing F m i1' mice and W t. Wt=5, KO=5 mice. (C-D) 
Frequency (C) and number (D) of donor-HSCs 17 weeks post transplantation. (E) Apoptosis assay 
with SytoxGreen and AnnexinV staining of LT-HSCs comparing F m r  mice and Wt. Wt=2, KO=2 mice. 
(Modified from Sugimura et al., Cell 150, 351-365, 2012)
I next asked whether H2B-GFPhl LRCs (quiescent HSCs) were affected by 
Fmi knockout. H2B-GFPhl LRCs were predominantly observed in TBR in Wt, but
less so in Fmi ' (Figure 6-3A-B, D-E). The H2B-GFP signal intensity was
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significantly reduced in FmTA LT-HSCs, suggesting that label retention was lost due 
to decrease of quiescence in HSCs (Figure 6-3G). The frequency of H2B-GFPhl 
LRCs in FmiA was decreased 8-fold in TBR and 10-fold in CBR (Figure 6-3H). 
Within TBR in Wt control, 65% of H2B-GFPhl LRCs were in direct contact with N- 
cad+OBs, which was reduced 20% in FmfA (Figure 6-31). The localization of Fz8 
protein was observed at the interface between H2B-GFPhl LRCs and N-cad+OBs in 
Wt (Figure 6-3C); however, its distribution became random in remaining FmiA H2B- 
GFPhl LRCs (Figure 6-3F). These observations provide further evidence to support 
the conclusion that Fmi facilitates the maintenance of quiescent LT-HSCs in vivo.
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Figure 6-3 Label retention of FmrA HSC
(A-F) Immunostaining of Fz8, N-cad, and H2B-GFPhl LRC in TBR and CBR from Scl-H2B-GFP (A-C) and 
F m i'': Scl-H2B-GFP (D-F) mice. Scale bar is 20uM (A-B, D-E) or 5uM (C, F). High-resolution 3D image 
of localization of Fz8 (red arrow) in H2B-GFP ' LRC (C, F). (G) Flow cytometric analysis of H2B-GFP 
signal in LT-HSCs from W t and F m r .  (H) H2B-GFP ' LRC distribution in TBR and CBR from W t and Fmi" 
\  Wt=2, KO=2 mice. (I) Frequency of H2B-GFPhl LRCs directly contacting with N-cad+OBs in TBR from 
W t or F m r mice. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Chapter 7. Frizzled8 maintains quiescent long-term 
HSCs in vivo
In this chapter, I will analyze the functional role of Fz8 in HSC maintenance 
in vivo, using the conventional Fz8 knockout mouse model.
Since subcellular distribution of Fz8 is regulated by Fmi in quiescent LT- 
HSCs (H2B-GFPhlFlk2‘LSK), I examined the functional role of Fz8 in HSCs using 
Fz8 conventional knockout mouse model. The gender and age (>40 days old) of mice 
were matched for the analyses (Figure 7-1A). The frequency of LT-HSCs decreased 
40%. In addition, the number of LT-HSCs decreased 50%, and the numbers of ST- 
HSCs and MPPs declined as well in the Fz8'A mice (Figure 7-IB). The results from 
Fz8 knockout suggest loss of LT-HSCs followed by subsequent loss of ST-HSCs and 
MPPs, which correlates with predominant expression of Fz8 in quiescent LT-HSCs. I 
performed a cell cycle analysis and found that within Flk2'LSK HSCs, the 
percentage of quiescent (GO) cells declined from 22 ± 2.9% (control) to 16 ± 1.9% 
(Fz8'a) (Figure 7-1C-D).
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(A-D) Analyses of conventional Fz8 knockout mice. Frequency (A) and number (B) of HSCs in BM. 
DNA content (DAPI) versus Ki67 staining of Flk2"LSK cells to compare percentage of GO phase cells (C- 
D). (Modified from Sugimura et al., Cell 150, 351-365, 2012)
Next, I transplanted 100 LSK (alive) enriched with HSPCs (CD45.2) with 
rescue 2x105 BM (CD45.1) into lethally irradiated recipient mice (CD45.1) (Figure
7-2 A). Homing efficiency analysis of the recipient mice 16 hours posttransplantation 
confirmed that knockout of Fz8 did not affect HSPC homing to BM and spleen 
(Figure 7-2B). After 16 weeks, the Fz8'A group reduced 70% of the hematopoietic 
reconstitution from donor-derived HSCs (Figure 7-2A). The analyses of recipients 
showed a 70% decrease of donor-derived LT-HSCs and a 70% decrease of donor- 
derived ST-HSCs in frequency and number (Figure 7-2C-D). In addition, the loss of
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HSCs was not due to apoptosis, since Fz8 knockout did not increase 
AnnexinV+SytoxGreen+ LT-HSCs (Figure 7-2E).
A
Donor
100 LSK (CD45.2) 
+
2x105 BM (CD45.1)
I ,
Recipient
CD45.1
Wt
Recip ent
Donoi
4
Fz8+
Recipient
Donor
fej
% 
<5 30
2 20
10 10 10 10 10 10 10 10
Repopulation -1 6  weeks 
o
oo0o
CD45.2 (Donor)
1©Q-
Wt Fz&- 
Wt=9, KO=10
CD
|4 H
o  
XvP 24
Homing, Live HSPC
□  w  JL
U F z S ' -
C Frequency of Donor-HSC
x10*
2.0 n
sm 
= 1.0
□ Wt 
Fz&-
n *i
2.0 *8
XX
E3= 1-0 
8
Number of Donor-HSC 
□  Wt
mFztr T
a i
c0)s>
CD
xo■Skco
Femur Spleen
Wt=5, KO=5
W t
LT-HSC ST-HSC MPP 
Wt=7, KO=5
LT-HSC ST-HSC MPP 
Wfc=7, KO=5
F z & -
102 ’
10 1
.0 :10
CD34LSK
Live cells
* ' *
( K * s
98±0.0
0 1 2 3
10 10 10 10 10
1 CD34LSK
■ Live cells
97±1.0
• hjhii iiiim
10 10 10 10 10
Annexin V Wt=2, KO=2
Figure 7-2 Transplantation analysis of FzS'7' mice
(A) Chimerism analysis of transplantation: 100 LSK (CD45.2) + 2x10s BM (CD45.1). Recipients were 
lethally irradiated (CD45.1). The repopulation was analyzed 16 weeks post injection. (B) Homing 
analysis of live CFDA+HSPC (7AAD‘CFDA+LSK) comparing Fz8 mice and W t. Wt=5, KO=5 mice. (C-D) 
Analyses of recipient mice 20 weeks post transplantation. Frequency (C) and number (D) of donor- 
HSC. (E) Apoptosis assay with SytoxGreen and AnnexinV staining of LT-HSCs comparing F m r  mice 
and W t. Wt=2, KO=2 mice. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
I next asked whether H2B-GFPhl LRCs (quiescent HSCs) were affected by 
Fz8 knockout. H2B-GFPhl LRCs were predominantly observed in TBR in Wt, but 
less so in Fz8v~ (Figure 7-3A-B, D-E). The H2B-GFP signal intensity was 
significantly reduced in Fz8'A LT-HSCs, suggesting that label retention was lost due 
to decrease in HSC quiescence (Figure 7-3G). The frequency of H2B-GFPhl LRCs in
84
Fz8'A was decreased 6-fold in TBR and 8-fold in CBR (Figure 7-3H). Within TBR in 
Wt, 63% of H2B-GFPhl LRCs were in direct contact with N-cad+OBs, which was 
reduced 10% in Fz8'A mice (Figure 7-31). The localization of Fmi protein was not 
affected in Fz8'A LRCs (Figure 7-3 C, F), further supporting that the function of Fmi 
is to determine Fz8 distribution, but Fmi distribution is not affected by Fz8. Taken 
together, these observations indicate that Fz8 plays a critical role in the maintenance 
of quiescent LT-HSCs in vivo.
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Figure 7-3 Label retention of Fz8v' HSC
(A-F) Immunostaining of Fmi, N-cad, and H2B-GFPhl LRC in TBR and CBR from W t: Scl-H2B-GFP  (A-C) 
and Fz8 : Scl-H2B-GFP (D-F). Scale bar is 20uM f.A-B, D-E) or 5uM (C, F). High-resolution 3D image of 
Fmi protein localization (red arrow) in H2B-GFP ' LRC (C, F). (G) Flow cytometric analysis of H2B-GFP 
signal in LT-HSCs from W t and F z8 . (H) H2B-GFP ' LRC distribution in TBR and CBR from W t and Fz8~ 
. Wt=2, KO=3 mice. (I) Frequency of H2B-GFP 1 LRCs directly contacting with N-cad+OBs in TBR of W t  
and Fz8 . (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Chapter 8. Frizzled8 maintains quiescent HSCs by 
suppressing NFAT-induced IFNy expression and 
antagonizing canonical Wnt signaling
In this chapter, I will analyze the downstream molecular events of non- 
canonical Wnt signaling mediated by Fz8 in HSCs.
I investigated the underlying molecular mechanism by which Fmi and Fz8- 
mediated non-canonical Wnt signaling maintains quiescent LT-HSCs. Non-canonical 
Wnt5a ligand stimulates the Ca -NFAT signals in embryonic cells (Huang et al.,
2011; Saneyoshi et al., 2002) but downregulates the Ca2+-NFAT signals in adult cells 
(Dejmek et al., 2006). It is also known that non-canonical Wnt5a suppresses 
canonical Wnt activity (Nemeth et al., 2007) (Figure 8-1 A). To examine the function 
of non-canonical Wnt signaling in HSCs in this context, I observed that the 
intracellular Ca2+ level, as measured using a Ca2+ reporter (see Experimental 
Procedure), increased 2-fold in the Fz8'A LT-HSCs (Figure 8-1B, D-E). Canonical 
Wnt target gene Axin2 was upregulated 6 times more in active HSCs (Flk2‘H2B- 
GFP'LSK cells) than in quiescent HSCs (H2B-GFPhi Flk2'LSK cells) (Figure 8-1C). 
These observations indicate that non-canonical Wnt signaling mediated by Fz8 
suppresses the Ca -NFAT pathway as well as canonical Wnt signaling in HSCs.
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Figure 8-1 Canonical and non-canonical Wnt signaling in HSC
(A) Ca2+-NFAT pathway and (3-catenin pathway regulated by non-canonical Wnt signaling. (B) 
Intracellular Ca + level in LT-HSCs in W t and Fz8 . 2 independent experiments. (C) qRT-PCR analysis 
of A xin 2  in quiescent HSCs (Flk2'H2B-GFP LSK LRCs) and active HSCs (Flk2'H2B-GFP'LSK). (D) Fluo-3 
intracellular Ca2+ analysis of LT-HSCs comparing Fz8 and W t. (E) Positive control of Fluo-3 analysis 
with lonomycin in LT-HSCs (Omin, lm in and lOmin post lonomycin). (Modified from Sugimura et al., 
Cell 150, 351-365, 2012)
To confirm this, I observed in quiescent Fmi+Fz8+ HSCs (H2B-GFPhl Flk2‘ 
LSK) that NFATcl (shown to be highly expressed in LT-HSCs by RNA-seq) was 
mainly localized in the cytoplasm (Figure 8-2A, left panel). In contrast, however, in 
active Fmi'Fz8'HSCs (H2BGFP' Flk2'LSK), NFATcl was accumulated in the 
nucleus (Figure 8-2A, right panel). Statistically, only 4.3% of quiescent HSCs 
exhibited nuclear localized NFATcl versus 87.7% of active HSCs (Figure 8-2B).
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This observation indicates a correlation between cytoplasmic versus nuclear 
localization of NFAT and the quiescent versus active state of HSCs.
I further tested whether Fmi and Fz8 regulate NFAT protein localization in 
HSCs using knockdown analysis. In the scramble control, NFAT was mainly 
localized in the cytoplasm of infected LSK cells. In contrast, when either Fmi or Fz8 
was knocked down, more than 80% of LSK cells showed nuclear accumulation of 
NFAT (Figure 8-2C-D). In addition, Fmi knockdown in OP9 cells induced NFAT 
nuclear translocation in LSKs that were co-cultured with OP9, suggesting that 
homophilic interaction of Fmi in adjacent cells regulates NFAT nuclear 
translocation.
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Figure 8-2 NFAT nuclear translocation in HSC
(A) Fmi, Fz8, and NFAT staining in sorted quiescent HSCs (Flk2'H2B-GFPhlLSK LRCs) and active HSCs 
(Flk2‘H2B-GFP‘LSK); NFAT (red), Fmi (white), Fz8 (green), and DAPI (blue). Scale bar is 5uM. (B) 
Percentage of HSCs with NFAT nuclear translocation. (C) Fmi-, Fz8- knockdown LSK cells stained with 
NFAT; NFAT (red), and DAPI (blue). (D) Percentage of cells with NFAT nuclear translocation. 
(Modified from Sugimura et al., Cell 150, 351-365, 2012)
I then forced expression of a constitutive active (or nuclear localized) form of
NFAT (CA-NFAT) (Monticelli and Rao, 2002) (Figure 8-3A) to test whether NFAT
activates HSCs. Cell-cycle analysis of LSKs expressing CA-NFAT showed a
decrease of quiescent HSCs and a substantial increase of cycling HSCs (Figure 8-3B-
C), indicating that NFAT promotes HSC activation. I further confirmed this
observation by showing that NFAT inhibitor could rescue the phenotype of a
reduction in the GO-phase Flk2'LSK HSCs (compare Figure 8-3B to 8-3D).
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Figure 8-3 NFAT regulates HSC activation
(A) Immunostaining of NFAT with CA-NFAT and vector control transfected cells. (B-C) DNA content 
(DAPI) versus Ki67 staining of GFP+LSK cells. Representative flow panels. Percentage of cells with GO, 
G l, and S/G2/M phases; vector control (white), and CA-NFAT (black). (D) Percentage of quiescent 
(GO phase) Flk2'LSK comparing W t and Fz8 with or without NFAT inhibitor (NFATi). (Modified from 
Sugimura et al., Cell 150, 351-365, 2012)
To further specify the downstream target genes of NFAT, I examined the 
genes involved in maintaining HSC quiescence, such as p57, Ren and Txnip (Jeong 
et al., 2009; Yilmaz et al., 2006b; Yoshihara et al., 2007; Zhang et al., 2006; Zou et 
al., 2011). I showed that these genes were overall downregulated to varying degrees 
in Fmi or Fz8 knockdown HSCs (Figure 8-4A).
Using qRT-PCR analysis of NFAT target genes, I found a 4-fold increase of 
IFNy expression and a 1.8-fold increase of Cox2 in FmfA LT-HSCs respectively 
(Figure 8-4B). I further observed a 3-fold increase of IFNy expression in Fz8'A LT- 
HSCs (Figure 8-4C), which is consistent with the observation that forced expression 
of CA-NFAT increased IFNy by 2-fold in HSCs (Figure 8-4D). This upregulation of 
IFNy expression could not be rescued by non-canonical Wnt5a ligand (Figure 8-4E), 
but could be rescued by NFAT inhibitor (Figure 8-4F). The results support that non- 
canonical Wnt5a-Fz8 signaling has a role in suppressing the NFAT-IFNy pathway.
To examine the antagonization between canonical and non-canonical Wnt 
signaling, I conducted an in vitro culture experiment. Non-canonical Wnts
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downregulated, whereas canonical Wnts upregulated IFNy expression, and the latter 
showed a synergistic effect with Fz8'f' LT-HSCs (Figure 8-4G). All these results 
support an antagonization between canonical and non-canonical Wnt signaling to 
regulate downstream IFNy expression.
□  Scramble
□  Flamingo-shRNA 
■  Frizzled8-shRNA
<d GFPLSK
® 2 .0 -
n  1 .0 -
LT-HSC, 
Fmr* I Wt
LT-HSC IFNy 
□  WT S12,
2 
■s£ 2H
I Fz8''- -2
LT-HSC IFNy
IFNy Cox2
LT-HSC IFNy
D
Wt Fz&- Vector CA-NFAT
j|J i f f
LT-HSC IFNy 
§30T a WT. m Fz8'~
2  Ctrl 3a 7b 5a
Canonical
Wnt
Figure 8-4 NFAT target genes in HSC
(A) qRT-PCR analysis of quiescence-related genes; scramble (white), Fmi-shRNA (gray), and Fz8- 
shRNA (black). Reactions were triplicated (hereafter). (B) qRT-PCR analysis of NFAT-target genes, 
IFNy and Cox2 in LT-HSCs comparing W t and F m r .  (C) qRT-PCR of IFNy in LT-HSCs comparing W t and 
Fz8'f\  (D) qRT-PCR for IFNy of CA-NFAT infected HSCs. (E) qRT-PCR analysis of IFNy in LT-HSCs 
cultured with Wnt5a. (F) qRT-PCR analysis of IFNy in LT-HSCs comparing W t and Fz8 with or without 
NFAT inhibitor (NFATi). (G) qRT-PCR analysis of IFNy in LT-HSCs cultured with Wnt ligands. (Modified 
from Sugimura et al., Cell 150, 351-365, 2012)
Mechanistically, non-canonical Wnt ligands suppress the Ca2+-NFAT-IFNy 
pathway. In contrast, canonical Wnt ligands and Fz8'A promote NFAT nuclear 
translocation (Figure 8-5A, E-G, Figure 8-6A). I also examined the downstream 
event of canonical Wnt signaling using immunostaining of active p-catenin (P-cat- 
pS552) (He et al., 2007), TOP-Gal staining, Axin2-d2EGFP reporter, and canonical 
Wnt target Axin2 expression. I confirmed that canonical Wnts, loss of Fz8 or Fmi, all
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increased nuclear-localized P-catenin-pS552, TOP-Gal staining, Axin2-d2EGFP 
level, in LT-HSCs (Figure 8-5B-D, Figure 8-6B-E). Taken together, all these 
observations indicate that non-canonical Wnt signaling via Fmi-Fz8 blocks the Ca 
NFAT-IFNy pathway and canonical Wnt signaling.
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Figure 8-5 Analysis of canonical and non-canonical Wnt signaling in HSC
(A) NFAT immunostaining of LT-HSCs cultured with Wnt ligands. Percentage of NFAT nuclear 
translocation. n=28, 31, 36, 40 cells. (B) |3-catenin-pS552 staining of LT-HSCs cultured with Wnt 
ligands. Percentage of HSCs with |3-catenin-pS552 in nucleus. (C) 3-catenin-pS552 staining of LT-HSCs 
from F m r and W t. Percentage of HSCs with 3-catenin-pS552 in nucleus. (D) TOP-GAL and Axin2- 
d2EGFP staining in LT-HSCs cultured with Wnt ligands or F m r .  n=24, 21, 27,15, 38, 55 cells. (E) NFAT 
and 3-catenin-pS552 staining of LT-HSCs cultured with Wnt ligands. Green arrows indicate cells with 
nuclear-localized |3-catenin-pS552. (F) NFAT and |3-catenin-pS552 staining of LT-HSCs from F zS f' and 
Wt. Green arrow indicates a cell with nuclear-localized |3-catenin-pS552. (G) |3-catenin-pS552 staining 
of LT-HSCs from F m r and Wt mice. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Figure 8-6 Analysis of canonical and non-canonical Wnt signaling in HSC (continued)
(A) Fluo-3 intracellular Ca2+ analysis of LT-HSCs cultured with Wnt ligands. (B-C) TOPGal staining (B) 
and Axin2-d2EGFP reporter analysis (C) of LT-HSCs cultured with Wnt ligands. n=24, 21, 27,15 cells. 
(D) qRT-PCR for Axin2 in Fm/ and Fz8 compared to Wt. (E) d2EGFP reporter staining for Wt and 
F m f LT-HSCs. (Modified from Sugimura et al., Cell 150, 351-365, 2012)
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Chapter 9. General Discussion
In this work, I observed that a protein complex of Fmi and Fz8 co-localized 
in quiescent LT-HSCs that are predominantly located in TBR. Functionally, Fmi- 
and Fz8-mediated non-canonical Wnt signaling plays a critical role in maintaining 
quiescent LT-HSCs. Mechanistically, this non-canonical Wnt signaling suppresses 
HSC activation, in part through inhibiting the NFAT-IFNy pathway, and in part 
through antagonizing canonical Wnt signaling during homeostasis. In response to 
stress, however, there is a decline of non-canonical Wnt signaling, accompanied by 
an increase of canonical Wnt signaling and activation of HSCs. Thus I provide strong 
evidence to distinguish the roles of non-canonical and canonical Wnt signaling in 
maintaining quiescent HSCs and in activating HSCs respectively.
9.1 Flamingo-Frizzled8-mediated non-canonical Wnt signaling, 
predominantly in the N-cad+OB niche, is critical for 
maintaining quiescent long-term HSCs 
I found a correlation between the expression of Fmi and Fz8 in quiescent LT- 
HSCs and their function in maintaining these HSCs. The remaining question was at 
which niche component did Fmi and Fz8 primarily function. Multiple HSC niche 
components have been reported to date, including OBs (particularly N-cad+OBs), 
endothelial cells, Nestin-GFP+ MSC-like cells, bipotential CAR (CXCL12 abundant 
reticular) cells, and Schwann cells (Calvi et al., 2003; Kiel et al., 2005; Mendez- 
Ferrer et al., 2010; Omatsu et al., 2010; Sugiyama et al., 2006; Yamazaki et al., 2011; 
Zhang et al., 2003a). The functional role of OBs was previously tested by 
Col2.3ATK-induced ablation of mature OB cells, and this resulted in a much delayed
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loss of HSCs (Visnjic et al., 2004). Osteoclasts also influenced HSCs by indirectly 
regulating osteoblasts (Lymperi et al., 2011). In contrast, genetic ablation of 
Nestin+MSCs and CAR cells caused a rapid mobilization of 50-60% of HSCs from 
BM to spleen. This was consistent with the distribution of 60% of HSCs in the 
sinusoidal perivascular niche (Kiel et al., 2005). Notably, the lost or mobilized HSCs 
were initially proliferating (or active) HSCs (Omatsu et al., 2010). These 
observations suggested that different niche components may form different 
microenvironments— quiescent versus active niches (Li and Clevers, 2010). The 
perivascular-localized Nestin-GFP+ and CAR cells, together with endothelial cells, 
most likely form an active niche, as they mainly support active HSCs (Butler et al., 
2010). In contrast, the endosteal-localized N-cad+OBs in TBR may form a quiescent 
niche. A previous report (Dominici et al., 2009) and my finding that N-cad+OB is 
quiescent and drug-resistant show that N-cad+OB is a very stable niche component 
even under stress (Figure 9A-B).
The model that N-cad+OBs form a quiescent HSC niche is further supported 
by my observation that Fmi and Fz8 expressed at the interface between quiescent 
HSCs and N-cad+OBs in TBR. Fmi homophilic adhesion has been shown to mediate 
‘contact inhibition’ and transduce non-canonical Wnt signaling between neural axons 
(Kimura et al., 2006). I have shown that Fmi, in both HSCs and niche cells, regulates 
Fz8 distribution, consistent with the “contact inhibition” function of Fmi in 
maintaining the quiescent state of HSCs in the niche. Additionally, by comparing the 
expression of non-canonical Wnts and canonical Wnts/inhibitors, I found that 
endothelial cells expressed detectable levels of Wnt5b and that Nestin-GFP+ cells 
expressed limited canonical Wnts, such as WntlOb. In contrast, N-cad+OBs
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expressed the highest levels of Wnt inhibitors that suppress canonical Wnt signaling 
in homeostasis. Although, both Nestin-GFP+ cells and N-cad+OBs expressed several 
non-canonical Wnts, N-cad+OBs predominantly expressed additional Wnt6 and 
Wntl6. Notably, Wntl6 was recently shown to be critical in inducing HSC 
generation from endothelial progenitor cells during fetal development of zebrafish 
(Clements et al., 2011). All these observations support that N-cad+OBs maintain a 
quiescent niche with dominant non-canonical Wnt signaling and simultaneously 
suppress canonical Wnt signaling in homeostasis. This dominant expression of non- 
canonical Wnts is consistent with the presence of Fmi-Fz8 complex in the N-cad+OB 
niche (Figure 9B).
9.2 FIamingo-FrizzIed8-mediated non-canonical Wnt signaling 
suppresses Ca2+-NFAT-IFNy-pathway and antagonizes 
canonical Wnt signaling, thereby preventing HSCs from 
activation
Recently, non-canonical Wnt signaling was shown to be involved in HSC 
development (Clements et al., 2011; Heinonen et al., 2011; Louis et al., 2008) and in 
HSC maintenance in vitro culture (Murdoch et al., 2003; Nemeth et al., 2007). The 
underlying mechanism, however, was undefined. The downstream pathways of non- 
canonical Wnt signaling have diverse functions: forming planar cell polarity,
^  I
blocking Ca -NFAT nuclear translocation, and suppressing p-catenin activity. In 
this work, I demonstrated that Fmi-Fz8 mediated non-canonical Wnt signaling 
indeed suppresses nuclear translocation of NFAT. NFAT was previously shown to 
maintain hair follicle stem cells through suppression of Cdk4 (Horsley et al., 2008)
96
and to play an important role in hematopoiesis (Muller et al., 2009). In HSCs, I 
identified that NFAT stimulates IFNy. Another niche component, Treg cell, also 
expresses IFNy post 5FU. I do not exclude that other stromal cells as well might 
express IFNy. While IFNs play a critical role in activating HSCs (Baldridge et al., 
2010; Essers et al., 2009), Fmi- and Fz8-mediated non-canonical Wnt signaling 
maintains quiescence, partially through downregulation of IFNy expression (Figure 
9C). I further demonstrated that culturing HSCs with Wnt5a inhibits IFNy 
expression. This inhibitory effect ended when Fz8 was knocked out, further 
supporting the critical role of Fz8-mediated non-canonical Wnt signaling to suppress 
the Ca2+-NFAT-IFNy pathway. In addition, I showed that Fmi-Fz8-mediated non- 
canonical Wnt signaling antagonizes canonical Wnt signaling, which is consistent 
with a previous report that Wnt5a and Fz8-mediated non-canonical Wnt signaling 
inhibited canonical Wnt signaling (Mikels and Nusse, 2006; Nemeth et al., 2007) 
(Figure 9C).
9.3 Non-canonical versus canonical Wnt signaling have
distinguished roles respectively in maintenance vs. activation of 
HSCs
Wnt signaling, particularly the canonical pathway through activation of p- 
catenin, has been shown across several species to be prominent in regulating stem 
cell self-renewal in both embryonic and adult stem cells (Blanpain and Fuchs, 2009; 
Reya et al., 2003; van de Wetering et al., 2002; Ying et al., 2008). The role of 
canonical Wnt signaling in HSC maintenance, though, is debatable. For example, 
forced expression of Dkkl in osteoblasts suppressed canonical Wnt signaling in
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HSCs, accompanied by a decrease in quiescent HSCs (Fleming et al., 2008). 
However, other studies showed that Dkkl-transgenic mice had a defect in trabecular 
bone formation (Guo et al., 2010; Li et al., 2006). This is consistent with the role of 
canonical Wnt signaling in osteogenesis during trabecular bone formation. For 
example, absence of P-catenin in osteoblasts led to a defect in trabecular bone 
formation, resulting in a decrease of quiescent HSCs (Nemeth et al., 2009).
Therefore, it is most likely that Dkkl directly affects the osteoblastic niche, and thus 
indirectly influences the resident quiescent HSCs. A similar observation was reported 
that inactivation in bone of Sfrpl, a soluble canonical Wnt inhibitor, resulted in the 
decrease of HSCs (Renstrom et al., 2009). Another example is that forced expression 
of Wifi in osteoblasts reduced quiescent HSCs. Although overexpression of Wifi in 
a transgenic model did not alternate bone architecture, Wifi inhibited non-canonical 
Wnt signaling (Hsieh et al., 1999) and thus increased canonical Wnt signaling 
(evidenced by increased Wnt3a) in HSCs (Schaniel et al., 2011).
The association of non-canonical Wnt signaling with N-cad+OBs provides 
insight to reconciling previous contradictory observations.
First, ablation of Nestin-GFP+ cells or CAR-cells leads to a rapid loss of a 
portion of HSCs. This observation can be explained by the role of these niche 
components to support primarily the active HSC subpopulation (Omatsu et al.,
2010). In contrast, ablation of mature osteoblasts induced by Col2.3ATK (thymidine 
kinase) results in a much delayed reduction of HSCs, which is consistent with the 
role of this niche component to support the long-term quiescent HSC subpopulation 
(Visnjic et al., 2004). This is because loss of quiescent HSCs often does not have an 
immediate influence on hematopoiesis, as the active population still supports
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hematopoiesis. Furthermore, reduction in quiescent HSCs often leads to an increase 
in cycling HSCs, and therefore the immunophenotypic measurement of total HSCs is 
not affected in the short term. The observation that there is a subsequent recovery of 
HSCs following deletion of mature OBs induced by Col2.3 ATK (Visnjic et al., 2004) 
can be explained by Col2.3 being mainly expressed in mature OBs. Therefore,
Col2.3 induced TK cannot efficiently target N-cad+OBs that enrich quiescent 
osteoprogenitors (Xie et al., 2009). The untargeted N-cad+OBs can facilitate recovery 
of osteogenesis initially and then subsequent HSC recovery.
Second, Fmi, as an atypical cadherin family molecule, mediates a homophilic 
interaction between N-cad+OBs and HSCs, and provides a redundant role as that of 
N-cadherin in mediating HSC-niche interaction (Figure 9C). This may account for 
the subtle phenotype seen in the N-cad conditional KO model (Kiel et al., 2008).
N-cad+OBs may not just play a passive role in maintaining quiescent HSCs, 
as they have been implicated to facilitate HSC expansion in response to irradiation- 
induced BM damage (Dominici et al., 2009). Another report also showed the 
correlation between the number of HSCs and N-cad+OBs, but not mature OBs 
(Lymperi et al., 2008). Consistent with this observation, I found that in response to 
5FU-induced BM damage, non-canonical Wnt signaling in N-cad+OBs was 
downregulated (Figure 9D-E). This microenvironmental change was further 
supported by specific and strong stimulation of IFNy by Wnt7b in vitro. In this 
experiment, Wnt7b also promoted an increase in the active form (p-cat-pS552) of f3- 
catenin in the HSC nucleus, clearly indicating antagonizing roles between canonical 
and non-canonical Wnt signaling. The attenuation of non-canonical Wnt signaling 
may coordinate with other niche components with different activation signals (such
99
as SCF etc.) to facilitate HSC activation and subsequent expansion. This new finding 
may help reconcile the contradictory reports regarding canonical Wnt signaling in 
HSCs. In a previous study, for example, inactivation of p-catenin did not affect 
homeostatic HSCs (Cobas et al., 2004). This is because canonical Wnt signaling is 
not prominent during homeostasis, as revealed in my study. On the other hand, 
inactivation of p-catenin during embryonic and fetal stages indeed affected 
hematopoiesis, due to involvement of canonical Wnt signaling in HSC expansion. 
Transgenic expression of stabilized p-catenin leading to HSC reduction (Kirstetter et 
al., 2006; Scheller et al., 2006) seems not to support the role of canonical Wnt 
signaling in HSC self-renewal and expansion. However, this observation can be 
explained by our recent report that constitutive expression of p-catenin in HSCs 
induced apoptosis. Only in coordination with PI3K/Akt (or Bcl2) signaling, can 
HSCs be expanded with canonical Wnt signaling (Perry et al., 201 lb; Reya et al., 
2003). My study provides novel evidence to distinguish the respective roles of non- 
canonical versus canonical Wnt signaling in maintenance versus activation and 
expansion of HSCs.
9.4. Expression of Flamingo subtypes in HSCs
Flamingo family has 3 subtypes, Celsrl, 2, and 3. In this study, I found that 
Flamingo/Celsr2 is expressed in quiescent label-retaining HSCs in the endosteal zone 
of TBR. I also found Celsrl was not expressed in HSCs. In contrast, Celsr3 is 
expressed in mobilized HSCs following 5FU-mediated activation in blood vessels. 
This indicates Celsr3 may regulate HSC maintenance of mobilized HSCs which have 
been reported in quiescent state (Morrison et al., 1997). In the future, it will be 
interesting to test whether deletion of Celsr3 affects HSCs during circulation.
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9.5. Canonical and non-canonical Wnt signaling
Wnt signaling can be separated into canonical and non-canonical signaling. 
Which signaling is to be used depends on the tissue types that express different types 
of Frizzleds and other co-receptors. For example, Wnt5a activates non-canonical 
Wnt signaling in the presence of Ror2 co-receptor. In contrast, Wnt5a activates 
canonical Wnt signaling in the presence of Frizzled4 (Mikels and Nusse, 2006). In 
my study using TOP-Gal and Axin2-d2EGFP reporter models, I have confirmed that 
Wnt5a activates non-canonical Wnt and suppresses canonical Wnt signaling.
The structure of Wnt and Frizzled recognition remains unclear. A recent 
report showed the 3D structure of Xenopus Wnt8 and mouse Fz8 binding (Janda et 
al., 2012). According to the report, Wnt structure resembles a “hand” with “thumb” 
and “index” fingers extended to grasp Frizzled8 cysteine-rich domain at two distinct 
binding sites. This observation suggests that the different biding sites of Wnts and 
Frizzleds may fine-tune the downstream pathways with co-receptors, thus 
determining canonical or non-canonical Wnt signaling.
9.6. Wnt signaling and BMP signaling in determination of quiescent vs. active 
niches
Our lab previously showed that BMP signaling in the endosteal zone 
regulates HSC and ISC maintenance (He et al., 2004b; Zhang et al., 2003a). In 
contrast, canonical Wnt signaling through p-catenin promotes proliferation of HSCs 
and ISCs (He et al., 2007; Perry et al., 201 la). These observations indicate “Yin- 
Yang control” of stem cells by canonical Wnt signaling and BMP signaling. In my 
study, non-canonical Wnt signaling has been identified as another signaling to 
maintain quiescent HSCs. My preliminary data showed that BMP4 is expressed in
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the TBR; in contrast, BMP inhibitor Noggin is expressed in the compact bone region. 
A recent report showed that BMP4 and BMP7 induce osteoblast differentiation of 
MSCs via histone demethylases KDM4B and KDM6B which activate the chromatin 
region (Ye et al., 2012). These observations suggest that BMP signaling may form 
the endosteal zone of TBR, where non-canonical Wnt signaling facilitates a local 
control of quiescent HSCs adjacent to N-cad+OBs. After stress, non-canonical Wnt 
signaling switches to canonical Wnt signaling to allow HSC activation. Canonical 
Wnt signaling determines the active HSC niche.
9.7. Dynamic regulation of Wnt signaling balance during development and 
aging
It is very interesting to consider the state of Wnt signaling balance in the 
niches in fetal stage BM and adult mice. Since fetal HSCs are proliferating and a 
portion of adult HSCs are quiescent, it seems that the balance of canonical and non- 
canonical Wnt signaling may be different between fetal and adult stages. Adult HSCs 
are more deeply quiescent which are difficult to activate. This may suggest non- 
canonical Wnt signaling is very high in the adult HSC niche. It is intriguing to see 
the level of non-canonical Wnts expression in adult niche cells.
Recently, Eaves and colleagues studied a-HSCs (lymphoid-deficient) and p- 
HSCs (balanced-lineage) and revealed that a-HSCs became predominant in adult 
mice, which explains why adult HSCs are more committed to myeloid and deficient 
for lymphoid lineage (Benz et al., 2012). Indeed, their data showed that a-HSCs and 
p-HSCs interconverted at secondary transplantation, which suggests HSCs can be 
redistributed to different niches so that HSC states can be extrinsically influenced. It
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is intriguing to see whether this switch is correlated with canonical versus non- 
canonical Wnt signaling in association with niches.
9.8. Future direction
My study has revealed that the balance of Wnt signaling can regulate 
different populations of HSCs in anatomically distinct niches. Quiescent HSCs are 
adjacent with N-cad+OBs in the TBR endosteal zone. This population functions as a 
reserve population and is maintained by non-canonical Wnt signaling. Under stress, 
the endosteal zone switches to canonical Wnt signaling to activate HSCs. Normally, 
active HSCs are located in the perivascular zone.
So far, the field has focused on canonical Wnt signaling, with fewer studies 
focused on non-canonical Wnt signaling in HSCs. My study proposed the model in 
which canonical and non-canonical Wnt signaling have opposite functions to 
regulate HSCs. Considering functional cross-talk of canonical and non-canonical 
Wnt signaling and their opposing effect, it is critical to clarify canonical and non- 
canonical Wnt signaling when we investigate Wnt signaling in HSCs.
In recent years, the HSC niche field has made remarkable progress and also 
has been very controversial. This is partly because HSCs reside in different locations. 
Label-retaining quiescent HSCs are in the endosteal zone with N-cad+OBs (Zhang et 
al., 2003a); CD150+ CD48' HSCs are in the perivascular and sinusoidal zones (Kiel 
et al., 2005; Mendez-Ferrer et al., 2010). The debate is ongoing regarding which is 
the “real” HSC niche. This controversy can be reconciled by a new model that HSCs 
may include both active and quiescent HSCs. The former is responsible for daily 
production of blood cells, whereas the latter is a reserve population that rarely enters
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cell-cycle, but can be triggered to replenish lost active HSCs when needed (Li and 
Clevers, 2010; Wilson et al., 2008).
The remaining questions related to my study are how the balance of Wnt 
signaling is regulated in different niches, and whether and how active HSCs revert to 
quiescent HSCs (Wilson et al., 2008).
This thesis study showed the different and sequential process of HSC 
activation in anatomically and molecularly distinct zones, and the related different 
types of Wnt signaling. In order to have a systematic and comprehensive 
understanding of the niche network and the associated signaling, it will be important 
to investigate not only just one type of niche or signaling, but also multiple niches 
and both canonical and non-canonical Wnt signaling.
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Figure 9-1 Model of non-canonical Wnt signaling maintaining HSC in the  niche
(A) Sagit ta l  s e c t i o n  o f  f e m u r  ind ica t in g  TBR a n d  CBR. (B) HSC m a i n t e n a n c e  d u r in g  h o m e o s t a s i s .  
W ith in  TBR, a p o r t io n  o f  q u i e s c e n t  LT-HSCs a r e  a d h e r e d  t o  N -c a d +OBs t h a t  m a in t a in  d o m i n a n t  n o n -  
c a n o n ic a l  W n t  s igna ls  a n d  s u p p r e s s  c a n o n ic a l  W n t  s igna ling  by t h e i r  in h ib i to rs .  Fmi ( red  bo x  in B) 
r e s t r i c t s  Fz8 (g re e n  b o x  in B) a t  t h e  i n t e r f a c e  b e t w e e n  q u i e s c e n t  HSCs a n d  N -c a d +OBs, e n g a g in g  
i n t e r a c t i o n  w i th  local n o n - c a n o n ic a l  W n t  l igands  f r o m  N -c a d +OBs. (C) Fz8 s u p p r e s s e s  Ca2+-NFAT 
n u c le a r  t r a n s l o c a t i o n  a n d  N F A T -d e p e n d e n t  IFNy e x p r e s s io n .  N-cad t e t h e r s  P -c a te n in ,  inh ib i t in g  
c a n o n ic a l  W n t  s igna ling .  In a d d i t io n ,  Fmi a n d  Fz8 a n t a g o n i z e  c a n o n ic a l  W n t  s igna ling .  T h e r e f o r e ,  
n o n - c a n o n ic a l  W n t  s igna ling  is p r e d o m i n a n t  in q u i e s c e n t  HSCs. (D) P o s t  5FU t r e a t m e n t ,  c a n o n ic a l  
W n t  l igand  (e.g. W n t 7 b )  e x p re s s io n  is u p r e g u l a t e d .  In a d d i t i o n ,  t h e  e x p r e s s io n  o f  n o n - c a n o n ic a l  W n t  
l igands  ( W n t l l  a n d  W n t l 6 )  a n d  ca n o n ic a l  W n t  in h ib i to rs  a r e  d e c l in e d .  HSCs r e d u c e  b o t h  F lam in g o  
a n d  Fz8 e x p r e s s io n .  N -cad +OBs r e d u c e  Fz8 e x p r e s s io n .  (E) D e c r e a s e  in Fmi-Fz8 m e d i a t e d  n o n -  
c a n o n ic a l  W n t  s igna ling  r e s u l t e d  in NFA T-induced  IFNy e x p r e s s io n ;  a n d  i n c r e a s e  in W n t 7 b  led  t o  
r e l e a s e  o f  P -c a te n in  t o  c y to p la s m  a n d  f u r t h e r  in to  n u c le u s ,  t h u s  t o g e t h e r  p r o m o t i n g  HSC a c t iv a t io n .  
( M o d if ie d  f r o m  S u g im u ra  e t  al., Cell 150 ,  3 5 1 -3 6 5 ,  2 0 1 2 )
105
REFERENCES
Ahumada, A, Slusarski, DC, Liu, X, Moon, RT, Malbon, CC, Wang, HY (2002) 
Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298, 
2006-2010.
Akashi, K, He, X, Chen, J, Iwasaki, H, Niu, C, Steenhard, B, Zhang, J, Haug, J, Li, L
(2003) Transcriptional accessibility for genes of multiple tissues and hematopoietic 
lineages is hierarchically controlled during early hematopoiesis. Blood 101, 383-389.
Alonso, L, Fuchs, E (2003a) Stem cells in the skin: waste not, Wnt not. Genes Dev 
17, 1189-1200.
Alonso, L, Fuchs, E (2003b) Stem cells of the skin epithelium. Proc Natl Acad Sci U 
S A lOOSuppl 1, 11830-11835.
Arai, F, Hirao, A, Ohmura, M, Sato, H, Matsuoka, S, Takubo, K, Ito, K, Koh, GY, 
Suda, T (2004) Tie2/angiopoietin-l signaling regulates hematopoietic stem cell 
quiescence in the BM niche. Cell 118, 149-161.
Arron, JR, Winslow, MM, Polleri, A, Chang, CP, Wu, H, Gao, X, Neilson, JR, Chen, 
L, Heit, JJ, Kim, SK, Yamasaki, N, Miyakawa, T, Francke, U, Graef, IA, Crabtree, 
GR (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on 
chromosome 21. Nature 441, 595-600.
Baksh, D, Tuan, RS (2007) Canonical and non-canonical Wnts differentially affect 
the development potential of primary isolate of human BM MSCs. Journal of cellular 
physiology 212, 817-826.
Baldridge, MT, King, KY, Boles, NC, Weksberg, DC, Goodell, MA (2010) 
Quiescent haematopoietic stem cells are activated by IFN-gamma in response to 
chronic infection. Nature 465, 793-797.
Beall, SA, Boekelheide, K, Johnson, KJ (2005) Hybrid GPCR/cadherin (Celsr) 
proteins in rat testis are expressed with cell type specificity and exhibit differential 
Sertoli cell-germ cell adhesion activity. Journal of andrology 26, 529-538.
Benveniste, P, Frelin, C, Janmohamed, S, Barbara, M, Herrington, R, Hyam, D, 
Iscove, NN Intermediate-term hematopoietic stem cells with extended but time- 
limited reconstitution potential. Cell Stem Cell 6, 48-58.
Benz, C, Copley, MR, Kent, DG, Wohrer, S, Cortes, A, Aghaeepour, N, Ma, E, 
Mader, H, Rowe, K, Day, C, Treloar, D, Brinkman, RR, Eaves, CJ (2012) 
Hematopoietic stem cell subtypes expand differentially during development and 
display distinct lymphopoietic programs. Cell stem cell 10, 273-283.
Bhanot, P, Fish, M, Jemison, JA, Nusse, R, Nathans, J, Cadigan, KM (1999) Frizzled 
and Dfrizzled-2 function as redundant receptors for Wingless during Drosophila 
embryonic development. Development 126, 4175-4186.
Bhat, RA, Stauffer, B, Della Pietra, A, Bodine, PV (2010) Wnt3-frizzled 1 chimera 
as a model to study canonical Wnt signaling. J Cell Biochem 109, 876-884.
Blankesteijn, WM, Essers-Janssen, YP, Ulrich, MM, Smits, JF (1996) Increased 
expression of a homologue of drosophila tissue polarity gene "frizzled" in left
106
ventricular hypertrophy in the rat, as identified by subtractive hybridization. J Mol 
Cell Cardiol 28, 1187-1191.
Blanpain, C, Fuchs, E (2009) Epidermal homeostasis: a balancing act of stem cells in 
the skin. Nature reviews 10, 207-217.
Blanpain, C, Lowry, WE, Geoghegan, A, Polak, L, Fuchs, E (2004) Self-renewal, 
multipotency, and the existence of two cell populations within an epithelial stem cell 
niche. Cell 118, 635-648.
Boisset, JC, van Cappellen, W, Andrieu-Soler, C, Galjart, N, Dzierzak, E, Robin, C
(2010) In vivo imaging of haematopoietic cells emerging from the mouse aortic 
endothelium. Nature 464, 116-120.
Boland, GM, Perkins, G, Hall, DJ, Tuan, RS (2004) Wnt 3a promotes proliferation 
and suppresses osteogenic differentiation of adult human MSCs. J Cell Biochem 93, 
1210-1230.
Boutros, M, Paricio, N, Strutt, DI, Mlodzik, M (1998) Dishevelled activates JNK and 
discriminates between JNK pathways in planar polarity and wingless signaling. Cell 
94, 109-118.
Boyden, LM, Mao, J, Belsky, J, Mitzner, L, Farhi, A, Mitnick, MA, Wu, D, Insogna, 
K, Lifton, RP (2002) High bone density due to a mutation in LDL-receptor-related 
protein 5. The New England journal of medicine 346, 1513-1521.
Butler, JM, Nolan, DJ, Vertes, EL, Vamum-Finney, B, Kobayashi, H, Hooper, AT, 
Seandel, M, Shido, K, White, IA, Kobayashi, M, Witte, L, May, C, Shawber, C, 
Kimura, Y, Kitajewski, J, Rosenwaks, Z, Bernstein, ID, Rafii, S (2010) Endothelial 
cells are essential for the self-renewal and repopulation of Notch-dependent 
hematopoietic stem cells. Cell stem cell 6, 251-264.
Calvi, LM, Adams, GB, Weibrecht, KW, Weber, JM, Olson, DP, Knight, MC, 
Martin, RP, Schipani, E, Divieti, P, Bringhurst, FR, Milner, LA, Kronenberg, HM, 
Scadden, DT (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. 
Nature 425, 841-846.
Challen, GA, Goodell, MA (2008) Promiscuous expression of H2B-GFP transgene in 
hematopoietic stem cells. PloS one 3, e2357.
Chang, J, Sonoyama, W, Wang, Z, Jin, Q, Zhang, C, Krebsbach, PH, Giannobile, W, 
Shi, S, Wang, CY (2007) Noncanonical Wnt-4 signaling enhances bone regeneration 
of MSCs in craniofacial defects through activation of p38 MAPK. The Journal of 
biological chemistry 282, 30938-30948.
Chen, CM, Struhl, G (1999) Wingless transduction by the Frizzled and Frizzled2 
proteins of Drosophila. Development 126, 5441-5452.
Chen, WS, Antic, D, Matis, M, Logan, CY, Povelones, M, Anderson, GA, Nusse, R, 
Axelrod, JD (2008) Asymmetric homotypic interactions of the atypical cadherin 
flamingo mediate intercellular polarity signaling. Cell 133, 1093-1105.
Christian, JL, Gavin, BJ, McMahon, AP, Moon, RT (1991) Isolation of cDNAs 
partially encoding four Xenopus Wnt-1/int-l-related proteins and characterization of 
their transient expression during embryonic development. Dev Biol 143, 230-234.
107
Ciani, L, Boyle, KA, Dickins, E, Sahores, M, Anane, D, Lopes, DM, Gibb, AJ, 
Salinas, PC (2011) Wnt7a signaling promotes dendritic spine growth and synaptic 
strength through Ca(2)/Calmodulin-dependent protein kinase II. Proceedings of the 
National Academy of Sciences of the United States of America 108, 10732-10737.
Clements, WK, Kim, AD, Ong, KG, Moore, JC, Lawson, ND, Traver, D (2011) A 
somitic W ntl6/Notch pathway specifies haematopoietic stem cells. Nature 474, 220- 
224.
Cobas, M, Wilson, A, Ernst, B, Mancini, SJ, MacDonald, HR, Kemler, R, Radtke, F 
(2004) Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. The Journal 
of experimental medicine 199,221-229.
Cotsarelis, G, Sun, TT, Lavker, RM (1990) Label-retaining cells reside in the bulge 
area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin 
carcinogenesis. Cell 61, 1329-1337.
De Calisto, J, Araya, C, Marchant, L, Riaz, CF, Mayor, R (2005) Essential role of 
non-canonical Wnt signalling in neural crest migration. Development (Cambridge, 
England) 132, 2587-2597.
Deininger, M, Buchdunger, E, Druker, BJ (2005) The development of imatinib as a 
therapeutic agent for chronic myeloid leukemia. Blood 105, 2640-2653.
Dejmek, J, Safholm, A, Kamp Nielsen, C, Andersson, T, Leandersson, K (2006) 
Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein 
kinase 1 alpha signaling in human mammary epithelial cells. Molecular and cellular 
biology 26, 6024-6036.
Devenport, D, Fuchs, E (2008) Planar polarization in embryonic epidermis 
orchestrates global asymmetric morphogenesis of hair follicles. Nature cell biology 
10, 1257-1268.
Ding, L, Saunders, TL, Enikolopov, G, Morrison, SJ (2012) Endothelial and 
perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462.
Dominici, M, Rasini, V, Bussolari, R, Chen, X, Hofmann, TJ, Spano, C, Bemabei, D, 
Veronesi, E, Bertoni, F, Paolucci, P, Conte, P, Horwitz, EM (2009) Restoration and 
reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow 
radioablation. Blood 114, 2333-2343.
Drouet, M, Mourcin, F, Grenier, N, Delaunay, C, Mayol, JF, Lataillade, JJ, 
Peinnequin, A, Herodin, F (2005) MSCs rescue CD34+ cells from radiation-induced 
apoptosis and sustain hematopoietic reconstitution after coculture and cografting in 
lethally irradiated baboons: is autologous stem cell therapy in nuclear accident 
settings hype or reality? BM Transplant 35, 1201-1209.
Elmslie, FV, Vivian, AJ, Gardiner, H, Hall, C, Mowat, AP, Winter, RM (1995) 
Alagille syndrome: family studies. J Med Genet 32, 264-268.
Ema, H, Morita, Y, Yamazaki, S, Matsubara, A, Seita, J, Tadokoro, Y, Kondo, H, 
Takano, H, Nakauchi, H (2006) Adult mouse hematopoietic stem cells: purification 
and single-cell assays. Nature protocols 1, 2979-2987.
108
Essers, MA, Offner, S, Blanco-Bose, WE, Waibler, Z, Kalinke, U, Duchosal, MA, 
Trumpp, A (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. 
Nature.
Etienne-Manneville, S, Hall, A (2001) Integrin-mediated activation of Cdc42 
controls cell polarity in migrating astrocytes through PKCzeta. Cell 106, 489-498.
Etienne-Manneville, S, Hall, A (2003) Cdc42 regulates GSK-3beta and adenomatous 
polyposis coli to control cell polarity. Nature 421, 753-756.
Flaherty, MP, Abdel-Latif, A, Li, Q, Hunt, G, Ranjan, S, Ou, Q, Tang, XL, Johnson, 
RK, Bolli, R, Dawn, B (2008) Noncanonical Wntl 1 signaling is sufficient to induce 
cardiomyogenic differentiation in unfractionated BM mononuclear cells. Circulation 
117, 2241-2252.
Fleming, HE, Janzen, V, Lo Celso, C, Guo, J, Leahy, KM, Kronenberg, HM, 
Scadden, DT (2008) Wnt signaling in the niche enforces hematopoietic stem cell 
quiescence and is necessary to preserve self-renewal in vivo. Cell stem cell 2, 274- 
283.
Florian, MC, Dorr, K, Niebel, A, Daria, D, Schrezenmeier, H, Rojewski, M, Filippi, 
MD, Hasenberg, A, Gunzer, M, Scharffetter-Kochanek, K, Zheng, Y, Geiger, H 
(2012) Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell 
stem cell 10, 520-530.
Fotaki, V, Dierssen, M, Alcantara, S, Martinez, S, Marti, E, Casas, C, Visa, J, 
Soriano, E, Estivill, X, Arbones, ML (2002) Dyrkl A haploinsufficiency affects 
viability and causes developmental delay and abnormal brain morphology in mice. 
Mol Cell Biol 22, 6636-6647.
Foudi, A, Hochedlinger, K, Van Buren, D, Schindler, JW, Jaenisch, R, Carey, V, 
Hock, H (2008) Analysis of histone 2B-GFP retention reveals slowly cycling 
hematopoietic stem cells. Nature biotechnology.
Friedenstein, AJ, Deriglasova, UF, Kulagina, NN, Panasuk, AF, Rudakowa, SF, 
Luria, EA, Ruadkow, IA (1974) Precursors for fibroblasts in different populations of 
hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2, 
83-92.
Friedenstein, AJ, Gorskaja, JF, Kulagina, NN (1976) Fibroblast precursors in normal 
and irradiated mouse hematopoietic organs. Exp Hematol 4, 267-274.
Friedenstein, AJ, Ivanov-Smolenski, AA, Chajlakjan, RK, Gorskaya, UF,
Kuralesova, Al, Latzinik, NW, Gerasimow, UW (1978) Origin ofBM stromal 
mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol 6, 440- 
444.
Fuentes, JJ, Genesca, L, Kingsbury, TJ, Cunningham, KW, Perez-Riba, M, Estivill, 
X, de la Luna, S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of 
calcineurin-mediated signaling pathways. Hum Mol Genet 9, 1681-1690.
Fujisaki, J, Wu, J, Carlson, AL, Silberstein, L, Putheti, P, Larocca, R, Gao, W, Saito, 
TI, Lo Celso, C, Tsuyuzaki, H, Sato, T, Cote, D, Sykes, M, Strom, TB, Scadden, DT,
109
Lin, CP (2011) In vivo imaging of Treg cells providing immune privilege to the 
haematopoietic stem-cell niche. Nature 474, 216-219.
Fukuda, T, Chen, L, Endo, T, Tang, L, Lu, D, Castro, JE, Widhopf, GF, 2nd, 
Rassenti, LZ, Cantwell, MJ, Prussak, CE, Carson, DA, Kipps, TJ (2008) Antisera 
induced by infusions of autologous Ad-CD 154-leukemia B cells identify ROR1 as an 
oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci U S A 105, 3047-3052.
Gelebart, P, Anand, M, Armanious, H, Peters, AC, Dien Bard, J, Amin, HM, Lai, R 
(2008) Constitutive activation of the Wnt canonical pathway in mantle cell 
lymphoma. Blood 112, 5171-5179.
Giles, RH, van Es, JH, Clevers, H (2003) Caught up in a Wnt storm: Wnt signaling 
in cancer. Biochim Biophys Acta 1653, 1-24.
Goss, AM, Tian, Y, Tsukiyama, T, Cohen, ED, Zhou, D, Lu, MM, Yamaguchi, TP, 
Morrisey, EE (2009) Wnt2/2b and beta-catenin signaling are necessary and sufficient 
to specify lung progenitors in the foregut. Developmental cell 17, 290-298.
Grassinger, J, Haylock, DN, Williams, B, Olsen, GH, Nilsson, SK (2010) 
Phenotypically identical hemopoietic stem cells isolated from different regions of 
BM have different biologic potential. Blood 116, 3185-3196.
Gregory, MA, Phang, TL, Neviani, P, Alvarez-Calderon, F, Eide, CA, O'Hare, T, 
Zaberezhnyy, V, Williams, RT, Druker, BJ, Perrotti, D, Degregori, J (2010) 
Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition 
of Bcr-Abl. Cancer Cell 18, 74-87.
Guo, J, Liu, M, Yang, D, Bouxsein, ML, Saito, H, Galvin, RJ, Kuhstoss, SA,
Thomas, CC, Schipani, E, Baron, R, Bringhurst, FR, Kronenberg, HM (2010) 
Suppression of Wnt signaling by Dkkl attenuates PTH-mediated stromal cell 
response and new bone formation. Cell Metab 11, 161-171.
Guo, N, Hawkins, C, Nathans, J (2004) Frizzled6 controls hair patterning in mice. 
Proc Natl Acad Sci U S A 101, 9277-9281.
Habas, R, Dawid, IB (2005) Dishevelled and Wnt signaling: is the nucleus the final 
frontier? J Biol 4, 2.
Habas, R, Dawid, IB, He, X (2003) Coactivation of Rac and Rho by Wnt/Frizzled 
signaling is required for vertebrate gastrulation. Genes Dev 17, 295-309.
Hardy, KM, Garriock, RJ, Yatskievych, TA, D'Agostino, SL, Antin, PB, Krieg, PA
(2008) Non-canonical Wnt signaling through Wnt5a/b and a novel Wntl 1 gene,
Wntl lb, regulates cell migration during avian gastrulation. Developmental biology 
320, 391-401.
Haug, JS, He, XC, Grindley, JC, Wunderlich, JP, Gaudenz, K, Ross, JT, Paulson, A, 
Wagner, KP, Xie, Y, Zhu, R, Yin, T, Perry, JM, Hembree, MJ, Redenbaugh, EP, 
Radice, GL, Seidel, C, Li, L (2008) N-cadherin expression level distinguishes 
reserved versus primed states of hematopoietic stem cells. Cell stem cell 2, 367-379.
Hauge, EM, Qvesel, D, Eriksen, EF, Mosekilde, L, Melsen, F (2001) Cancellous 
bone remodeling occurs in specialized compartments lined by cells expressing 
osteoblastic markers. J Bone Miner Res 16, 1575-1582.
110
He, XC, Yin, T, Grindley, JC, Tian, Q, Sato, T, Tao, WA, Dirisina, R, Porter- 
Westpfahl, KS, Hembree, M, Johnson, T, Wiedemann, LM, Barrett, TA, Hood, L, 
Wu, H, Li, L (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. 
Nature genetics 39, 189-198.
He, XC, Zhang, J, Tong, WG, Tawfik, O, Ross, J, Scoville, DH, Tian, Q, Zeng, X, 
He, X, Wiedemann, LM, Mishina, Y, Li, L (2004a) BMP signaling inhibits intestinal 
stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 
36, 1117-1121.
He, XC, Zhang, J, Tong, WG, Tawfik, O, Ross, J, Scoville, DH, Tian, Q, Zeng, X, 
He, X, Wiedemann, LM, Mishina, Y, Li, L (2004b) BMP signaling inhibits intestinal 
stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nature 
genetics 36, 1117-1121.
Heinonen, KM, Vanegas, JR, Lew, D, Krosl, J, Perreault, C (2011) Wnt4 enhances 
murine hematopoietic progenitor cell expansion through a planar cell polarity-like 
pathway. PloS one 6, e l9279.
Horsley, V, Aliprantis, AO, Polak, L, Glimcher, LH, Fuchs, E (2008) NFATcl 
balances quiescence and proliferation of skin stem cells. Cell 132, 299-310.
Hsieh, JC, Kodjabachian, L, Rebbert, ML, Rattner, A, Smallwood, PM, Samos, CH, 
Nusse, R, Dawid, IB, Nathans, J (1999) A new secreted protein that binds to Wnt 
proteins and inhibits their activities. Nature 398, 431 -436.
Huang, T, Xie, Z, Wang, J, Li, M, Jing, N, Li, L (2011) Nuclear factor of activated T 
cells (NFAT) proteins repress canonical Wnt signaling via its interaction with 
Dishevelled (Dvl) protein and participate in regulating neural progenitor cell 
proliferation and differentiation. The Journal of biological chemistry 286, 37399- 
37405.
Ikeya, M, Lee, SM, Johnson, JE, McMahon, AP, Takada, S (1997) Wnt signalling 
required for expansion of neural crest and CNS progenitors. Nature 389, 966-970.
Iozzo, RV, Eichstetter, I, Danielson, KG (1995) Aberrant expression of the growth 
factor Wnt-5A in human malignancy. Cancer Res 55, 3495-3499.
Ishikawa, T, Tamai, Y, Zorn, AM, Yoshida, H, Seldin, MF, Nishikawa, S, Taketo, 
MM (2001) Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental 
angiogenesis. Development (Cambridge, England) 128, 25-33.
Ishitani, T, Kishida, S, Hyodo-Miura, J, Ueno, N, Yasuda, J, Waterman, M, Shibuya, 
H, Moon, RT, Ninomiya-Tsuji, J, Matsumoto, K (2003) The TAK1-NLK mitogen- 
activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to 
antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23, 131-139.
Janda, CY, Waghray, D, Levin, AM, Thomas, C, Garcia, KC (2012) Structural basis 
of Wnt recognition by Frizzled. Science (New York, NY 337, 59-64.
Jeong, M, Piao, ZH, Kim, MS, Lee, SH, Yun, S, Sun, HN, Yoon, SR, Chung, JW, 
Kim, TD, Jeon, JH, Lee, J, Kim, HN, Choi, JY, Choi, I (2009) Thioredoxin- 
interacting protein regulates hematopoietic stem cell quiescence and mobilization 
under stress conditions. J Immunol 183, 2495-2505.
I l l
Jho, E-h, Zhang, T, Domon, C, Joo, C-K, Freund, J-N, Costantini, F (2002) 
Wnt/{beta}-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative 
Regulator of the Signaling Pathway. Mol Cell Biol 22, 1172-1183.
Jordan, BK, Shen, JH, Olaso, R, Ingraham, HA, Vilain, E (2003) Wnt4 
overexpression disrupts normal testicular vasculature and inhibits testosterone 
synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad 
Sci U S A 100, 10866-10871.
Kalajzic, I, Kalajzic, Z, Kalitema, M, Gronowicz, G, Clark, SH, Lichtler, AC, Rowe, 
D (2002) Use of type I collagen green fluorescent protein transgenes to identify 
subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 
17, 15-25.
Kang, S, Bennett, CN, Gerin, I, Rapp, LA, Hankenson, KD, Macdougald, OA (2007) 
Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by 
suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator- 
activated receptor gamma. J Biol Chem 282, 14515-14524.
Kennerdell, JR, Carthew, RW (1998) Use of dsRNA-mediated genetic interference to 
demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95, 1017- 
1026.
Kiel, MJ, Acar, M, Radice, GL, Morrison, SJ (2008) Hematopoietic Stem Cells Do 
Not Depend on N-Cadherin to Regulate Their Maintenance. Cell stem cell.
Kiel, MJ, Yilmaz, OH, Iwashita, T, Terhorst, C, Morrison, SJ (2005) SLAM family 
receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial 
niches for stem cells. Cell 121, 1109-1121.
Kimura, H, Usui, T, Tsubouchi, A, Uemura, T (2006) Potential dual molecular 
interaction of the Drosophila 7-pass transmembrane cadherin Flamingo in dendritic 
morphogenesis. Journal of cell science 119, 1118-1129.
Kirstetter, P, Anderson, K, Porse, BT, Jacobsen, SE, Nerlov, C (2006) Activation of 
the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and 
multilineage differentiation block. Nat Immunol 7, 1048-1056.
Kishida, S, Yamamoto, H, Hino, S, Ikeda, S, Kishida, M, Kikuchi, A (1999) DIX 
domains of Dvl and axin are necessary for protein interactions and their ability to 
regulate beta-catenin stability. Mol Cell Biol 19, 4414-4422.
Koga, T, Matsui, Y, Asagiri, M, Kodama, T, de Crombrugghe, B, Nakashima, K, 
Takayanagi, H (2005) NFAT and Osterix cooperatively regulate bone formation. Nat 
Med 11, 880-885.
Kohn, AD, Moon, RT (2005) Wnt and calcium signaling: beta-catenin-independent 
pathways. Cell Calcium 38, 439-446.
Koschmieder, S, Gottgens, B, Zhang, P, Iwasaki-Arai, J, Akashi, K, Kutok, JL, 
Dayaram, T, Geary, K, Green, AR, Tenen, DG, Huettner, CS (2005) Inducible 
chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a 
transgenic model of BCR-ABL leukemogenesis. Blood 105, 324-334.
112
Kuan, CY, Yang, DD, Samanta Roy, DR, Davis, RJ, Rakic, P, Flavell, RA (1999) 
The Jnkl and Jnk2 protein kinases are required for regional specific apoptosis during 
early brain development. Neuron 22, 661-616.
Kuo, CK, Tuan, RS (2008) Mechanoactive tenogenic differentiation of human 
MSCs. Tissue Eng Part A  14, 1615-1627.
Kurayoshi, M, Oue, N, Yamamoto, H, Kishida, M, Inoue, A, Asahara, T, Yasui, W, 
Kikuchi, A (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric 
cancer by stimulating cell migration and invasion. Cancer Res 66, 10439-10448.
Lan, Y, Ryan, RC, Zhang, Z, Bullard, SA, Bush, JO, Maltby, KM, Lidral, AC, Jiang, 
R (2006) Expression of Wnt9b and activation of canonical Wnt signaling during 
midfacial morphogenesis in mice. Developmental dynamics : an official publication 
of the American Association of Anatomists 235, 1448-1454.
Langmead, B, Trapnell, C, Pop, M, Salzberg, SL (2009) Ultrafast and memory- 
efficient alignment of short DNA sequences to the human genome. Genome biology 
10, R25.
Larsson, J, Karlsson, S (2005) The role of Smad signaling in hematopoiesis. 
Oncogene 24, 5676-5692.
Leatherman, JL, Dinardo, S Germline self-renewal requires cyst stem cells and stat 
regulates niche adhesion in Drosophila testes. Nat Cell Biol 12, 806-811.
Lee, JE, Wu, SF, Goering, LM, Dorsky, RI (2006) Canonical Wnt signaling through 
Lefl is required for hypothalamic neurogenesis. Development (Cambridge, England) 
133, 4451-4461.
Lee, KH, Dinner, AR, Tu, C, Campi, G, Raychaudhuri, S, Varma, R, Sims, TN, 
Burack, WR, Wu, H, Wang, J, Kanagawa, O, Markiewicz, M, Allen, PM, Dustin, 
ML, Chakraborty, AK, Shaw, AS (2003) The immunological synapse balances T cell 
receptor signaling and degradation. Science (New York, NY 302, 1218-1222.
Lejeune, S, Huguet, EL, Hamby, A, Poulsom, R, Harris, AL (1995) Wnt5a cloning, 
expression, and up-regulation in human primary breast cancers. Clin Cancer Res 1, 
215-222.
Levesque, JP, Helwani, FM, Winkler, IG (2010) The endosteal 'osteoblastic' niche 
and its role in hematopoietic stem cell homing and mobilization. Leukemia 24, 1979- 
1992.
Li, C, Chen, H, Hu, L, Xing, Y, Sasaki, T, Villosis, MF, Li, J, Nishita, M, Minami,
Y, Minoo, P (2008) Ror2 modulates the canonical Wnt signaling in lung epithelial 
cells through cooperation with Fzd2. BMC molecular biology 9, 11.
Li, J, Sarosi, I, Cattley, RC, Pretorius, J, Asuncion, F, Grisanti, M, Morony, S, 
Adamu, S, Geng, Z, Qiu, W, Kostenuik, P, Lacey, DL, Simonet, WS, Bolon, B,
Qian, X, Shalhoub, V, Ominsky, MS, Zhu Ke, H, Li, X, Richards, WG (2006) Dkkl- 
mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39, 754- 
766.
Li, L, Clevers, H (2010) Coexistence of quiescent and active adult stem cells in 
mammals. Science (New York, NY 327, 542-545.
113
Liang, H, Chen, Q, Coles, AH, Anderson, SJ, Pihan, G, Bradley, A, Gerstein, R, 
Jurecic, R, Jones, SN (2003) Wnt5a inhibits B cell proliferation and functions as a 
tumor suppressor in hematopoietic tissue. Cancer Cell 4, 349-360.
Lindsley, RC, Gill, JG, Kyba, M, Murphy, TL, Murphy, KM (2006) Canonical Wnt 
signaling is required for development of embryonic stem cell-derived mesoderm. 
Development (Cambridge, England) 133, 3787-3796.
Liu, G, Bafico, A, Aaronson, SA (2005) The mechanism of endogenous receptor 
activation functionally distinguishes prototype canonical and noncanonical Wnts. 
Mol Cell Biol 25, 3475-3482.
Liu, P, Wakamiya, M, Shea, MJ, Albrecht, U, Behringer, RR, Bradley, A (1999) 
Requirement for Wnt3 in vertebrate axis formation. Nature genetics 22, 361-365.
Logan, CY, Nusse, R (2004) The Wnt signaling pathway in development and 
disease. Annu Rev Cell Dev Biol 20, 781-810.
Longo, KA, Wright, WS, Kang, S, Gerin, I, Chiang, SH, Lucas, PC, Opp, MR, 
MacDougald, OA (2004) Wntl 0b inhibits development of white and brown adipose 
tissues. The Journal of biological chemistry 279, 35503-35509.
Louis, I, Heinonen, KM, Chagraoui, J, Vainio, S, Sauvageau, G, Perreault, C (2008) 
The signaling protein Wnt4 enhances thymopoiesis and expands multipotent 
hematopoietic progenitors through beta-catenin-independent signaling. Immunity 29, 
57-67.
Luis, TC, Naber, BA, Roozen, PP, Brugman, MH, de Haas, EF, Ghazvini, M, Fibbe, 
WE, van Dongen, JJ, Fodde, R, Staal, FJ (2011) Canonical wnt signaling regulates 
hematopoiesis in a dosage-dependent fashion. Cell stem cell 9, 345-356.
Luo, J, Chen, J, Deng, ZL, Luo, X, Song, WX, Sharff, KA, Tang, N, Haydon, RC, 
Luu, HH, He, TC (2007) Wnt signaling and human diseases: what are the therapeutic 
implications? Lab Invest 87, 97-103.
Lyden, D, Hattori, K, Dias, S, Costa, C, Blaikie, P, Butros, L, Chadbum, A, Heissig, 
B, Marks, W, Witte, L, Wu, Y, Hicklin, D, Zhu, Z, Hackett, NR, Crystal, RG,
Moore, MA, Hajjar, KA, Manova, K, Benezra, R, Rafii, S (2001) Impaired 
recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells 
blocks tumor angiogenesis and growth. Nat Med 7, 1194-1201.
Lymperi, S, Ersek, A, Ferraro, F, Dazzi, F, Horwood, NJ (2011) Inhibition of 
osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117, 
1540-1549.
Lymperi, S, Horwood, N, Marley, S, Gordon, MY, Cope, AP, Dazzi, F (2008) 
Strontium can increase some osteoblasts without increasing hematopoietic stem cells. 
Blood 111, 1173-1181.
Lyuksyutova, Al, Lu, CC, Milanesio, N, King, LA, Guo, N, Wang, Y, Nathans, J, 
Tessier-Lavigne, M, Zou, Y (2003) Anterior-posterior guidance of commissural 
axons by Wnt-frizzled signaling. Science 302, 1984-1988.
Ma, L, Wang, HY (2007) Mitogen-activated protein kinase p38 regulates the 
Wnt/cyclic GMP/Ca2+ non-canonical pathway. J Biol Chem 282, 28980-28990.
114
Macian, F (2005) NFAT proteins: key regulators of T-cell development and function. 
Nat Rev Immunol 5, 472-484.
Mahmood, A, Napoli, C, Aldahmash, A (2011) In vitro differentiation and 
maturation of human embryonic stem cell into multipotent cells. Stem cells 
international 2011, 735420.
Malhotra, S, Kincade, PW (2009) Wnt-related molecules and signaling pathway 
equilibrium in hematopoiesis. Cell stem cell 4, 27-36.
Martin, V, Agirre, X, Jimenez-Velasco, A, Jose-Eneriz, ES, Cordeu, L, Garate, L, 
Vilas-Zomoza, A, Castillejo, JA, Heiniger, A, Prosper, F, Torres, A, Roman-Gomez, 
J (2008) Methylation status of Wnt signaling pathway genes affects the clinical 
outcome of Philadelphia-positive acute lymphoblastic leukemia. Cancer Sci 99, 
1865-1868.
Matthews, HK, Marchant, L, Carmona-Fontaine, C, Kuriyama, S, Larrain, J, Holt, 
MR, Parsons, M, Mayor, R (2008) Directional migration of neural crest cells in vivo 
is regulated by Syndecan-4/Racl and non-canonical Wnt signaling/RhoA. 
Development 135, 1771-1780.
Mendez-Ferrer, S, Michurina, TV, Ferraro, F, Mazloom, AR, Macarthur, BD, Lira, 
SA, Scadden, DT, Ma'ayan, A, Enikolopov, GN, Frenette, PS Mesenchymal and 
haematopoietic stem cells form a unique BM niche. Nature 466, 829-834.
Mendez-Ferrer, S, Michurina, TV, Ferraro, F, Mazloom, AR, Macarthur, BD, Lira, 
SA, Scadden, DT, Ma'ayan, A, Enikolopov, GN, Frenette, PS (2010) Mesenchymal 
and haematopoietic stem cells form a unique BM niche. Nature 466, 829-834.
Merkel, CE, Kamer, CM, Carroll, TJ (2007) Molecular regulation of kidney 
development: is the answer blowing in the Wnt? Pediatr Nephrol 22, 1825-1838.
Mignone, JL, Kukekov, V, Chiang, AS, Steindler, D, Enikolopov, G (2004) Neural 
stem and progenitor cells in nestin-GFP transgenic mice. The Journal of comparative 
neurology 469, 311 -324.
Miharada, K, Karlsson, G, Rehn, M, Rorby, E, Siva, K, Cammenga, J, Karlsson, S
(2011) Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor 
through cell surface receptor GRP78. Cell stem cell 9, 330-344.
Mikels, AJ, Nusse, R (2006) Purified Wnt5a protein activates or inhibits beta- 
catenin-TCF signaling depending on receptor context. PLoS Biol 4, e l 15.
Mikkola, HK, Orkin, SH (2006) The journey of developing hematopoietic stem cells. 
Development (Cambridge, England) 133, 3733-3744.
Miller, CL, Eaves, CJ (1997) Expansion in vitro of adult murine hematopoietic stem 
cells with transplantable lympho-myeloid reconstituting ability. Proceedings of the 
National Academy of Sciences of the United States of America 94, 13648-13653.
Miller, SC, Jee, WS (1987) The bone lining cell: a distinct phenotype? Calcified 
tissue international 41, 1-5.
115
Minta, A, Kao, JP, Tsien, RY (1989) Fluorescent indicators for cytosolic calcium 
based on rhodamine and fluorescein chromophores. The Journal of biological 
chemistry 264, 8171-8178.
Monticelli, S, Rao, A (2002) NFAT1 and NFAT2 are positive regulators of IL-4 
gene transcription. European journal of immunology 32, 2971-2978.
Moon, RT (1993) In pursuit of the functions of the Wnt family of developmental 
regulators: insights from Xenopus laevis. Bioessays 15, 91-97.
Moon, RT, Kohn, AD, De Ferrari, GV, Kaykas, A (2004) WNT and beta-catenin 
signalling: diseases and therapies. Nat Rev Genet 5, 691-701.
Morgan, R, El-Kadi, AM, Theokli, C (2003) Flamingo, a cadherin-type receptor 
involved in the Drosophila planar polarity pathway, can block signaling via the 
canonical wnt pathway in Xenopus laevis. The International journal of 
developmental biology 47, 245-252.
Morrison, SJ, Wright, DE, Weissman, IL (1997) Cyclophosphamide/granulocyte 
colony-stimulating factor induces hematopoietic stem cells to proliferate prior to 
mobilization. Proceedings of the National Academy of Sciences of the United States 
of America 94, 1908-1913.
Muller, MR, Sasaki, Y, Stevanovic, I, Lamperti, ED, Ghosh, S, Sharma, S, Gelinas, 
C, Rossi, DJ, Pipkin, ME, Rajewsky, K, Hogan, PG, Rao, A (2009) Requirement for 
balanced Ca/NFAT signaling in hematopoietic and embryonic development. 
Proceedings of the National Academy of Sciences of the United States of America 
106, 7034-7039.
Mulroy, T, McMahon, JA, Burakoff, SJ, McMahon, AP, Sen, J (2002) Wnt-1 and 
Wnt-4 regulate thymic cellularity. European journal of immunology 32, 967-971.
Murdoch, B, Chadwick, K, Martin, M, Shojaei, F, Shah, KV, Gallacher, L, Moon, 
RT, Bhatia, M (2003) Wnt-5A augments repopulating capacity and primitive 
hematopoietic development of human blood stem cells in vivo. Proceedings of the 
National Academy of Sciences of the United States of America 100, 3422-3427.
Nakano, T, Kodama, H, Honjo, T (1994) Generation of lymphohematopoietic cells 
from embryonic stem cells in culture. Science (New York, NY 265, 1098-1101.
Naveiras, O, Nardi, V, Wenzel, PL, Hauschka, PV, Fahey, F, Daley, GQ (2009)
B one-marrow adipocytes as negative regulators of the haematopoietic 
microenvironment. Nature 460, 259-263.
Nelson, WJ, Nusse, R (2004) Convergence of Wnt, beta-catenin, and cadherin 
pathways. Science 303, 1483-1487.
Nemeth, MJ, Mak, KK, Yang, Y, Bodine, DM (2009) beta-Catenin expression in the 
BM microenvironment is required for long-term maintenance of primitive 
hematopoietic cells. Stem cells (Dayton, Ohio) 27, 1109-1119.
Nemeth, MJ, Topol, L, Anderson, SM, Yang, Y, Bodine, DM (2007) Wnt5a inhibits 
canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. 
Proceedings of the National Academy of Sciences of the United States of America 
104, 15436-15441.
116
Nilsson, SK, Johnston, HM, Coverdale, JA (2001) Spatial localization of 
transplanted hemopoietic stem cells: inferences for the localization of stem cell 
niches. Blood 97, 2293-2299.
Nusse, R, Varmus, HE (1982) Many tumors induced by the mouse mammary tumor 
virus contain a provirus integrated in the same region of the host genome. Cell 31, 
99-109.
Nygren, MK, Dosen, G, Hystad, ME, Stubberud, H, Funderud, S, Rian, E (2007) 
Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) 
cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 136, 400-413.
Ohira, T, Gemmill, RM, Ferguson, K, Kusy, S, Roche, J, Brambilla, E, Zeng, C, 
Baron, A, Bemis, L, Erickson, P, Wilder, E, Rustgi, A, Kitajewski, J, Gabrielson, E, 
Bremnes, R, Franklin, W, Drabkin, HA (2003) WNT7a induces E-cadherin in lung 
cancer cells. Proceedings of the National Academy of Sciences of the United States 
of America 100, 10429-10434.
Olson, DJ, Gibo, DM (1998) Antisense wnt-5a mimics wnt-1-mediated C57MG 
mammary epithelial cell transformation. Exp Cell Res 241, 134-141.
Olson, DJ, Gibo, DM, Saggers, G, Debinski, W, Kumar, R (1997) Reversion of 
uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a. Cell 
Growth Differ 8, 417-423.
Omatsu, Y, Sugiyama, T, Kohara, H, Kondoh, G, Fujii, N, Kohno, K, Nagasawa, T 
(2010) The essential functions of adipo-osteogenic progenitors as the hematopoietic 
stem and progenitor cell niche. Immunity 33, 387-399.
Parkin, DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2, 533- 
543.
Parr, BA, Cornish, VA, Cybulsky, MI, McMahon, AP (2001) Wnt7b regulates 
placental development in mice. Developmental biology 237, 324-332.
Perry, JM, He, XC, Sugimura, R, Grindley, JC, Haug, JS, Ding, S, Li, L (201 la) 
Cooperation between both Wnt/(beta)-catenin and PTEN/PI3K/Akt signaling 
promotes primitive hematopoietic stem cell self-renewal and expansion. Genes & 
development 25, 1928-1942.
Perry, JM, He, XC, Sugimura, R, Grindley, JC, Haug, JS, Ding, S, Li, L (2011b) 
Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling 
promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev.
Perry, JM, Li, L (2007) Disrupting the stem cell niche: good seeds in bad soil. Cell 
129, 1045-1047.
Perry, JM, Li, L (2012) To be or not to be a stem cell: dissection of cellular and 
molecular components of haematopoietic stem cell niches. The EMBO journal 31, 
1060-1061.
Pinto, D, Gregorieff, A, Begthel, H, Clevers, H (2003) Canonical Wnt signals are 
essential for homeostasis of the intestinal epithelium. Genes & development 17, 
1709-1713.
117
Piters, E, Boudin, E, Van Hul, W (2008) Wnt signaling: a win for bone. Arch 
Biochem Biophys 473, 112-116.
Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD, 
Moorman, MA, Simonetti, DW, Craig, S, Marshak, DR (1999) Multilineage 
potential of adult human MSCs. Science (New York, NY 284, 143-147.
Planutis, K, Planutiene, M, Moyer, MP, Nguyen, AV, Perez, CA, Holcombe, RF
(2007) Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC 
cell biology 8, 12.
Pukrop, T, Klemm, F, Hagemann, T, Gradl, D, Schulz, M, Siemes, S, Trumper, L, 
Binder, C (2006) Wnt 5a signaling is critical for macrophage-induced invasion of 
breast cancer cell lines. Proc Natl Acad Sci U S A 103, 5454-5459.
Raaijmakers, MH, Mukherjee, S, Guo, S, Zhang, S, Kobayashi, T, Schoonmaker, JA, 
Ebert, BL, Al-Shahrour, F, Hasserjian, RP, Scadden, EO, Aung, Z, Matza, M, 
Merkenschlager, M, Lin, C, Rommens, JM, Scadden, DT (2010) Bone progenitor 
dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852-857.
Raggatt, LJ, Partridge, NC (2010) Cellular and molecular mechanisms of bone 
remodeling. The Journal of biological chemistry 285, 25103-25108.
Ranheim, EA, Kwan, HC, Reya, T, Wang, YK, Weissman, IL, Francke, U (2005) 
Frizzled 9 knock-out mice have abnormal B-cell development. Blood 105, 2487- 
2494.
Rasmussen, JT, Deardorff, MA, Tan, C, Rao, MS, Klein, PS, Vetter, ML (2001) 
Regulation of eye development by frizzled signaling in Xenopus. Proceedings of the 
National Academy of Sciences of the United States of America 98, 3861-3866.
Renstrom, J, Istvanffy, R, Gauthier, K, Shimono, A, Mages, J, Jardon-Alvarez, A, 
Kroger, M, Schiemann, M, Busch, DH, Esposito, I, Lang, R, Peschel, C, Oostendorp, 
RA (2009) Secreted ffizzled-related protein 1 extrinsically regulates cycling activity 
and maintenance of hematopoietic stem cells. Cell stem cell 5, 157-167.
Reya, T, Clevers, H (2005) Wnt signalling in stem cells and cancer. Nature 434, 843- 
850.
Reya, T, Duncan, AW, Ailles, L, Domen, J, Scherer, DC, Willert, K, Hintz, L,
Nusse, R, Weissman, IL (2003) A role for Wnt signalling in self-renewal of 
haematopoietic stem cells. Nature 423, 409-414.
Reya, T, Morrison, SJ, Clarke, MF, Weissman, IL (2001) Stem cells, cancer, and 
cancer stem cells. Nature 414, 105-111.
Roman-Gomez, J, Jimenez-Velasco, A, Cordeu, L, Vilas-Zomoza, A, San Jose- 
Eneriz, E, Garate, L, Castillejo, JA, Martin, V, Prosper, F, Heiniger, A, Torres, A, 
Agirre, X (2007) WNT5A, a putative tumour suppressor of lymphoid malignancies, 
is inactivated by aberrant methylation in acute lymphoblastic leukaemia. Eur J 
Cancer 43, 2736-2746.
Rousselot, P, Huguet, F, Rea, D, Legros, L, Cayuela, JM, Maarek, O, Blanchet, O, 
Marit, G, Gluckman, E, Reiffers, J, Gardembas, M, Mahon, FX (2007) Imatinib
118
mesylate discontinuation in patients with chronic myelogenous leukemia in complete 
molecular remission for more than 2 years. Blood 109, 58-60.
Sancho, E, Batlle, E, Clevers, H (2004) Signaling pathways in intestinal development 
and cancer. Annual review of cell and developmental biology 20, 695-723.
Saneyoshi, T, Kume, S, Amasaki, Y, Mikoshiba, K (2002) The Wnt/calcium 
pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature 
417, 295-299.
Schaniel, C, Sirabella, D, Qiu, J, Niu, X, Lemischka, IR, Moore, KA (2011) Wnt- 
inhibitory factor 1 dysregulation of the BM niche exhausts hematopoietic stem cells. 
Blood.
Scheller, M, Huelsken, J, Rosenbauer, F, Taketo, MM, Birchmeier, W, Tenen, DG, 
Leutz, A (2006) Hematopoietic stem cell and multilineage defects generated by 
constitutive [beta]-catenin activation. Nature immunology 7, 1037-1047.
Schlessinger, K, Hall, A, Tolwinski, N (2009) Wnt signaling pathways meet Rho 
GTPases. Genes Dev 23, 265-277.
Schlessinger, K, McManus, EJ, Hall, A (2007) Cdc42 and noncanonical Wnt signal 
transduction pathways cooperate to promote cell polarity. J Cell Biol 178, 355-361.
Schmidt, C, McGonnell, IM, Allen, S, Otto, A, Patel, K (2007) Wnt6 controls 
amniote neural crest induction through the non-canonical signaling pathway. 
Developmental dynamics : an official publication of the American Association of 
Anatomists 236, 2502-2511.
Schofield, R (1978) The relationship between the spleen colony-forming cell and the 
haemopoietic stem cell. Blood Cells 4, 7-25.
Scoville, DH, Sato, T, He, XC, Li, L (2008) Current view: intestinal stem cells and 
signaling. Gastroenterology 134, 849-864.
Semenov, MV, Habas, R, Macdonald, BT, He, X (2007) Snapshot: Noncanonical 
Wnt Signaling Pathways. Cell 131, 1378.
Sen, B, Styner, M, Xie, Z, Case, N, Rubin, CT, Rubin, J (2009) Mechanical loading 
regulates NFATcl and beta-catenin signaling through a GSK3beta control node. J 
Biol Chem 284, 34607-34617.
Sharma, RP, Chopra, VL (1976) Effect of the Wingless (wgl) mutation on wing and 
haltere development in Drosophila melanogaster. Developmental biology 48, 461- 
465.
Sheldahl, LC, Slusarski, DC, Pandur, P, Miller, JR, Kuhl, M, Moon, RT (2003) 
Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell 
Biol 161, 769-777.
Shima, Y, Kawaguchi, SY, Kosaka, K, Nakayama, M, Hoshino, M, Nabeshima, Y, 
Hirano, T, Uemura, T (2007) Opposing roles in neurite growth control by two seven- 
pass transmembrane cadherins. Nat Neurosci 10, 963-969.
119
Shima, Y, Kengaku, M, Hirano, T, Takeichi, M, Uemura, T (2004) Regulation of 
dendritic maintenance and growth by a mammalian 7-pass transmembrane cadherin. 
Developmental cell 7, 205-216.
Slusarski, DC, Yang-Snyder, J, Busa, WB, Moon, RT (1997) Modulation of 
embryonic intracellular Ca2+ signaling by Wnt-5A. Dev Biol 182, 114-120.
Sousa, KM, Villaescusa, JC, Cajanek, L, Ondr, JK, Castelo-Branco, G, Hofstra, W, 
Bryja, V, Palmberg, C, Bergman, T, Wainwright, B, Lang, RA, Arenas, E (2010) 
Wnt2 regulates progenitor proliferation in the developing ventral midbrain. The 
Journal of biological chemistry 285, 7246-7253.
Spater, D, Hill, TP, Gruber, M, Hartmann, C (2006) Role of canonical Wnt- 
signalling in joint formation. European cells & materials 12, 71-80.
Sugimura, R, Li, L (2010) Shifting in balance between osteogenesis and 
adipogenesis substantially influences hematopoiesis. J Mol Cell Biol 2, 61-62.
Sugiyama, T, Kohara, H, Noda, M, Nagasawa, T (2006) Maintenance of the 
hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in BM 
stromal cell niches. Immunity 25, 977-988.
Takada, I, Mihara, M, Suzawa, M, Ohtake, F, Kobayashi, S, Igarashi, M, Youn, MY, 
Takeyama, K, Nakamura, T, Mezaki, Y, Takezawa, S, Yogiashi, Y, Kitagawa, H, 
Yamada, G, Takada, S, Minami, Y, Shibuya, H, Matsumoto, K, Kato, S (2007) A 
histone lysine methyltransferase activated by non-canonical Wnt signalling 
suppresses PPAR-gamma transactivation. Nature cell biology 9, 1273-1285.
Tissir, F, Bar, I, Jossin, Y, De Backer, O, Goffinet, AM (2005) Protocadherin Celsr3 
is crucial in axonal tract development. Nat Neurosci 8, 451-457.
Tissir, F, De-Backer, O, Goffinet, AM, Lambert de Rouvroit, C (2002) 
Developmental expression profiles of Celsr (Flamingo) genes in the mouse. Mech 
Dev 112, 157-160.
Tissir, F, Qu, Y, Montcouquiol, M, Zhou, L, Komatsu, K, Shi, D, Fujimori, T, 
Labeau, J, Tyteca, D, Courtoy, P, Poumay, Y, Uemura, T, Goffinet, AM Lack of 
cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal 
hydrocephalus. Nat Neurosci 13, 700-707.
Tissir, F, Qu, Y, Montcouquiol, M, Zhou, L, Komatsu, K, Shi, D, Fujimori, T, 
Labeau, J, Tyteca, D, Courtoy, P, Poumay, Y, Uemura, T, Goffinet, AM (2010) Lack 
of cadherins Celsr2 and Celsr3 impairs ependymal ciliogenesis, leading to fatal 
hydrocephalus. Nat Neurosci 13, 700-707.
Trapnell, C, Pachter, L, Salzberg, SL (2009) TopHat: discovering splice junctions 
with RNA-Seq. Bioinformatics 25, 1105-1 111.
Trapnell, C, Williams, BA, Pertea, G, Mortazavi, A, Kwan, G, van Baren, MJ, 
Salzberg, SL, Wold, BJ, Pachter, L (2010) Transcript assembly and quantification by 
RNA-Seq reveals unannotated transcripts and isoform switching during cell 
differentiation. Nature biotechnology 28, 511-515.
120
Tumbar, T, Guasch, G, Greco, V, Blanpain, C, Lowry, WE, Rendl, M, Fuchs, E 
(2004) Defining the epithelial stem cell niche in skin. Science (New York, NY 303, 
359-363.
Uccelli, A, Moretta, L, Pistoia, V (2008) MSCs in health and disease. Nat Rev 
Immunol.
Usui, T, Shima, Y, Shimada, Y, Hirano, S, Burgess, RW, Schwarz, TL, Takeichi, M, 
Uemura, T (1999) Flamingo, a seven-pass transmembrane cadherin, regulates planar 
cell polarity under the control of Frizzled. Cell 98, 585-595.
van Amerongen, R, Bems, A (2006) Knockout mouse models to study Wnt signal 
transduction. Trends Genet 22, 678-689.
van de Wetering, M, Sancho, E, Verweij, C, de Lau, W, Oving, I, Hurlstone, A, van 
der Horn, K, Batlle, E, Coudreuse, D, Haramis, AP, Tjon-Pon-Fong, M, Moerer, P, 
van den Bom, M, Soete, G, Pals, S, Eilers, M, Medema, R, Clevers, H (2002) The 
beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal 
cancer cells. Cell 111, 241-250.
van Es, JH, Jay, P, Gregorieff, A, van Gijn, ME, Jonkheer, S, Hatzis, P, Thiele, A, 
van den Bom, M, Begthel, H, Brabletz, T, Taketo, MM, Clevers, H (2005) Wnt 
signalling induces maturation of Paneth cells in intestinal crypts. Nature cell biology 
7, 381-386.
van Gijn, ME, Daemen, MJ, Smits, JF, Blankesteijn, WM (2002) The wnt-frizzled 
cascade in cardiovascular disease. Cardiovasc Res 55, 16-24.
Veeman, MT, Axelrod, JD, Moon, RT (2003) A second canon. Functions and 
mechanisms of beta-catenin-independent Wnt signaling. Developmental cell 5, 367- 
377.
Vijayaragavan, K, Szabo, E, Bosse, M, Ramos-Mejia, V, Moon, RT, Bhatia, M
(2009) Noncanonical Wnt signaling orchestrates early developmental events toward 
hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 4, 248-262.
Visnjic, D, Kalajzic, Z, Rowe, DW, Katavic, V, Lorenzo, J, Aguila, HL (2004) 
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. 
Blood 103, 3258-3264.
Wallingford, JB, Habas, R (2005) The developmental biology of Dishevelled: an 
enigmatic protein governing cell fate and cell polarity. Development (Cambridge, 
England) 132, 4421-4436.
Wallingford, JB, Vogeli, KM, Harland, RM (2001) Regulation of convergent 
extension in Xenopus by Wnt5a and Frizzled-8 is independent of the canonical Wnt 
pathway. The International journal of developmental biology 45, 225-227.
Wang, Y, Guo, N, Nathans, J (2006) The role of Frizzled3 and Frizzled6 in neural 
tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci 26, 
2147-2156.
Wang, Y, Thekdi, N, Smallwood, PM, Macke, JP, Nathans, J (2002) Frizzled-3 is 
required for the development of major fiber tracts in the rostral CNS. J Neurosci 22, 
8563-8573.
121
Wang, YJ, Chen, GH, Hu, XY, Lu, YP, Zhou, JN, Liu, RY (2005a) The expression 
of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of 
patients with Alzheimer's disease and its links with AD-related pathology. Brain Res 
1031, 101-108.
Wang, Z, Shu, W, Lu, MM, Morrisey, EE (2005b) Wnt7b activates canonical 
signaling in epithelial and vascular smooth muscle cells through interactions with 
Fzdl, FzdlO, and LRP5. Molecular and cellular biology 25, 5022-5030.
Weeraratna, AT, Jiang, Y, Hostetter, G, Rosenblatt, K, Duray, P, Bittner, M, Trent, 
JM (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic 
melanoma. Cancer Cell 1, 279-288.
Weissman, IL, Anderson, DJ, Gage, F (2001) Stem and progenitor cells: origins, 
phenotypes, lineage commitments, and transdifferentiations. Annual review of cell 
and developmental biology 17, 387-403.
Weston, CR, Wong, A, Hall, JP, Goad, ME, Flavell, RA, Davis, RJ (2003) JNK 
initiates a cytokine cascade that causes Pax2 expression and closure of the optic 
fissure. Genes Dev 17, 1271-1280.
Wilson, A, Laurenti, E, Oser, G, van der Wath, RC, Blanco-Bose, W, Jaworski, M, 
Offner, S, Dunant, CF, Eshkind, L, Bockamp, E, Lio, P, Macdonald, HR, Trumpp, A
(2008) Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self- 
Renewal during Homeostasis and Repair. Cell 135, 1118-1129.
Wilson, A, Trumpp, A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat 
Rev Immunol 6, 93-106.
Xie, T, Spradling, AC (1998) Decapentaplegic is essential for the maintenance and 
division of germline stem cells in the Drosophila ovary. Cell 94, 251-260.
Xie, Y, Yin, T, Wiegraebe, W, He, XC, Miller, D, Stark, D, Perko, K, Alexander, R, 
Schwartz, J, Grindley, JC, Park, J, Haug, JS, Wunderlich, JP, Li, H, Zhang, S, 
Johnson, T, Feldman, RA, Li, L (2009) Detection of functional haematopoietic stem 
cell niche using real-time imaging. Nature 457, 97-101.
Yamanaka, H, Moriguchi, T, Masuyama, N, Kusakabe, M, Hanafusa, H, Takada, R, 
Takada, S, Nishida, E (2002) JNK functions in the non-canonical Wnt pathway to 
regulate convergent extension movements in vertebrates. EMBO Rep 3, 69-75.
Yamazaki, S, Ema, H, Karlsson, G, Yamaguchi, T, Miyoshi, H, Shioda, S, Taketo, 
MM, Karlsson, S, Iwama, A, Nakauchi, H (2011) Nonmyelinating schwann cells 
maintain hematopoietic stem cell hibernation in the BM niche. Cell 147, 1146-1158.
Yang, FC, Atkinson, SJ, Gu, Y, Borneo, JB, Roberts, AW, Zheng, Y, Pennington, J, 
Williams, DA (2001) Rac and Cdc42 GTPases control hematopoietic stem cell 
shape, adhesion, migration, and mobilization. Proceedings of the National Academy 
of Sciences of the United States of America 98, 5614-5618,
Yang, L, Bryder, D, Adolfsson, J, Nygren, J, Mansson, R, Sigvardsson, M, Jacobsen, 
SE (2005) Identification of Lin(-)Scal(+)kit(+)CD34(+)Flt3- short-term 
hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated 
transplant recipients. Blood 105, 2717-2723.
122
Yang, L, Wang, L, Geiger, H, Cancelas, JA, Mo, J, Zheng, Y (2007) Rho GTPase 
Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the 
BM. Proceedings of the National Academy of Sciences of the United States of 
America 104, 5091-5096.
Ye, L, Fan, Z, Yu, B, Chang, J, Al Hezaimi, K, Zhou, X, Park, NH, Wang, CY
(2012) Histone Demethylases KDM4B and KDM6B Promotes Osteogenic 
Differentiation of Human MSCs. Cell stem cell 11, 50-61.
Ye, X, Wang, Y, Rattner, A, Nathans, J (2011) Genetic mosaic analysis reveals a 
major role for frizzled 4 and frizzled 8 in controlling ureteric growth in the 
developing kidney. Development (Cambridge, England) 138, 1161-1172.
Yilmaz, OH, Valdez, R, Theisen, BK, Guo, W, Ferguson, DO, Wu, H, Morrison, SJ 
(2006a) Pten dependence distinguishes haematopoietic stem cells from leukaemia- 
initiating cells. Nature 441, 475-482.
Yilmaz, OH, Valdez, R, Theisen, BK, Guo, W, Ferguson, DO, Wu, H, Morrison, SJ 
(2006b) Pten dependence distinguishes haematopoietic stem cells from leukaemia- 
initiating cells. Nature 441, 475-482.
Ying, Q-L, Wray, J, Nichols, J, Batlle-Morera, L, Doble, B, Woodgett, J, Cohen, P, 
Smith, A (2008) The ground state of embryonic stem cell self-renewal. Nature 453, 
519-523.
Yoshihara, H, Arai, F, Hosokawa, K, Hagiwara, T, Takubo, K, Nakamura, Y, Gomei, 
Y, Iwasaki, H, Matsuoka, S, Miyamoto, K, Miyazaki, H, Takahashi, T, Suda, T 
(2007) Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence 
and interaction with the osteoblastic niche. Cell stem cell 1, 685-697.
You, L, He, B, Uematsu, K, Xu, Z, Mazieres, J, Lee, A, McCormick, F, Jablons, DM
(2004) Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient 
mesothelioma cells. Cancer research 64, 3474-3478.
Zhang, J, Grindley, JC, Yin, T, Jayasinghe, S, He, XC, Ross, JT, Haug, JS, Rupp, D, 
Porter-Westpfahl, KS, Wiedemann, LM, Wu, H, Li, L (2006) PTEN maintains 
haematopoietic stem cells and acts in lineage choice and leukaemia prevention. 
Nature 441, 518-522.
Zhang, J, Niu, C, Ye, L, Huang, H, He, X, Tong, WG, Ross, J, Haug, J, Johnson, T, 
Feng, JQ, Harris, S, Wiedemann, LM, Mishina, Y, Li, L (2003a) Identification of the 
haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841.
Zhang, T, Maier, LS, Dalton, ND, Miyamoto, S, Ross, J, Jr., Bers, DM, Brown, JH 
(2003b) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and 
induces dilated cardiomyopathy and heart failure. Circ Res 92, 912-919.
Zou, P, Yoshihara, H, Hosokawa, K, Tai, I, Shinmyozu, K, Tsukahara, F, Maru, Y, 
Nakayama, K, Nakayama, KI, Suda, T (2011) p57(Kip2) and p27(Kipl) Cooperate 
to Maintain Hematopoietic Stem Cell Quiescence through Interactions with Hsc70. 
Cell stem cell 9, 247-261.
123
APPENDIX
Primers Sequence
Flamingo (Celsr2) Fwd TGTACAGCAGTAGCCCGTTACG
Flamingo (Celsr2) Rev CGCCAGCGCTTCCACTT
Frizzled 1 Fwd CAAGGTTTACGGGCTCATGT
Frizzled 1 Rev GTAACAGCCGGACAGGAAAA
Frizzled2 Fwd GAGGTGCATCAGTTCTACCC
Frizzled2 Rev ATGGCCTGCTCCAGCACT
Frizzled3 Fwd GCAGATAGGTGGGCACAGTT
Frizzled3 Rev AAAGAAATGGCCGAAAATCC
Frizzled4 Fwd CACGCCGCTCATCCAGTA
Frizzled4 Rev GCCGATGGGGATGTTGAT
Frizzled5 Fwd CAACCATGACAGGCAGGAC
Frizzled5 Rev GGGCGTGTACATAGAGCACA
Frizzled6 Fwd TTCCCTAACCTGATGGGTCA
Frizzled6 Rev ACATTTCAATGTTTGGTGAACA
Frizzled7 Fwd ATATCGCCTACAACCAGACCATCC
Frizzled7 Rev AAGGAACGGCACGGAGGAATG
Frizzled8 Fwd ATGGAGTGGGGTTACCTGTTG
Frizzled8 Rev CACCGTGATCTCTTGGCAC
Frizzled9 Fwd GTCCGCGTTGTGTTTCTTCT
Frizzled9 Rev CAGACCCTCCTGGATCACAT
Frizzled 10 Fwd GTACCCCGAACGTCCTATCA
Frizzled 10 Rev GTGCTCTCCAGTCCTTCCTG
Cox2 Fwd CC ACC ACTACTGCC ACCTC
Cox2 Rev TGGTCAAATCCTGTGCTCAT
IL2 Fwd AACCTGAAACTCCCCAGGAT
IL2 Rev CGCAGAGGTCCAAGTTCATC
CD34 Fwd ACAGGAGAATGCAGGTCCAC
CD34 Rev TGGTAGGAACTGATGGGGATA
Ifny Fwd GCTTTGCAGCTCTTCCTCAT
Ifny Rev TTTTGCCAGTTCCTCCAGAT
p57 Fwd ACAGGACAAGCGATCCAGAC
p57 Rev GCGCTAT C ACT GGG AAGGT
Pten Fwd AGATCGTTAGCAGAAACAAAAGG
Pten Rev TCTGCAGGAAATCCCATAGC
Txnip Fwd GCAGTGCAAACAGACTTTGG
Txnip Rev AGCTCGAAGCCGAACTTGTA
Tnfa Fwd CCACCACGCTCTTCTGTCTA
Tnfa Rev AGGGTCTGGGCCATAGAACT
N-cadherin Fwd AGCGCAGTCTTACCGAAGG
N-cadherin Rev TCGCTGCTTTCATACTGAACTTT
Osterix Fwd ATGGCGTCCTCTCTGCTTG
Osterix Rev TGAAAGGTCAGCGTATGGCTT
Runx2 Fwd CGGCCCTCCCTGAACTCT
Runx2 Rev TGCCTGCCTGGGATCTGTA
124
Rpll9 Fwd ATGAGTATGCTCAGGCTACAGA
Rpll9 Rev GCATTGGCGATTTCATTGGTC
Gapdh Fwd TGGCAAAGTGGAGATTGTTGCC
Gapdh Rev AAGATGGTGATGGGCTTCCCG
TaqMan assays Serial number (Applied Biosystems)
Wntl Mm-01300555 gl
Wnt2 Mm-00470018 ml
Wnt2b Mm-00437330 ml
Wnt3 Mm-00437336 ml
Wnt3a Mm-00437337 ml
Wnt4 Mm-01194003 ml
Wnt5a Mm-00437347 ml
Wnt5b Mm-01183986 ml
Wnt6 Mm-00437353 ml
Wnt7a Mm-00437354 ml
Wnt7b Mm-01301717 ml
Wnt8a Mm-00436822 ml
Wnt8b Mm-00442107 ml
Wnt9a Mm-00460518 ml
Wnt9b Mm-00457102 ml
WntlOa Mm-00437325 ml
Wntl Ob Mm-00442104 ml
W ntll Mm-00437328 ml
Wntl 6 Mm-00446420 ml
Dkkl Mm-00438422 ml
Dkk3 Mm-00443800 ml
Sfrp4 Mm-00840104 ml
Wifi Mm-00442355 ml
Axin2 Mm-00443610 ml
N-cadherin Mm-00483213 ml
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